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SUMMARY
The use of gas chromatography for the analytical 
resolution of optical enantiomers provides a means of 
assigning configurations, on a correlative basis, to small, 
and often impure, samples of biological origin. This 
problem has previously been approached in ;two ways, viz : 
direct resolution of optical enantiomers on chiral 
stationary phases, or the employment of chiral reagents 
to form diastereomeric derivatives which have been separated 
on conventional columns. In the present work, the latter 
approach was employed.
It was considered that conferment of sufficiently 
distinctive chromatographic properties would depend on the 
enhancement of conformational differences between 
diastereomers. Accordingly, it seemed likely that reagents 
in which the chirality and the functional group were embodied 
in a rigid molecular skeleton would be useful as chromatographic 
resolving agents. On the basis of this hypothesis, a study 
of the suitability of terpenoid acids for the resolution 
of enantiomeric alcohols and amines was initiated. The 
two acids examined were the sesquiterpenoid drimanoic acid 
and the monoterpenoid chrysanthemic acid. Many good 
separations were in fact observed for a wide range of 
enantiomeric alcohols, amines and amino acid methyl esters.
The results achieved with these derivatives on columns packed 
with a non-selective stationary phase (SE-30) are com­
parable with, or in many cases superior to, those reported
- 2 -
with other chiral reagents on capillary columns.
An observation that the a-phenylbutyryl derivatives 
of (R)-a-phenylethylamine were well separated on 
conventional packed columns prompted an investigation into 
the use of a-substituted phenylacetic acids as gas 
chromatographic resolving agents for amines and amino acid 
methyl esters. Within the series studied, a resolution 
was achieved for every enantiomeric pair as their amides 
derived from at least one, and in many cases all of the chiral 
phenylacetic acids.
The mechanisms involved in the resolution are still 
open to speculation, but examination of the separations 
obtained within a series of related diastereomeric amides 
indicated some trends. In general, the degree of 
resolution achieved increased with the size of the substituent 
on the chiral acid centre (i.e. R = Me <. Et < iPr). 
Introduction of a more polar substituent (as in a-methoxy- 
phenylacetic acid) produced resolutions comparable to those 
obtained with the isopropylphenylacetic acid but some 
effects which could be attributed to the increased polarity 
of the substituent were noted. The derivatives of a- 
chlorophenylacetic acid showed satisfactory resolutions, 
but this reagent was judged unsuitable because of 
racemisation during acylation.
All the derivatives were easily prepared, in good 
yield, without racemisation (except for the a-chlorophenyl- 
acetamides). The diastereomers were thermally and 
chromatographically stable, as shown by analysis using
- 3 -
combined gas chromatography-mass spectrometry (GC-MS).
The considerable degree of regularity observed in the 
elution order of these derivatives rendered the 
correlative assignment of configuration a feasible 
proposition.
The techniques developed during the examination of 
enantiomer resolution were subsequently applied to a study 
of the in vivo metabolism of the oral anti-rheumatic drug 
(RS)-2-(4-isobutylphenyl) propionic acid (”ibuprofen”) in 
humans. Pour metabolites, resulting from oxidation of the 
isobutyl side chain, were identified by GLC and GC-MS.
Gas chromatographic resolution of diastereomeric 
amides formed with (R)-(+)-a-phenylethylamine showed that 
the excreted drug was enriched in the (S)-(+)-enantiomer. 
Similarly, two of the hydroxylated metabolites were shown 
to be enriched in the (S)-form. Synthesis of one of the 
minor hydroxylated metabolites, 2,4’-(1-hydroxy-2-methylpropyl) 
phenylpropionic acid, allowed complete characterisation of the 
metabolite. Separation of the enantiomeric alcohols as 
esters of (R)-(-)-a-phenylbutyric acid indicated some 
stereoselectivity in the metabolic hydroxylation.
A brief examination of the metabolism of the aldosterone 
antagonist, spironolactone was also undertaken. Several 
drug-related components were excreted as conjugates in the 
urine of patients receiving treatment. Structures were 
proposed for nine of these on the basis of the data obtained 
on examination by TLC, GLC, and GC-MS. Some of the 
metabolites contained oxidised sulphur functions at C-7 which
- 4 -
proved thermally labile, rendering complete structural 
identification of small samples difficult. Isolation 
of more material under mild conditions should enable 
confirmation of the structures which have been 
tentatively proposed.
Section 1. Introduction
- 5 -
1.1. Stereochemical aspects of metabolism
1.1.1. Introduction
Metabolic processes are controlled by the stereo­
chemical requirements of the enzyme systems which have
1 2evolved through processes of natural selection. 9 
Most foreign compounds are oxidised or reduced by the
"drug-metabolising" enzymes, associated with the smooth
3 6endoplasmic reticulum of liver cells, although small 
amounts of the enzymes are also located in those organelles
7
of the gastro-intestinal tract, kidneys, lung, and
O
placenta. The most common foreign compound biotrans­
formations are probably oxidations catalysed by "mixed
q ti 10function oxidases" or mono-oxygenases" , which require a
reducing agent (NADPH), atmospheric oxygen and cytochrome 
11P-450. (A phrase which encompasses several enzyme
systems.) These enzymic reactions include aromatic
hydroxylation, oxidation of aliphatics, and alkyl side-
chains, deamination, N-oxidation, sulphoxide formation, N-
12dealkylation, and 0-dealkylation . Stereochemical aspects
of these metabolic processes can be divided into three 
1 'Stypes. When the two enantiomers of an asymmetric subs­
trate are metabolised at different rates, without the 
introduction of a subsequent asymmetric centre, the 
reaction shows substrate stereoselectivity; when an 
asymmetric centre is created in an achiral molecule, and the 
two stereoisomeric products are formed at different rates, 
product stereoselectivity is displayed and when an 
asymmetric substrate is transformed into diastereomeric
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products at different rates both substrate and product 
stereoselectivity are involved.
1.1.2. Substrate stereoselectivity 
Amphetamines (Pig. 1)
The metabolism of amphetamine (1) has been extensively
14-21 14 15 22-25studied in man and various animals ’ '9  ^both
in vivo and in vitro.
1 5The major route of metabolism in man is deamination,
14 15 20but a-C-oxidation, 9 9 and hydroxylation of the
aromatic ring also occur. Recovery of the unmetabolised 
amphetamine indicated excretion of an excess of the (R)-
(-)-enantiomer over the (S)-(+)-form when either the
16 17 18racemic drug, or individual enantiomers 9 were ingested.
1 9Gunne, by gas chromatographic analysis of the excreted
amphetamines as N-trifluoroacetyl-(S)-(-)-prolyl derivatives,
found that approximately equal amounts of each enantiomer
were excreted during the first twelve hours after
ingestion of racemic drug, but subsequent samples contained
decreasing amounts of (S)-(+)-amphetamine. These results
indicated some stereoselective metabolism of the (S)-(+)-
enantiomer. The stereoselectivity was shown to be in the
1 5deamination process, since the benzoic acid production 
from (-)-amphetamine was less than from either (+)- 
amphetamine or the racemic mixture, with little difference 
being observed in the other metabolism routes.
26Considerable species variation has been observed both
- 7 -
in mode of metabolism and in the stereoselectivity
encountered. The results obtained in several species
are summarised in Table 1.
The in vivo metabolism of N-methylamphetamine (2)
showed stereoselective demethylation of the (S)-(+)- 
1 9 27 PR 50enantiomer. '»^ 0»^ uThe N-alkyl chain length, however, 
affected the metabolism since the (+)-isomers of
methyl- and ethyl-amphetamine (3) were N-dealkylated
29more rapidly than their (-)-enantiomers but (-)-n-propyl-
amphetamine (4) was N-dealkylated more rapidly than the
31(+)-isomer. Also, the total metabolism of (+)-methyl-,
ethyl-, and n-propyl-amphetamine was greater than that of 
the corresponding (-)-isomers but there was no difference 
in the total metabolism of the (+)- and (-)-n-butyl- 
amphetamine (5). Similarly, under conditions of acidic 
urinary pH, (+)-dimethylamphetamine (6) was N-dealkylated
to (+)-methylamphetamine to a greater extent than the
32(-)-isomer. The (-)-enantiomer produced larger
quantities of the N-oxide than the (+)-dimethylamphetamine, 
but this was probably due to the faster removal of the 
(+)-isomer by dealkylation.
Studies on the in vitro demethylation of the four 
diastereomeric ephedrines (7) using male rabbit 78,000 x g 
hepatic preparations, showed that (1R, 2S)-(-)-ephedrine 
and (1S, 2S)-(+)-pseudo-('lj.)-ephedrine were N-demethylated 
at rates 15-31$ greater than their respective enantiomers.^^ 
These results suggest that the rate of demethylation depends 
on the configuration at the 2-position. (-)-Ephedrine was
Table 1 Species variation in stereoselectivity of
amphetamine metabolism
Species Stereoselectivity Route
(Rate of metabolism)
Rabbit (£)-(-)- > (§)- +)- Deamination
Guinea pig (s)-(+)- > (£)- Deamination
Rat (§)-(+)- * (£)- -)- -
Man (s)-(+)- > (£)- -) Deamination
Swine (§)-(+)- E (£)- -)-
Cattle (S)-(+)- = (£)-
.
Horse (£)-(+)- > (£)- -)- Unknown
Sheep (§)-(+)- > (£)- N J
Rhesus monkey (s)-(+)- = (£)- -)- 11.
Mouse (§)-(+)- s (£)- -) %
Ref.
15,23,24
14
14,15
1 4 , 1 5 , 1 6 , 1 7 , 1 8 , 1
25
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also found to be deaminated faster than the (+)-
34 / \enantiomer, and since (-)-ephedrine was deaminated to
a greater extent than (-)-nor-ephedrine (8), the
stereoselectivity was probably not due to different
rates of N-dealkylation.
Dopa and related compounds
The metabolism of (D)-dopa (3,4-dihydroxy-phenylalanine)
(9) by isolated perfused rat liver was slower than that of 
(L)-dopa in all respects except in the formation of the 
3-methyl ether.^ After administration of ^C-(D)-dopa 
radioactivity was detected in the bile due to the 
presence of dopamine (10) and 3^~i^^S|dopamine (11).
•7 C
Since (D)-dopa is not a substrate for dopa decarboxylase,
these results were explained by deamination of (D)-dopa by
(D)-amino acid oxidase to give 3,4-dihydroxyphenylpyruvic acid
which was then transaminated to (L)-dopa (Pig. 2). These reactions,
were, however, minor compared to the decarboxylation of (L)-dopa.
The metabolism of ct-methyldopa (12) also showed
37stereoselectivity for the (L)-form, the metabolites
being free and conjugated a-methyl dopa, free and
conjugated 3-0-methyl-a-methyldopa, a-methyldopamine,
3-0-methyl-a-methyldopamine and 3,4-dihydroxyphenylacetone.
14The metabolism of o-hydroxy-phenylalanine-2- C (13)
70
was studied in rats. Both (D) and (L) forms gave the
same metabolites, mainly o-hydroxyphenylacetic acid and 
o-tyramine, but injection of the (D)-isomer produced more 
unchanged material due to slower metabolism. In vitro
 UPh — ^Ph ^ — l^Ph
: H_-N NH H - N ^ N H  R - N ^ IH
II 11 M
o  o  o
(14) (15) (16) R=H
(17) R=Me
U H (18) R = Et
/ N \  i ^
0= C  C-=>C00H i_| w
NH2 Ph H -4— ^*Ph
(R)-(-)-(19) O ^N H C2° OH
(R )-(-)-(20)
■ , H  H  
H y__L.Ph
o = c  c o n h 2
(21) R=Me OH
(22) R=H (23)
H Me 
H~J— UPh
0 * ^ * 0
R
(25) R=H
(26) R = Me
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evidence was obtained for the deamination of the (D)-isomer 
and subsequent transamination to the (L)-form.
Ant i-convulsant s
Mesantoin ((±)-5-ethyl-3-niethyl-5-phenylhydantoin) (14) 
is N-demethylated to give Nirvanol (5-ethyl-5-phenylhydantoin) 
(15). In dogs and humans the excretion of (-)-Nirvanol 
in the urine is greater than that of the (+)-isomer, 
whether (-)-Mesantoin or (-)-Nirvanol is administered.-^
This suggests initial complete demethylation of Mesantoin 
followed by stereoselective metabolism of Nirvanol.
In dogs, administration of the (RS)-forms of 5- 
phenylhydantoin (16), its 3-methyl derivative (17), or its 
3-ethyl derivative, ethotoin (18), resulted in the excretion 
of (RS)-5-phenylhydantoin in the urine.^ (&)-(-)-
Phenylhydantoic acid (19) was the major metabolite of all 
three drugs. The yields of (R)-(-)-(19), and the 
racemic nature of the initial urinary metabolite (16) 
indicated that the residual (S)-form of (16) underwent 
epimerisation in the body.
2-Phenylsuccinamic acid (20), isolated from the urine 
of dogs treated either with (RS)-N-methy1-2-phenylsuccinimide 
(21) or (RS)-a-phenylsuccinimde (22) was the optically pure 
(-)-form shown to have the (R)-configuration.^ The 
absence of 3-phenylsuccinamic acid (23) was demonstrated 
indicating the high ^ e&ih^specificity of the enzyme system. 
Administration of (RS)-(20) showed that the stereoselectivity 
was not due to removal of the (S)-form and metabolic studies
- 10 -
on (S)-(22) showed that no ring opening of the (S)-form
occurred. Once again epimerisation of the (S)-enantiomer
to the (R)-enantiomer which then undergoes ring opening,
was proposed,
5,5-disubstituted hydantoins undergo little ring
cleavage.42>43 (RS)-2-methyl-2-phenylsuccinimide (24)
44undergoes significant demethylation and ring cleavage
but the stereochemistry of the products has not been
determined. Ring cleavage of 2-phenyl-2-ethylglutarimide 
/ \ 45(25) did not occur in dogs. but the metabolism was
stereospecific. The (-)-isomer underwent hydroxylation
of the 2-ethyl group while the (+)-isomer was hydroxylated
in the glutarimide ring. N-methylglutethimide (26)
showed partially stereospecific metabolism after 
46demethylation, and both isomers were excreted as 
glucuronides of hydroxymethylglutethimide.
Barbiturates
The enantiomers of hexobarbital (27) showed sex
differences in rats both in anaesthetic activity and
47-49 , xmetabolic elimination.  ^ The increased potency of (+)-
hexobarbital appeared to be related to the decreased ability
RDof the (-)-isomer to cross the blood-brain barrier. The
sex difference could partially be ascribed to the
poorer abilityof female rats to transform the (+)-
i s o m e r . j y [ aie rats metabolised the (+)-form faster than
the (-)-isomer. The isomers were also affected
differently by enzyme-inducing agents, and both in vivo^
5land in vitro studies showed that phenobarbital (29)
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Ch
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increased the total amount of (+)-hexobarbital oxidase, 
while the content of (-)-hexobarfeital oxidase was 
unchanged although the substrate affinity was increased.
The effect of varying the substituents at C-5 on the 
anaesthetic activity and metabolism has also been 
examined*^*^  (Table 2).
Analgesics
The in vitro metabolism of methadone (31) and its
isomer (32) by rat liver microsomes showed that (S)-(+)-
(31) and (R)-(+)-(32) were metabolised to a greater extent
than their (-)-enantiomers. Using guinea pig microsomes,
however, (S)-(+)-(31) and (S)-(-)-(32) were metabolised 
54faster. Also, using the guinea pig preparation more 
N-oxide was formed from (S)-(-)-(32) than from the (+)-
isomer. N-oxidation of (31), was minor. In vivo studies
3 55 56in rats using methadone-1 - H-confirmed the stereoselectivity. *
The metabolism of (+)- and (-)-a-prodine (33,34) and
(+)- and (-)-j3-prodine (35,36 respectively) has been
CT*7
studied in mice. In vitro the (+)-isomers were 
demethylated at a slower rate than the (-)-isomers. In vivo 
only the |3-prodine isomers showed any significant 
difference in rates of decline of blood and brain levels.
No relationship between metabolism and analgesic activity 
could be proposed.
Warfarin
14After administration of warfarin-4- C (37) to female
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rats the less active (R)-(+)-isomer was more rapidly 
58excreted. The same results were obtained with
phenoprocoumon (38). Both warfarin-resistant and
non-resistant rats excreted the (R)-(+)-form faster than
the (S)-(-)-form.^ The potency of the (S)-(-)-form can
fio fi 1be explained partly by its longer plasma half-life 9 
and partly by a difference in inhibition of prothrombin
62complex synthesis. The metabolism of warfarin in rats
and man has been elucidated with the aid of synthetic
compounds, mass spectra, and fragmentation patterns (Pig. 3).
The stereochemical aspects of the metabolism in man have
64.also been examined and stereoselectivity observed.
(R)-(+)-warfarin was ^ ^1$ )selectively oxidised to 6-
hydroxy warfarin (39) and reduced to the (R,S)-diastereomeric
alcohol (43). In contrast (S)-(-) warfarin gave 7-
hydroxy warfarin (40) as a major metabolite and some
6-hydroxy warfarin (39). Reduction gave the (S,S)-alcohol
(43). Warfarin, therefore, shows both substrate and
product stereoselectivity. Detection of a new metabolite
of warfarin, produced by hydroxylation in the benzylic
position, was achieved using an ion doublet chemical
65ionisation mass spectrometry technique. Larger amounts 
of the metabolite were obtained from (R)-warfarin than 
from (S)-warfarin during in vitro experiments with rat 
liver microsomal preparations.
- 13 -
1.1.3. Product stereoselectivity 
a) Hydroxylation
66Initial studies suggested that ethylbenzene was 
hydroxylated in the rabbit without any stereoselectivity, 
but a reinvestigation subsequently showed that the (R)-
67
(+)-isomer always predominated. The methylphenyl- 
carbinol produced showed substrate stereoselectivity in 
rats, since the (R)-(+)-isomer was excreted as a
glucuronide, while the (S)-(-)-form was further
6Rmetabolised to (S)-(-)-mandelic acid. The oxidation
1 8mechanism was studied using Og and DgO media and was
68shown to involve molecular oxygen. The oxidation of 
2
(S)-(+)-a-[ ]-ethylbenzene showed that microsomal 
hydroxylation proceeded with retention of configuration
fio
i.e. by an '’insertion” mechanism. The use of microsomal 
inducing agents reduced the stereoselectivity of 
metabolism. ^ 9^
Indane (45) was hydroxylated by rat-liver microsomes 
to (S)-(+)-indanol (10%).^ The stereoselectivity of 
hydroxylation would be even higher than it appeared since 
the (S)-(+)-indanol was selectively oxidised to indanone.
The formation of indanone was catalysed by an NADP - 
dependent dehydrogenase which was subsequently isolated.^
Similar systems have been found which dehydrogenate trans-
71 72acenaphthene-1,2-diol and methylphenylcarbinol.
The in vivo metabolism of cyclohexylamine (46) in man
and animals was examined using G-LC to determine the trans/cis
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ratio of the products'^ (Table 3). If it is assumed 
that the cyclohexylamine is in the preferred conformation, 
with the amino-group equatorial, during hydroxylation
73then "the addition of the hydroxyl group is mainly axial", 
(Pig. 4).
Hydroxylation of butamoxane (47) both in vivo and
in vitro by rat liver yielded 6-hydroxy (47) and 7-
/ v 74hydroxy-(47) in a ratio of 2:1. In addition the
microsomal oxidation of (47) yielded the catechol, 6,7-
dihydroxy- (47). This same catechol was produced by
hydroxylation of either 6-hydroxy-(47) or 7-hydroxy-(47).
1 8The use of 02supported the concept that 6,7-
dihydroxy (47) was formed by two consecutive hydroxylations,
74rather than via a dihydrodiol or an endoperoxide.
b) The hydration of epoxides
75Since the first suggestion that epoxides might be
intermediates in the metabolism of aromatic hydrocarbons
there have been indications that arene oxides are
concerned in the biological effects produced by these 
76compounds. The oxidative metabolism of naphthalene in
rabbit and rat liver slices and kidney homogenates
yielded three main products : 1-naphthol, S-(1,2-dihydr0-2-
hydroxy- 1 -naphthyl) glutathione , and 1,2-dihydro-1,2-dihydroxy- 
77naphthalene. Indene was similarly converted to the
7ftdihydro-trans-diol derivative. These results supported 
the suggestion of arene oxides as metabolic intermediates.
The system catalysing the hydrolysis of epoxides to trans-
CH2 NHBu
(45) (47)
:o Cl — C H-C H-C H
(48) (49)
c h^-c h -(ch2^ - c h 3
O
(51) (52)
(50)
O
^ r C H 2 C - C H 3
(54) R = CH3 (57)
(55) R = CH2CH3
(56) R=CH2CH2CH3
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diols is commonly known as epoxide hydrase. The 
purification of styrene epoxide hydrase from guinea pig
70
microsomes has been reported. The enzyme, which requires
no co-factors, catalyses the hydration of a variety of
epoxides, including cyclohexene oxide (48)> £-chlorophenyl-
2, 3-epoxypropyl ether (49)>naphthalene-1 ,2-oxide (50),
octene-1,2-oxide (51), indene-1,2-oxide (52), and
80phenanthrene-9,10-oxide (53).
c) Ketone reduction
Acetophenone (54) was stereoselectively reduced in the
ftfi R1rabbit to (S)-(-)-methylphenylcarbinol. 9 Examination
of higher homologues showed that ethylphenyl (55) and
phenyl n-propyl ketones (56) were selectively reduced to
the corresponding (-)-carbinols and benzylmethyl ketone
82(57) to the (+)-carbinol. These carbinols all had the 
(S)-configuration.
One of the most important and well-studied enzymatic 
reactions is the oxidation-reduction reaction catalysed 
by nicotinamide-nucleotide-linked dehydrogenases. The
R^—RRsubject has been extensively reviewed.
The coenzyme nicotinamide adenine dinucleotide (NAD+) 
(58, R = adenosinediphosphoribosyl) in conjunction 
with the enzyme alcohol dehydrogenase (ADH) oxidises 
ethanol to acetaldehyde with the formation of the reduced 
coenzyme NAD-H (59) (Dig. 5). The reduction of 
acetaldehyde is the reverse of this reaction.
o ’z or 07
It has been shown 9 9 that the hydrogen transfer
is direct, reversible, and stereospecific. ADH catalyses
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the reversible addition of hydrogen to only one side
of the plane of the nicotinamide ring of NAD+. The
pro-(R) hydrogen of ethanol is always transferred in
the presence of the enzyme and becomes the pro-(R)
hydrogen at C-4 of reduced NAD (Pig. 5). Isotopic
substitution does not alter the stereospecificity, i.e.
2
reduction of acetaldehyde-1- H with NAD-H in the
2presence of ADH produces ethanol-1- H which, upon
2
enzymatic reoxidation yields only acetaldehyde-1- H with
86no loss of deuterium.
In order to furnish proof of the stereospecificity
of carbonyl group reduction by actively fermenting yeast,
Mosher and co-workers^ investigated the yeast reduction
of a series of ketones which included all combinations
of the substituents methyl, ethyl, n-propyl, n-butyl, and
phenyl. Eight of the nine secondary alcohols produced
possessed the (S)-configuration (the configuration of the
ninth compound, (-)-3-heptanol, is in doubt).
These results, together with the observations that
2the reduction of acetaldehyde-1- H by purified yeast ADH-
NADH^,^ ° and trimethylacetaldehyde-1-^H by actively
91 / \fermenting yeast give alcohols of the (S)-configuration agree
with the assumption that the same enzyme system is
responsible for the in vitro and the in vivo reductions.
92Prelog has studied the rates and products of 
reduction of a large number of alicyclic ketones using horse 
liver alcohol dehydrogenase and an extensively purified 
oxido-reductase from Gurvularia falcata. He found that
the product stereospecificity of the reduction could 
he represented by the very simple scheme :
Where 1 is a large group and S a smaller one.
1.1.4. Substrate produced stereoselectivity
a) Hydroxylation reactions
Dopamine |3-hydroxylase catalyses the hydroxylation
of dopamine (10) to noradrenaline, the (1R) isomer being
93preferentially formed. a-Methyl-dopa (12) is
metabolised in vivo to (1R, 2S)-(-)-a-methylnoradrenaline 
via the intermediate (2S)-(+)-a-methyldopamine.^
(+)“> (“)”> or (-)-a-methyldopamine administration to 
mice showed conversion of the (2S)-(+)-isomer to 
(1R, 2S)-a-methyl-noradrenaline, with hardly any 
(1S, 2S)-isomer being produced. (2R)-(-)-a-methyl- 
dopamine underwent only negligible p-hydroxylation.^,^  ^
trans-1-Methyl-3(R)-hydroxy-5(S)-(3-pyridyl)-2- 
pyrrolidinone [(3R, 5S)-hydroxy cotinine)] (60) was
On
(60)
(62)
(61)
OH 
H
HOOC V  
H
(63)
HO
OH
(66) (67)
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96identified by M R  and MS in the urine of monkeys^
treated with (S)-(-)— cotinine (61), a metabolite of
nicotine. No cis-product was detected in the NMR.
(S)-(-)-proline (62) was also stereoselectively metabolised
to (2S, 4R)-hydroxyproline (63).^
The use of cis-4-H-(S)-proline and trans-4-H-
(S)-proline showed that the mechanism involved front side
97displacement with complete retention of configuration.
The similarity between the proline and cotinine metabolism
suggests an identical mechanism.
Hydroxylation of steroids proceeds stereoselectively.
Double-labelling experiments with cholesterol (64) showed
that the hydroxylation mechanism occurred by front-side 
98displacement. Some examples of stereoselective steroid
hydroxylations are the preferential formation of the
6-a-hydroxylated metabolite of 17-P-estradiol (65) by
99rat liver microsomes and the hydroxylation of 
testosterone (66) and A^-androstene-3,1 7-dione (67)»  ^
to mainly 6-P- and 7-a-products.
Substrate stereoselectivity was also observed in the 
hydroxylation of (-)-pentazocine^ (68) (Pig. 6). Both 
isomeric hydroxylated products were observed using rat or 
mouse hepatic preparations but the stereoselectivity was 
variable. Using mouse microsomes, the trans-isomer (69) 
predominated over the cis-form (70), while the rat 
preparation produced an excess of the cis-over the trans.
In vitro and in vivo experiments performed with the rhesus
rz
monkey using H-pentazocine (68) showed the presence of
o  c h 3 o  c h 3 o h
H |s /v X H -C H 2 -C H 2 -C H 3 h is i^ .C H - C H ^ - C H - G ^  
I 'cH-vCH-. I fCH2-CH3
C T ^ N ^  2 3 o ^ O
H (72) (73)
v\ / / V “ 9 H” r< Et G^c-CH-Nn-EtJ-l fU Et V  /  II ruO (- n 3 O Ch 3
(74) (75)
Q k c - c h - n h 2 
o  c h 3
(76)
(77)
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the acid (71), obtained by further oxidation of the 
trans-isomer. In this case the amount of the trans­
forms (69) and (71) exceeded that of the cis-isomer (70).
Pentobarbital (72) is hydroxylated in the (co-1 ) 
position to 5-ethyl-5-(3'-hydroxy-1'-methylbutyl)barbituric 
acid (73).
1 02 1 0*5In dogs, two diastereomers of (73) were produced. y
Administration of (R)-(+)-pentobarbital gave (1'R, 3'R) 
and (1'R, 3'S) (73) in a 1:1 ratio, while (S)-(-)-pentobarbital 
was metabolised into (1'S, 3'S) and (1'S, 3'R) (73) in a 
1:5 ratio. These results showed that there was no 
substrate stereoselectivity but that product stereo­
selectivity varied with the substrate. (R)-(+)- 
pentobarbital showed no product stereoselectivity but 
the metabolism of (S)-(-)-pentobarbital showed a high 
degree of stereoselectivity.
b) Ketone reduction
The metabolism of N-diethyl-amino-propiophenone (74) 
has been extensively studied.^4,105 maj0r mo&e
of metabolism was K-de-ethylation^^ but the stereo­
chemistry of the ^-hydroxylated metabolites has been 
1 OSexamined J from the point of view of substrate and
product stereoselectivity. The major hydroxylated
metabolites of racemic N-ethylaminopropiophenone (75)
and aminopropiophenone (76) have also been stereochemically 
1 O fexamined. The results are summarised in Table 4.
The tertiary and secondary amines showed substrate stereo-
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selectivity since 80% of the reduced ketone was the 
(2S)-enantiomer. The major products had the (1S, 2S) 
configuration and the small proportion of (2R)-amino ketone 
which was reduced preferentially gave the (1R, 2R)-amino 
alcohol. Product stereoselectivity was, therefore, also 
important. The primary amino-ketone, however, showed 
only slight substrate stereoselectivity (63% (2R) reduced) 
but very high product stereoselectivity since the products 
had almost exclusively the (1R) configuration.
c) N-oxidation
Nicotine (77) is metabolised to nicotine-1* N-oxide
and cotinine by 10,000 x jg hepatic preparations from rats,
mice, rabbits, guinea pigs and hamsters. Little
evidence was obtained for the stereoselective disappearance
of nicotine but some evidence was obtained for stereo-
107 108selectivity of total metabolite formation. ’ There
are four possible diastereomeric N-oxides.^^ (S)-(-)-
nicotine was transformed by rats, mice, hamsters and guinea
pig into more (R.S)-cis than (SS)-trans-N-oxide.
However, (R)-(+)-nicotine produced more (S,R)-trans than
(R.R)-cis. Using rabbit microsomes more cis
diastereomer was produced from both enantiomers.
110 111Similar results obtained previously * had been
explained on the basis of two distinct receptors for N-
111 108 oxidation. Jenner £t al, however, proposed a single
receptor site which could account for the formation of
both diastereomers in terms of orientation of the
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protonated enantiomers (Fig. 7).
Significant stereoselective redaction of the N-
111oxide occurs under anaerobic but not aerobic conditions.
Guinea pig hepatic microsomes reduced the (R.S)-cis-
N-oxide six times faster than the (SS)-trans-diastereomer.
An excess of (S,S)-trans-N-oxide was isolated from 
110smokers' urine, contrary to the in vitro findings, but 
this could be the result of overall stereoselective 
oxidation and reduction.
- 22 -
1.2. The gas chromatographic resolution of enantiomers
1.2.1. Introduction
The analytical resolution of optical enantiomers is
of considerable importance in the examination of
biological or biochemical systems such as are involved
in the study of drug metabolism or various enzymic
reactions. Since such systems often involve working
with small and frequently impure samples a chromatographic
method of resolution is desirable.
There have been many investigations of the
chromatographic resolution of racemates on optically active 
112adsorbents. Some success has been achieved with D-
n . 113 4. v, 114,115 . i , 116lactose, starch, 9 cross-linked chitosan ,
or synthetic polymers containing asymmetric centres,^ 7-119
as adsorbent. Multi-functional amino acids have been
120 121resolved by paper chromatography ’ through interaction 
with the asymmetric centres of cellulose, and ligand- 
exchange chromatography of racemic a-amino acids on 
asymmetric resins containing optically active bi- or
tridentate a-amino acids as fixed ligands co-ordinated with
or oth<
122-125
2+ 2+Cu , Ni er transition metal ions has been
effective.
Recently, complete optical resolution of a-amino acids 
has been described by differential complexation in
solution between a chiral cyclic polyether and the amino
Lave bee] 
127-130
1 26acid. Diastereomeric di- and tri-peptides ha n
separated on paper and thin layer chromatography
- 23 -
1 31and Jephadex gel chromatography. J A modified gel
1 32containing L-arginine residues was reported to
resolve (RS)-3,4-dihydroxyphenylalanine.
Partial separation of some asymmetric aromatic
1 33compounds has been reported on a column of silicic
acid impregnated with optically active (2,4,5,7-tetranitro-
9-fluoroenylideneaminooxy)propionic acid. Mandelic acid
can be resolved partially on either polyacrylic esters or
1 34amides of optically active ephedrine derivatives or by
135liquid liquid partition chromatography on Sephadex gels.
The most successful area of chromatographic resolution
has, however, been in the field of gas liquid chromatography 
136(G-LC). G-as chromatographic resolution of enantiomers
may be effected by one of two methods : a) preparation
of diastereomers by reaction of the enantiomers with a 
suitable asymmetric reagent and chromatography on an 
inactive phase and b) direct resolution of the enantiomers 
on an optically active stationary phase. Both approaches 
have been applied successfully as outlined below.
1.2.2. Gas chromatographic resolution of enantiomers 
by formation of diastereomeric derivatives
The separation of diastereomers by gas chromatography
can be described in thermodynamic terms using the relative
volatility, a, obtained from the retention times of the
1 37two components under isothermal conditions.
- 24 -
Where tj^  and are the retention times for the
first and second components respectively, t is the inerta
gas retention time, and K  ^ and are the respective gas- 
liquid partition coefficients.
The isothermal determination of a allows the computation 
of the standard free energy differences between the 
diastereomeric pairs with respect to their gas-liquid 
partition equilibria. Thus :
A G° = -RTlnK
and AG°2 -AG°1 = A (AG°) = -RTlnct
7
Where R is the gas constant = 8.31432 x 10 erg
1 1  o(g mole)- deg- and T the temperature in Kelvin.
a) Alcohols
The resolution of alcohols by formation of
diastereomeric esters has received considerable attention
1 38since work started in this field in the early 1960’s.
The preferred reagent for derivatising 2-n-alcohols has
139 140been a-acetoxypropionic acid. * A series of 2-n-
1 39alcohols containing 4-19 C atoms were well separated as 
their a-alkanoyloxypropionates on capillary columns coated 
with both non-polar (squalane) and polar (polypropylene- 
glycol and PS-1265) stationary phases. The polar phases 
produced better resolutions and polypropyleneglycol gave
- 25 -
the best results for alkanols containing 4-10 carbon 
atoms while the higher alcohols were better resolved 
on PS-1265. Separation factors (a-values) of 1.03-1.04 
were reported for the lower homologues and they increased 
with increasing chain length to a maximum of 1.10. A 
plot of the relative retention volume versus the number of 
carbon atoms in the alkanol, within the series studied, 
resulted in pairs of almost linear and parallel curves.
In all cases the lower curve corresponded to the (RS) 
or (SR) diastereomer. Series of straight- and branched- 
chain alkan-2-ols (4-8 C atoms) were examined^^ both as the 
a-acetoxypropionates and a-hydroxypropionates on packed 
columns (1,2,3-tris-(2-cyanoethoxy)-propane orDC710 
silicone oil). In general the straight-chain methylcarbinyl 
a-acetoxy esters yielded better separations than the 
corresponding a-hydroxy esters. The branched-chain 
methylcarbinyl a-hydroxy esters were separable on both 
columns but the A (AG-0) values for the diastereomers were 
greater on the non-polar column, contrary to the results 
obtained with the a-acetoxy esters. The authors also 
examined the derivatives of four alkan-3-ols and found them 
to be less well resolved than the analogous esters at the
2-position.
141Westley et al. resolved a series of straight- and 
branched-chain alcohols as their N-trifluoroacetyl(TFA)- 
(S)-phenylalanine esters on a polyester phase. They also 
observed the best resolutions when the alcohol was in 
the 2-position and an increase in branching of the chain,
- 26 -
particularly close to the asymmetric centre, improved
the value of A (AG-0).
Good resolutions were obtained on capillary columns
for both straight and branched chain alcohols
containing 4-8 carbon atoms as their (R)-(+)-1-phenyl- 
142ethylurethanes, derivatives originally applied to the
143resolution of alkan-2-ols by thin layer chromatography.
In the majority of cases studied by gas chromatography the
alcohol was in the 2-position but four examples of alkan-
3-ols are given. This reagent has also been found 
144suitable for the resolution of long chain hydroxy fatty 
acid methyl esters where the alcohol function is in the 
Cj-2 position in the chain. When the alcohol function was
145in the 3-,CO-4-, andco-3-positions, better derivatives were
the 2(S)-phenylpropionates. Preparation of esters by
146reaction with menthylchloroformate also produced
derivatives suitable for the optical analysis of a-hydroxy
fatty acid methyl esters. These derivatives have proved
useful in biochemical situations in allowing the
determination of the configuration of the 2-hydroxy acids 
 ^ 147from brain cerebrosides, of the 2-hydroxy-palmitic acid
148produced in the peanut oxidation system, and of the
hydroperoxides produced by lipoxygenase oxygenation of 
149linoleic acid.  ^ The use of this reagent, however, for the
optical analysis of hydroxy fatty acid methyl esters where
the hydroxyl group was further removed from the carboxyl
1 50end of the chain proved unsuccessful.
1 46Resolution factors of the order of 1.1 were obtained
- 27 -
for the (R)-(-)-menthylcarbonates of a series of
phenylalky}.carbinols. Since these derivatives were
formed in weakly basic medium at room temperature
they were suitable for heat- and acid-labile compounds.
1 51Comparable resolution factors have been reported
5
for these carbinols as the derivatives of 30-acetoxy-A -
etienic acid.
Pew examples of alicyclic alcohol resolutions have
been reported. Three asymmetric cyclohexanol
141derivatives were separated as their N-trifluoroacetyl-
(S)-phenylalanine esters, and the resolution of the (R)-
142(+)-1 -phenylethylurethane of menthol has been reported.
The resolution factors obtained when the asymmetric centre 
is within a rigid ring system are, as expected, fairly large 
(1.10-1.17 cf. ref. 141).
b) Amines
On the basis of preliminary experiments using
amphetamine with several chiral acylating reagents
1 52Halpern and Westley chose 5 N-trifluoroacetyl-(S)-
1 55(-)-prolyl chloride as the resolving agent for amines.
This has been the preferred reagent since that time.
Halpern and Westley have successfully resolved aliphatic,
152 154 154.155arylaliphatic, 9 and heterocyclic amines * as
amides of this reagent. The observed elution order of the
1 54-aliphatic or arylaliphatic amides was always (RS) < (SS), 
but a reversal of this order was noted for the heterocyclic 
amides whose absolute configuration was known. During a
- 28 -
study of the N-trifluoroacetyl-(S)-prolyl derivatives
of various ring and N-alkyl substituted amphetamines,
1 56seventeen enantiomeric pairs were examined. In all
cases the derivatives of the (2R) enantiomers had shorter
retention times than the derivatives of the (2S)
enantiomers. The introduction of a 1-OH group to give
ephedrines and ^ -ephedrines did not alter the control of
the relative retention times by the geometry of the carbon-2.
Steric analysis of a series of homologous amines possessing
two asymmetric centres (i.e. 2-amino-3-methylpentane—  2 -
amino-4-methylhexane) as their N-TFA-(S)-prolyl
1 57derivatives showed four peaks on G-LC. The order of
emergence of the peaks, with respect to the asymmetric
carbon atom carrying the amino function, was in agreement
with the elution pattern observed for diastereomeric
amides derived from aliphatic amines containing only one
asymmetric centre, i.e. (SR) (SS).
The N-TFA-(S)-prolylamides of ring-substituted 1-
1 58phenyl or naphthylalkylamines were better resolved 
on a relatively polar column (DEGS) than on a non-polar 
column (SE-30). On the contrary, for a series of ring- 
substituted 1,2-diphenylethylamines, the diastereomeric 
amides were better resolved on the non-polar column.
The N-TFA-(S)-prolylamides of amphetamine were 
sufficiently resolved to allow quantitative enantiomeric 
determinations. Metabolism studies conducted after 
ingestion of (RS)-amphetamine showed that the amount of 
(+)-amphetamine excreted in the urine was less than that
- 29 -
/ \ 19of the (-)-enantiomer. J
An excess of (+)-amphetamine, however, was found in
the urine of subjects receiving doses of methamphetamine.
The same derivatives were used to show that no in vivo
racemisation occurred when either (+)- or (-)-amphetamine was 
1 59ingested. The use of N-TEA-(S)-prolyl derivatives
has been recommended as the standard method for the
quantitative determination of the ratio of (+)- and
1 60(-)-amphetamine in commercial preparations.
Nanogram quantities of amphetamine and related substituted
arylalkylamines can be analysed by using electron capture
detection of the derivatives formed with N-pentafluoro-
161benzoyl-(S)-proly1-1-imidazolide or a-methyl-a-methoxy-
1 62pentafluorophenylacetyl-imidazolide. The latter reagent
can also be used for the correlation of the absolute 
configuration of certain substituted p-arylethylamines by 
NMR.
c) Aliphatic and alic.yclic acids
As already discussed, enantiomeric alcohols or 
amines may be resolved on gas chromatography by the 
formation -til diastereomers with a suitable chiral acylating 
agent. Conversely, the optical analysis of asymmetric 
acids can be performed with the aid of chiral alcohols or 
amines. Examples of both approaches can be found in the 
literature.
1 63A series of a-chloro-alkanoic acids were examined 
as the amides formed with valine methyl ester in an
- 30 -
investigation of steric effects about the amide bond.
The results showed that the differences between the 
diastereomers were enhanced by increased crowding about 
the amide bond. The resolution also improved on going 
from a non-polar phase (SE-30) to a more polar polyester 
phase, suggesting secondary bonding between the amide 
carbonyl and the polyester phase.
As an extension of their method for determining the 
absolute configuration of amino compounds using the
partial kinetic resolution of (-)-a-phenylpropionic
164 165acid, Cervinka et al developed a method for the
determination of the absolute configuration of asymmetric
carboxylic acids by reaction with (S)-(+)-methamphetamine.
Using this approach they claimed that (+)-a-alkylphenyl-
acetic acids have the absolute configuration (S) when
the alkyl group is Me, Et, n-Pr, but are of the (R)
configuration when the a-group is iso-Pr or iso-Bu. Gas
chromatographic analysis of these amides, however, showed
that the (S)-(+)-methamphetamine amides of all the (+)-
1 66acids, normal and branched chain, were eluted earliest.
The order of emergence of diastereomers was shown to be a
reliable criterion for the assignment of configuration in
this case when the absolute configuration of (-)-a-
1 6*7—1 69isopropylphenylacetic acid was reassigned as (R).
With the increasing use of inge-ct icicles based on 
pyrethroids containing chrysanthemic acid it became 
necessary to develop analytical methods to determine the 
optical purity of synthetic material. (+)-Trans- and
- 31 -
(-)-trans-Chr.y santhemic acid were separated^^ as the
esters of (-)-menthol or (-)-borneol, but no resolution
could be obtained for the cis-acids. The separation
of the bornyl esters was poorer than that of the
menthyl derivatives. Subsequently both the (-)-trans
and (-)-cia-chrysanthemic acids were resolved as their
1 71(+) or (-)-2-octyl esters on packed columns, or as
1 72(+)-a-phenylethylamine amides on capillary columns,
and these methods were applied to the determination
of the enantiomeric purity of synthetic pyrethroids.
Methods for the resolution of acyclic isoprenoid
acids as their (-)-menthyl esters on capillary columns have
been developed and applied to the determination of the
stereochemistry of the major acids present in geologically
1 7*5 1 7 ^3ancient sediments.
The gas chromatographic method has also been extended 
to the optical analysis of carbohydrates. Complete 
acetylation of the alcohol function followed by oxidation 
of the aldoses to aldonic acids produced compounds which 
could be resolved as esters of 2-butanol, 3-methy1-2- 
butanol or 3,3-dimethy 1-2-butanol. 177 r^ e or£er 0f 
elution of the peaks was determined by the configuration 
at the carbon adjacent to the carboxyl group.
d) Amino acids
Diastereomers can be formed from amino acids in two 
ways : the acid group may be treated with an asymmetric
alcohol or amine to form an ester or amide, or the amino
- 32 -
function can be derivatised with an optically active 
acid. The remaining polar group can then be derivatised 
with a non-asymmetric reagent prior to gas chromatography.
The former approach has been applied by many workers 
who have resolved N-trifluoroacetyl (N-TFA) amino acid alkanol 
esters. The most frequently used asymmetric alkanols
have been 2-butanol,178-183 2-octanol^^, and 
184-—187menthol. ~ Many amino acids have been resolved by
this method on both packed and capillary columns.
1 88Ayers et al examined the resolution of amino acid 
diastereomers by packed column chromatography, using 
various alcohols for derivatisation and various columns for 
the resolution. N-trifluoroacetyl-derivatives were generally 
found to be superior to N-acetyl-, N-trichloroacetyl- or N- 
propy1-derivatives. The effect of the alcohol structure
was quite pronounced. No resolution was achieved with 
2-methy1-1-butyl esters and in the alkan-2-ol series the 
degree of resolution attainable increased with the size 
of the alcohol. 3-Methy1-2-butanol and 3,3-dimethy1-2-
butanol were significantly superior in effecting a 
resolution to any other alcohols tested, and 3,3-dimethyl- 
2-butanol was the best. Using the latter derivatives 
fourteen protein amino acid diastereomers could be 
resolved to 93% or better. Aspartic acid and proline 
derivatives could be resolved to the extent of 70% and 82% 
respectively.
A problem is presented by the trifunctional amino 
acids which would form di-TFA derivatives under normal
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179conditions and are poorly resolved.  ^ A superior 
method was found to be preparation of 0- (or S-) 
acetyl-N-TFA-2-butyl esters.^ ^
N-TFA-2-butyl esters, have been successfully 
employed in the identification, and determination 
of enantiomeric composition of the amino acids occurring 
in meteorites,^ 9-192 SOjj_g183 an(^ se&iments.^93-195
This method has found application in the estimation 
of the age of fossils or bones by determination of the 
amino acid enantiomeric composition.^^ Several non­
protein amino acids occurring in the Murchison meteorite
1 90were poorly resolved as their 2-butyl esters. However
examination of the use of various acyl groups and 
1 97alcohols led to the choice of the 2-pentyl- or 2-hexyl- 
N-pentafluoropropionyl derivatives in this case.
The alternative approach to amino acid resolution
employs the nitrogen function to form a diastereomeric
198 199amide. In some of the earliest examples examined  ^9
the second asymmetric centre was already present in the
diastereomeric dipeptide. Subsequently many amino acids
have been resolved as their N-TFA-prolyl- amino acid methyl
esters.^54,200,201 Polyfunctional amino acids have been
201successfully examined by trimethylsilylating any free 
hydroxyl or sulphydryl groups before reaction with N-TFA- 
(S)-prolyl chloride. Both (R)-^^ and isomers
of N-TFA-prolyl chloride have been synthesised to 99% 
optical purity and used to determine the relative amounts 
of (R)- and (S)-threonine and (R)- and (S)-allothreonine
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202in a mixture, and in the quantitative determination
of (R)- and (S)-leucine enantiomers.2^
204Iwase has studied the effect of changing the
N-perfluoroacyl group, and the ester function, on the
separation of four racemic amino acids (alanine, valine,
leucine, and proline) and found an increase in the
separation factors, except for proline, as the number of
CP2 groups in the perfluoroacyl group increased : he
. s econdary . n-alkanes 
also found that esters of ~~£ " ".“we're more favourable
205than those of branched alcohols. He also compared 
the use of proline, hydroxyproline, 4-thiazolidine 
carboxylic acid and pyroglutamic acid as resolving agents 
and concluded that proline gave the best results. An 
examination of the relationship between separation factors and
structure was undertaken for fifteen amino acids as their N-TFA-
206(S)-prolyl amino acid methyl esters, and for twenty-five racemic
P 07amino acids as their N-TPA-Q-prolyl amino acid n-butyl esters.
208a-Halogeno-acyl chlorides were shown to be good
reagents for the gas chromatographic analysis of amino
acid methyl esters on SE-30, FFAP or DEGS phases. In
particular the use of a-chloroisovaleryl chloride was
209 210recommended. Both a-chloropropionic acid
211chloride and a-bromopropionic acid chloride have been
found suitable reagents for resolving amino acids but the
209use of a-chloropropionic acid is preferred since 
it is readily prepared in optically pure form.
Recently three camphor-related compounds, (+)- 
isoketopinyl chloride, (-)-dihydroteresantalinyl chloride
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o 1 p
and (-)-teresantalinyl chloride, have been applied
to the gas chromatographic resolution of amino acid
methyl esters. Initial studies with DL-alanine using
various stationary phases led to the choice of (-)-
teresantalinyl chloride as resolving agent and twelve
pairs of enantiomeric neutral and acidic amino acid
derivatives were run on PEG-A. Separation factors of the
order 1.01-1.07 were achieved, for the n-butyl esters, and
1.03-1.10 for the methyl esters. The high resolution
factors obtained reflect the utility of the rigid carbon
skeleton directly linked to the amino acid via an amide
21 3bond, as suggested previously by ourselves  ^and other 
214workers.
1*2.3. Mechanism of separation
Various mechanisms have been suggested to account for
the order of elution of diastereomers. In the case of
unsaturated alcohols or diols, the diastereomer having
the lower population of molecules in the hydrogen-bonded
21 5form has the higher retention volume on a polar phase.
Nurok et al., when studying the separation of diastereomeric
216dialkyl esters of butane-2,3-diol, suggested that a 
polar solvent stabilises the most polar conformer of a 
molecule with polar groups on adjacent atoms (i.e. the 
molecule with syn dipolar groups). The proportion of 
conformers existing with aligned dipoles will differ for 
each diastereomer, and hence the stabilisation will be
- 36 -
different for each diastereomer.
Differential interaction of functional groups with 
the stationary phase, due to different steric environments, 
can result in a separation of diastereomers. This
reasoning has been applied to the study of the resolution of 
diastereomeric esters and amides, where the ”key 
functional group” is the ester or amide grouping flanked 
by asymmetric centres.
217It has been suggested that the degree of steric 
crowding around the central polar group may be
218computed empirically by Newman’s ’Rule of Six”.
The calculation of the ’six number” is illustrated 
below for 2-hexyl-a-acetoxypropionate.
Commencing the count with the carbonyl oxygen, the number 
of atoms in position six is called the ”six number”. The 
rule is based on the assumption that a high ’six number” 
is directly associated with increased steric hindrance 
at the group in position 1_-2_. The magnitude of the
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effect will be dependent on absolute configuration and 
thus will be different for each diastereomer, leading to 
a separation. Correlations between resolution factors 
and the "six number" have been observed in the separation
the influence of structural and polar variations on the
diastereomeric esters and amides. Examination of the 
gas chromatographic behaviour of a-acetoxypropionates of
for, and hence the separation of diastereomeric pairs 
increased as the size differential of the groups on the 
alcoholic asymmetric centre increased. The esters were 
assumed to exist in "preferred" conformations in solution 
which allowed differential accessibility to the central 
functional group in diastereomeric pairs.
21 7of a-acetoxypropionates of secondary alcohols and of
1 6 *5a-chloroalkanoyl valine methyl esters. Data, however,
214 219have been cited 9 in disagreement with the empirical 
rule and it should only be used with caution.
Several workers have systematically studied140,141,214,220 221
separation factors andA.(AG°) values for series of
secondary alcohols showed^^*22  ^that the A (AG-0) values
3
a) (SS)-diastereomer b) (SR)-diastereomer
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As the size differential between R and R1 increased 
the conformational mobility about the carbon-oxygen bond 
would decrease, resulting in an increased population of 
the preferred conformers. The (SS)-diastereomer would 
be more accessible for interaction with the stationary 
phase since the two bulkier groups, -CH^  and R, are on 
the same side of the plane passing through the ester linkage, 
and the two hydrogen atoms are on the other side. As R 
increased in size the difference in accessibility to the 
diastereomers would also increase, with the resultant 
increase in This proposal also accounted for the
observed order of elution since the (SS)-diastereomer 
would be preferentially retained because of the increased 
interaction with the stationary phase.
Similar trends were noted in the separation of
diastereomeric N-TFA-prolyl derivatives of racemic amines
141 155and amino-acids. 9 Incorporation of the alcoholic
asymmetric centre into a ring system resulted in fairly
large A (AGr°) valuesdue to the increased conformational
immobility about the carbon-oxygen bond. A similar
increase inA(AG°) was observed for the N-TFA-(S)-prolyl
1 55derivatives of racemic cyclic amines. The effect of
the increased rigidity of the ring system in imposing 
"asymmetric preferred conformations" on the molecule was 
most noticeable in the case of the diastereomeric N-TFA-(S)- 
prolyl derivatives of 3-methylpiperidine, where a A(AG°) 
value of -78 cal/mole was obtained. Previously introduction 
of a methylene group between the asymmetric centre and the
- 39 -
ester group had resulted in indistinguishable
diastereomers.22<^
Examination of a series of structurally related
diastereomers in which the groups attached to either
221side of the polar linkage were the same, showed that
the diastereomeric amide (R'CONHR1) was better separated
than the corresponding ester (R'CC^ R') (R' = 1,2-dimethylpropyl).
The reason for this difference in A (AG-0) was attributed
to the ability of the amide to hydrogen-bond to the
solvent via the proton attached to the nitrogen. This
reasoning was substantiated by a lowering of theA(AG°)
value when this proton was replaced by a methyl group.
(RfCO.NMe,R'). Introduction of an ethereal oxygen 
(R’-O-CO-OR*, R2-0-C0 —OR2), (R2 = 1,2,2-trimethylpropyl) 
did not markedly affect theA(AG°) value although the 
separation of the asymmetric centres was increased.
Ethereal oxygens can themselves contribute to the
2 2separation since R'O.C^.OR* and R O.CH^.OR were still
resolved. However, further separation of the chiral
2 2centres in the di-ester of oxalic acid (R O2CCO2R )
produced indistinguishable diastereomers. Diastereomeric
symmetrically substituted hydrocarbons showed better
resolution in compounds having a methylene group between
222the chiral centres than those without it.
Replacement of the methylene group by an oxygen atom
223produced even higher resolution factors. When one of
the chiral carbons, however, was replaced by silicon the 
resolution factors decreased appreciably, and when both
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asymmetric centres were asymmetric silicon atoms
225no resolution was observed. ^
214Stern and coworkers showed that steric effects are 
not the only factors involved in the separation 
mechanism, and electronic effects must also be 
considered. A series of methylalkyl a-alkylpropionates, 
where there is no polar group on the acidic centre, gave 
much poorer separations than the corresponding a- 
acetoxypropionates. These results, and those obtained
214on the separation of methyl 2(DL),4(L)-dimethylhexanoate 
indicate that the polar group on the acidic centre may 
interact differently with the solvent for each member of 
the diastereomeric pair. Thus the total polar linkage, and 
not just the central ester linkage, may be thought of as 
contributing to the separation in terms of differential 
accessibility for the two diastereomeric forms.
Using experience gained during work on chiral
225stationary phases, Peibush proposed a mechanism of 
resolution which explained both the observed order of 
elution of diastereomers and the separation factors 
obtained. If the diastereomer is viewed along its long 
axis, from the alcohol to the acid moiety, (Pig. 8) the 
substituents on the asymmetric carbons have either a 
clockwise or anti-clockwise arrangement going from the 
large (L) to the medium (M) to the small (S) group. The 
rule states that the diastereomer emerging last from the 
column is the one in which both asymmetric carbons have 
their substituents arranged in the same direction. If
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the effective size of the two groups on the alcohol
asymmetric centre is equal no separation will be
observed. This was the case in the series of
unsaturated alkylcarbinyl a-acetoxypropionates when R
214was methyl and R* vinyl (CH=CH2). As the difference in
bulk between the R and R1 groups increases the separation of
the diastereomers also increases. If R’ is bigger than
R, the (SS) diastereomer will emerge last (Pig. 8) but if
R becomes larger than R1 the order of elution will
reverse. Examination of the data obtained for the series
of diastereomeric saturated and unsaturated alkylcarbinyl
214a-acetoxypropionates by Stern et al, showed that a given
structural change produced a constant difference in the
225free energy of solvation of the isomers.
When considering the separation of a-hydroxy- 
propionates of 2-n-alkanols the formation of an intra­
molecular hydrogen-bond between the free hydroxyl group
and the carbonyl group was thought to contribute to the 
140 214separation. 9 Disruption of this hydrogen-bond
was given as a reason2^  for the decrease of A (AG-0)
obtained as the alkyl chain attached to the alcoholic
asymmetric centre was lengthened. A similar reasoning
was used to explain the observed order of elution of the
2262-alkanol esters of (S)-(+)-mandelic acid. The
diastereomers were believed to assume preferred 
conformations which resembled cis-trans isomers. The 
ncis”-form (SS) involved more intramolecular hydrogen 
bonding and was, therefore, eluted before the "trans"
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(SR) which experienced more association with the phase.
Differential accessibility of the polar groups has
1 87recently been used to explain the observed order of 
elution of the (L)-menthyl esters of R-TFA-amino acids.
The steric repulsion between the isopropyl group in the 
menthyl moiety and the R-group in the amino acid fixes 
the ’’preferred"conformations as shown in Figure 9. In 
the ester of the (D)-amino acid the ester carbonyl and the 
amide group lie on the same side, where the steric 
hindrance of the isopropyl group is weak. In the 
derivative of the (L)-enantiomer the amide group is at the 
same side as the isopropyl group and is, therefore, 
shielded from the environment by this bulky group. This 
will result in stronger interactions between the (LD) 
diastereomer and the phase and hence its preferential 
retention. Infra-red evidence indicates that there is 
increased hydrogen-bonding between the (LD) diastereomer and 
polar solvents.
1.2.4. Resolution of enantiomers on chiral 
stationary phases
The first direct separation of enantiomers by gas
chromatography was reported in 1966 by Gil-Av and
co-workers.Since that time a number of studies
have evaluated various optically-active phases.
Two general classes of chiral solvent have been used :
227 2281) derivatives of a-amino acids, 9 and di- and
- 43 -
tri-peptides.
2) N,Nf-disubstituted urea derivatives.2^6,238 
In the former approach, promising results were 
obtained for the resolution of N-TFA-a-amino acid esters 
on capillaries coated with N-TFA-(L)-isoleucine lauryl 
ester or N-TFA-(L)-phenylalanine cyclohexyl ester.^^*^®
Much higher resolution factors were obtained, however,
230when dipeptide phases were examined, y and N-TFA-(L)- 
valyl-(L)-valine cyclohexyl ester produced sufficient
229resolution to be applicable to packed column chromatography. 
Examination of various solute structures showed that the 
separations improved with increasing bulk of the alcohol 
used to esterify the amino acid, (i.e. prim. < sec. <
O'ZA 1
tert.) 9 1 and isopropyl esters were recommended
since they combined reasonable retention times with good 
resolution factors. Comparison of various perfluoroacyl
23Q
derivatives indicated that N-pentafluoropropionyl (PFP) 
derivatives were more volatile than N-TFA derivatives 
without adversely affecting the resolution. N-TFA-(L)- 
valyl-(L)-valine cyclohexyl ester was found to be a very
231 240useful phase for resolving the more volatile amino acids, 9
although some overlap of different amino acids did occur
(e.g. serine and leucine). Operation of this phase above
100-115°C, however, was not feasible, and N-TFA-(L)-
232phenylalanyl-(L)-leucine cyclohexyl ester, which could 
be operated up to 140°C, was more useful for resolving the 
less volatile amino acids.Subsequent introduction of 
N-TFA-(L)-a-aminobutyryl-£L)-a-ariiinobutyric acid cyclohexyl
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235ester allowed unambiguous separation of the more
volatile amino acids. The separation of N-TFA-(DL)-
amino acid isopropyl esters has been examined on several
241dipeptide phases with respect to separation factors 
(a) and thermodynamic properties of interaction. An 
increase in size of the alkyl group on the asymmetric 
centre of the dipeptide stationary phase was found to 
produce greater solvent-solute interaction. The same 
modification applied to the side chain on the a-carbon 
of the solute, however, caused a decrease in interaction. 
Studies of this nature can lead to the prediction of the 
stationary phase necessary for particular separations.
On all the (l)-peptide phases examined the (D)-amino 
acids were eluted before the (L). It was also noteworthy 
that only ct-amino acids could be resolved on these phases. 
Both the resolution and the observed regularity of elution
order were explained by the formation of "diastereomeric”
230 234association complexes between the solute and solvent 9
121(Fig. 10). A three-point interaction complex was 
favoured and subsequent experiments confirmed that it 
was the amide portion of the peptide (complex B) which w.as
0A 0 0
involved in the interaction. 9 Consideration of the
e
association complex showed that the [-C0-NH-C-C0-J group
R
was necessary for the formation of three hydrogen-bonds. 
This explained why only a~amino acid esters could be 
resolved. Examination of various solutes on N-TFA-(L)- 
cc-amino—n-butyryl— (L)-a-amino-n-butyric acid cyclohexyl 
ester, however, showed2^  that the important structural 
feature for the resolution was the two carbonyl groups
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Pig. 11. Suggested association of enantiomers with a
chiral phase to give either a clockwise (1) or 
an anti-clockwise (2) arrangement of , R 
and H. The order of elution of the enantiomers 
from the phase can be predicted if it is 
assumed that the two 'diastereomeric1 association
complexes can be described as if the two asymmetric 
centres were on vicinal carbons. [(3) and (4).]
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separated by two atoms. Since N-TFA-prolyl esters 
could be resolved, although with poorer resolution 
factors, the N-H group could not be essential and a 
two-point association complex might be adequate in some 
instances.
The direct resolution of enantiomeric amines was
eventually achieved on the optically active ureide,
carbonyl-bis-(N-(h)-valine isopropyl e s t e r ) . T h e
enantiomers were found to emerge in a consistent
manner when the bulk of the substituents on the chiral
carbon was considered. These observations led to the
245proposal of a mechanism of resolution which was
successfully applied to the assignment of the absolute
246configuration of optical isomers. The ureide was
considered to be linked through two hydrogen-bonds to the 
amide group (Fig. 11). Viewing the asymmetric carbon from 
the side remote from the nitrogen atom, projection formulae 
were obtained with clockwise (1) or anticlockwise (2) 
arrangements of the substituents v (IT1, R and H).
The order of emergence of the enantiomers and the magnitude 
of the resolution factors would depend on the relative 
stability of these ’'diastereomeric” association complexes. 
It was assumed that differences in stability could be 
interpreted in terms of "preferred" conformations and that 
the non-bonded interactions between the chiral solvent and 
the enantiomers could be described as if the two asymmetric 
centres were on vicinal carbons ((3) and (4)). One of the 
combinations of the enantiomers with the chiral solvent
- 46 -
would be less stable than the other (cf. Fig. 11.
(3) less stable than (4) because of the interaction 
between L and L!). The larger the difference in size 
between the large and medium groups, the larger would be 
the effect on the relative stability and hence on the 
resolution factors. For a given configuration of 
solvent the order of emergence would depend on the 
clockwise or anticlockwise (]v[/^ ,Vss) arrangement
according to the size of the substituents, R1, R and H.
On the (L)-ureide phase the enantiomer with the anti­
clockwise arrangment emerged first. The configuration
of an unknown could, therefore, be determined from its
2order of emergence if the relative sizes of R1 and R
were known, e.g. for an amino acid R-CH-CNEO-CC^R1, the
COCF-z3
first peak would have the D-configuration if CC^R'> R 
and the (L)-configuration if CC^ R' < R. Studies of the 
selectivity of hydrogen-bond formation in chiral ureide- 
amide systems have been performed with the aid of H and 
1?C NMR,^^ and the only significant hydrogen-bond 
interaction appeared to be between the ester carbonyl of 
the stationary phase and the amide amido proton.
Corbin and Rogers2^'significantly extended this 
work when they showed that separations could easily be 
achieved on the solid ureide of (L)-valine isopropyl 
ester as well as on the liquid phase. The resolution 
factors obtained on the solid ureide,phase were larger 
than those obtained on the liquid phase, with a 
significantly shorter analysis time.
Further examination revealed that the ureide of
(L)-valine isopropyl ester existed in two forms below
249its melting point and that it was the high 
temperature form which effected the good resolutions. 
Examination of several ureide phases in the smectic 
liquid crystalline state and the isotropic liquid state 
has shown that enantiomers can be resolved with very 
large a values on optically active mesophases. 9
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1.3. Applications of gas chromatography-mass 
spectrometry in metabolism studies
1.3.1. Introduction
Mass spectrometry has become a powerful tool for 
metabolism studies since a large amount of structural informa­
tion can be obtained with little expenditure of sample.
The combination of gas chromatography with mass spectrometry 
allows the simultaneous analysis of multi-component 
mixtures, thus eliminating the necessity for extensive 
purification prior to analysis which considerably shortens 
analysis time. The extensive use of gas chromatography- 
mass spectrometry (GC-MS) in the metabolism field is 
exempl'ified by the vast amount of literature available on 
the subject and several pertinent reviews have been published 
The technique has application both in the detection and 
identification of metabolites and in their quantification 
in biological material.
1.3.2. The detection and structural identification
of metabolites
Direct analysis by G-C-MS, of suitably derivatised 
extracts from body fluids or incubation media after the 
administration of a drug can produce valuable information 
about metabolite structures. Comparison of the spectra 
obtained with those of authentic material or closely 
related analogues can lead to complete structural 
identification.
250-
253
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Permethylation of barbiturates produces compounds 
amenable to G-C-MS analysis.^^“^^ This method has
been applied to the metabolic study of several
 ^ , . 257-260barbiturates m  man.
A previously unreported major urinary metabolite
of ethosuximide (78) was isolated from a patient
suffering from petit mal epilepsy and identified as the
ring hydroxylated ethosuximide (79) by G-C-MS and M R
9 1
of the N-methyl derivative.
Hydroxylamines are now recognised as important
14 262metabolites of phenylalkylamines. ' The hydroxylamines
formed from primary amines are readily characterised by
GrC-MS as the corresponding oximes resulting from oxidation 
263during G-LC, or as their more stable trimethylsilyl
(TMS) e t h e r s >264 Further oxidation to C-nitroso- and
265nitro-compounds has been observed. Secondary amines are
263metabolised to hydroxylamines, oximes and nitrones,
which are amenable to GC-MS analysis, although some
decomposition of the secondary hydroxylamine may occur.
The hydroxylamines derived from N-demethylchlorpromazine.
and its sulphoxide were identified as metabolites of
chlorpromazine and the mass spectra obtained by direct
inlet techniques were compared with those of the main
267
thermolytic products obtained during GrC-MS analysis.
A knowledge of any thermal breakdown which occurs during 
GC-MS analysis permits the use of this technique even 
when labile compounds are being analysed.
The metabolites of compounds which contain an atom
C H p - C H ^
H O .
O'
CH^rCH
(78) (79)
( C H 2 )3- N ( C H 3 )2
(80)
Cl H j  C "  N H 2
N / /-^ t t
(81)
c h 3
- ,
I ^
0CH3 Cl
^CH-CH
c l
0
Cl
(82)
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with an abundant second isotope e.g. chlorine (^Cl :
57C1, 3:1) are easily recognised by the appearance of 
ion clusters of known relative abundance. The metabolism
of many chlorinated compounds has been studied using this
2 68 2 6 6 approach e.g. chlorpromazine, (80) chlorophentermine,
(81) and mitotane (o ,jd' - D D D ) 2 ^  (82). When no such
naturally occurring stable isotopes are present in the
molecule use has been made of synthetic materials. Drugs
or other precursors have been partially labelled with
15w 270 13« 271 ,272 2^ 273 . ,N, C, 9 or H in such a way that the [MjT
and [M+1 ]* ions occur in a 1:1 ratio. The metabolites are
then easily recognised by the presence of the 'twin ions'.
Other ion clusters can be easily created by the choice of
271suitable isotope combinations.
The analysis of more complex mixtures of biological
origin has been achieved with the increasing application
of capillary column G-C-MS274-278 an  ^ uge
handling systems.279-285 when the computer is programmed
with retention index data as well as mass spectra the
number of authentic spectra which require searching during
286 287the identification of an unknown is greatly reduced. 9
An alternative method of GrC-MS analysis uses the mass 
spectrometer as a highly specific gas-chromatographic 
detector. This is achieved by fixing the applied 
accelerating voltage to focus one particular ion - 
single ion monitoring (SIM). Quickly switching the 
applied voltage to a,number of pre-selected values, while 
keeping the magnetic field constant, brings a series of ions
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into focus within a short time - multiple ion detection
(MID). MID was achieved by application of an
accelerating voltage alternator (AVA) which could
monitor up to three characteristic ions by automatically
altering the applied accelerating voltage so swiftly
that the different ions were all apparently recorded 
288simultaneously. With the latest magnetic sector
instruments up to four mass fragments within a 10-30%
289mass range can be monitored using the AVA. Recent
modifications employing computer systems have improved the
290 291 /stability of the system. ’ (Many more mass
fragments, however, over the whole mass range can be monitored
292xusing a quadrupole mass spectrometer. ) This technique
268has been termed "mass fragmentography" by Hammar et al
and its application in biological research has been recently 
293reviewed.
Mass fragmentography allows very specific metabolite 
searches to be carried out. A knowledge of the precursor 
structure and metabolism of related compounds permits the 
prediction of metabolite structures and the choice of 
characteristic fragment ions. Monitoring of one or more 
predicted ions, can establish the presence or absence of 
the metabolites postulated to be present in the biological 
material. TMS ethers of steroid drug metabolites 
containing 17a-alkyl-, 17a-alkenyl-, and 17a-alkynyl~17p-ols 
may be detected selectively by the abundant ions at m/e 
128+R which in general do not occur in the mass spectra of 
natural s t e r o i d s . T h e  fragmentation mechanism has been
OH OH
- C HH
(83) (84)
NH-CH
CH
CHjCH-NH-C^g
(85) (86)
O
II
h N ^ C 2 H 5
CH^CHjCH^CHo
■'//NKI /\\ d d. d 3
o .N oH
(87)
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elucidated by deuterium labelling s ^
1 +
OTMS + OTMS OTMS 
II
- R / V H
m/e (128+R)
Preliminary investigations of the metabolism of the
anabolic steroids, 1 7a-ethyl-17|3-hydroxyestr-4-en-3-one (83)
and 1 73-hydroxy-17a-methylandrostan-1,4-dien-3-one (84) used
294
these techniques. Mass fragmentography has been
successfully applied to the identification of 10-
hydroxynortriptyline, desmethylnortriptyline and
demethyl-1O-hydroxynortriptyline, metabolites of
nortriptyline (85).^^,^ ‘^  The technique also
facilitated the detection of the N-dealkylated metabolites
of methamphetamine (2) and fenfluramine (86) in rat tissue
30after i.p. administration. A new metabolite of
butobarbitone (87) 3'-ketobutobarbitone, was detected in
259urine by mass fragmentography.
The use of precursors labelled with stable isotopes 
is readily amenable to mass fragmentographic analysis. 
Simultaneous monitoring of fragment ions at the isotopic 
masses allows identification of metabolites. An excess of
H O '
/ ^ v O H
o
(89)(88)
(9 0 ) (91)
N CH3
(92)
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added labelled compound may also act as a carrier for
endogenous material and reduce losses during work up
and G-LC. This has been applied to prostaglandin 
298 299analysis. 9 The use of stable isotopes may lead
to the discovery of previously unknown metabolites as 
in the case of the study of the metabolism of nortriptyline 
labelled with 2H and 15N.500
Chemical ionisation mass spectrometry employs a
milder form of ionisation produced by ion molecule reactions
between the sample and ionised reagent gas. This reaction
normally results in the formation of the [M+H]+ ion or
quasi-molecular ion. (The abundance of this ion is lower
when methane is used as reagent gas.) By selection of an
appropriate reagent gas the degree of fragmentation
obtained can also be varied, although in general little
fragmentation is observed. This technique should have
considerable application in drug metabolism work because
of the production of abundant quasi-molecular ions,
however, few studies have been reported as yet. Using
methane as reagent gas the major metabolites of sodium
phenobarbital (29), p-hydroxyphenobarbital (88),
dehydroepiandrosterone (89), pregnanediol (90) and
androsterone (91) were easily detected by their
301quasi-molecular ions. It was not necessary to
separate all the metabolites as individual peaks in the 
gas chromatograph to obtain identification. Normorphine 
and norcodedne have been identified by their chemical 
ionisation spectra as being metabolites of morphine (92)
C H jC O O H
Y ' O  CH 
HO 
(93)
CHp OH 
CH-OH
V ^ O C H
HO 
(94)
c h 3
\CH-OH
V ^ O C H
HO 
(95)
HO
C H-CO O H
^ O C H  
HO 
(96)
HO CH
H -C H j NH
OCH.
HO
HO
C H - C H 2 N H 2
X ^ O C H
HO
(97) (98)
OH
(99)
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302m  man.
1.5.5.- The quantification of drugs and drug
metabolites in biological material
Quantification is most suitably effected by the 
techniques of mass fragmentography already described. 
Addition of an internal standard to the biological 
material prior to extraction accounts for any losses 
which may occur during work-up. Two types of internal 
standard have been employed viz : a closely related
analogue with suitable gas chromatographic properties or 
the drug itself labelled with a suitable stable isotope.
Biogenic amines occurring at low concentrations 
have been analysed by SIM of various derivatives, often
also suitable for electron capture analysis e.g.
303 304 304pentafluoropropionates, * heptafluorobutyrates,
305TMS ethers, and pentafluorobenzylimine - TMS
derivatives. Homovanillic acid (93) bas been
307estimated in body fluids using deuterated or
3QO
isomeric compounds as internal standards. Similar
methods were used for 4-hydroxy-3-methoxyphenylglycol
(94) 4-hydroxy-3-methoxyphenylethanol (95)^^ and
31 14-hydroxy-3-methoxymandelic acid (96). Alternatively, 
metanephrine (97) and normetanephrine (98) could be 
quantified as the 0—ethyl ethers produced by derivatisation 
with EtOH-HCl.312
It was found possible to measure estra-1,3,5,-triene- 
3,1 5a,1 6a,1 7|3-tetrol ( estetrol) (99) in pregnancy urine
OH
(101)
CH3
CH-C-NH0
^  b n  
(102)
OxX ,Ph
/— ('P h  
Hh) NH
n
O
(103)
9H3/jo
f t  CH0 CH0 CH (CH.Jp
h K > r
(105) R=C2H5
(106) R = CH2-CH=CH2
HN"^ NcPh
O N ^ 'O
c h 3
(107)
C2 H5
H
H
(10 8)
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from the tenth week of pregnancy by monitoring the
ion at m/e 191 and using 4-methyl - estra-1 ,3,5(10)-
triene-1 ,1 5a, 1 6a, 1 7|3-tetrol (100) as internal standard.
There have been many reports published on the
determination of drugs and drug metabolites at the
nanogram (ng) level using closely related analogues
314-317as internal standards.  ^  ^ ' Some examples of such
studies are included in Table 5.
The use of deuterium labelled derivatives of the
studied substance as an internal standard allows
quantitative determination of biological metabolites
occurring at low levels. Examples of analyses include 5-
31 fihydroxyindole-3-acetic acid (101) in cerebrospinal fluid,
320 321 321amphetamine (1) ’ and phentermine (102) in plasma
and brain, rare amino acids in heart cell culture,
endogenous corticosteroids in rat adrenals and blood,
catecholamines in rat adrenals, and estrogens in non- 
322pregnant women.
1 3C-labelled drugs have also been used as internal
standards to quantify drugs and drug metabolites in
urine, plasma, and breast milk.^^"’^ ^ [2,4,5,-^C^]
1 ^
-diphenylhydantoin,[2,4,5- C^j-phenobarbital, and 
[1-0 H^] valium were used to quantify diphenylhydantoin
(103),523-325 phenobarbital (29),324,525 and valium (104)325
13respectively. [2,4,5- j-phenobarbital has been used
to quantify amobarbital (105), secobarbital (106),
butobarbital (87) and pentobarbital (72) ^ ^ ’-^ and
324mephobarbital (107) and primidone (108). Analyses
Table 5. The quantitative estimation of drugs and drug
metabolites in biological media using mass 
fragmentography.
Compound
4-hydroxy-3-methoxy- 
phenyl glycol (HMPG)
Standard Sensitivity Ref
HVA-[2H_]-methyl 9 ng/ml 307
ester
Isohomovanillic acid cerebro­
or 4-methoxy mandelic spinal 308
acid fluid (CSP)
a) 1-(4-hydroxy-3- 1 ng/ml
methoxypheny1) -2 - 
[2H2]-glycol
b) 4-hydroxy-3- 
methoxy mandelic 
acid methyl ester
c) hmpg-[2h,]
309
4-hydroxy-3-methoxy- 
phenyl ethanol
4-hydroxy-3-methoxy 
mandelic acid
tryptophol
CH0CH02 i 2
OH
4-hydroxy-3-[ H^]- 
methoxy mandelic 
acid
20 ng 310
311
5-hydroxyindole-3- 
acetic acid (HIAA)
[2H2]-HIAA 2-50 ng/ml 
CSP
3 1 8,
367
Compound Standard Sensitivity Ref.
Nortriptyline and 
metabolites
Piribedil
Lidocaine and 
metabolites
Oestetrol
Amphetamine
Phentermine 
D iphenylhydanto in
Phenobarbital
Secobarbital
CIBA 34276
r i il^ J
CH
CH
1
2
2
c h 2  
n h -c h 3
2-N-benzylamino-
5-chloro-benzo-
phenone
Trimecaine
4-methyl-oestra-1, 
3,5(10)-triene-1,
1 5a,16a,17p-tetrol
[ H^]-amphetamine 
2
[ ]-Phentermine
[2,4,5-
diphenylhydantoin
[2,4,5-13C3 ]-
phenobarbital
10 ng/ml 
plasma
10 ng/g or 
ng/ml brain 
tissue or 
plasma
0.5-10 
p-g/ ml
5 ng
0 .6-1
ng/ml
1 ng/ml 
Pg
Pg
Pg
317
314
313
320
321
323- 
325
324- 
325
323,
325
Compound Standard Sensitivity Ref.
Pent obarb it al [2,4,5-13C 3 ].
phenobarbital
Pg 323,
325
Mephobarbital
Primidone
Pg
Pg
324
324
Amylobarbital
Butobarbitone
Valium
Prostaglandin
butobarbitone
pentobarbitone
[2,4,5-3C,3 ]-
phenobarbitll
1 —C [ H^]-valium
[ ]-methoxime of 
PG-E.
Pg 323,
325
0.01 jig/ml 315
Pg
3 ng
316
324,
325
325
299
Prostaglandins E^  
and P2a
Indole alkylamines
Biogenic amines
[3,3,4,4- H4]-PGE2 250 pg
[3,3,4,4-2H4 ]-PGF2a
a-methylserotonin
N-acetyltryptamine
S.I.M. 10-15 moles
298
— 12- 10_1^10 lu 303a
moles
303c
304
305
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-were carried out in the picogram - nanogram range 
using both electron ionisation and chemical ionisation 
techniques with the aid of data handling systems.
Section 2. Experimental
Table 6
Source of Reagents
Supplier
Dr. S.W. Head
Pyrethrum Marketing Board,
Nakuru, Kenya
Norse Laboratories Inc., 
Santa Barbara,
Ca.,
U.S.A.
Aldrich Chemical Co. Inc., 
Milwaukee,
Wis., U.S.A.
PCR Inc.,
Gainesville,
Florida, U.S.A.
Burdick and Jackson, 
Laboratories Inc., 
Muskegon,
Michigan, U.S.A.
Dr. A.A. Manian,
NIMH,
Bethesda, Rockville,
Md., U.S.A.
Reagent/Substrate
(R)-(+)-trans-chrysanthemic
acid
(R)-(-)-Phenylbutyric acid
(S)-(+)-Phenylbutyric acid
(S)-(+)-a-Chlorophenylacetyl 
chloride
(RS)-Phenylpropionic acid
(RS)-3-Methyl-2-phenylbutyric 
acid
(RS)-a-Methoxyphenylacetic 
acid
para-chloroamphetamine
Buchs
Fluka A.G-.,
Switzerland
(&)“(")-Menthol 
(R)-(-)-Borneol 
(RS)-Borneol
(S)-(+)-2-0ctanol
(R)-(-)-2-0ctanol
(R)-(-)-Mandelic acid
(S)-(+)-Mandelic acid
(!)-(+) -N-methyl-a-phenylethylamine
(S)-(-)-N-methyl-a-phenylethylamine
(R)-(-)-Valine
(RS)-Proline
(RS)-Phenylglycine
(R)-(-)-Phenylglycine
(R)-(+)-Phenylalanine
(S)-(-)-Phenylalanine
(lS,2R)-(+)-Ephedrine HC1
Koch-Light Laboratories Ltd
Colnbrook,
(RS)-Pant olact one 
(RS)-3-Methoxy-4,5-
Bucks., methy1enedioxyamphetamine 
(R)-(-)-NorvalineEngland
L. Light & Co. Ltd., 
Colnbrook,
England
(1R, 2R) - (-) -Ephedrine HC1
(1S,2R)-(+)-Nor-ephedrine Sulphat e
Sigma,
St. Louis, 
Mo., U.S.A.
R.N. Emanuel Ltd., 
Wembley,
Middlesex
BDH Ltd.,
Poole,
England
Prof. J.I.G. Cadogan, 
University of Edinburgh
Dr. J.D. Gilbert, 
University of Glasgow
Drs. G. Amiard and 
R. Bucourt, 
Roussel-UCLAF, 
Romainville, France
(R)-(-)-Pant olact one 
(S)-(+)-Amphetamine sulphate 
(S)-(+)-Methamphetamine HC1 
(RS)-Methamphetamine HC1 
(S)-(-)-Proline
(E) - (+) -cc-Phenylethylamine 
(S)-(-)-a-Phenylethylamine 
(R)-(-)-Amphetamine
(RS)-Norvaline
(S)-(+)-Valine Methyl ester HC1 
(1R,2S)-(-)-Ephedrine HC1
(S)-(+)-Menthol 
(S)-(+)-Isomenthol 
(RS)-Isomenthol 
(S)-(+)-Neomenthol 
(RS)-Neomenthol
Methyl (RS)-12-hydroxystearate 
Methyl (R)-(-)-12-hydroxystearate 
Methyl (RS)-13-hydroxystearate 
Methyl (S)-(+)-13-hydroxystearate
(-)-Estradiol 3-methyl ether 
(+)-Estradiol 3-methyl ether
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2.1. Gas chromatographic resolution of enantiomers
2.1.1. Reagents and substrates
Most reagents and substrates were obtained commercially 
or as gifts, as shown in Table 6.
Drimanoic acid was synthesized by the oxidation of
326drimanol, obtained by catalytic hydrogenation of drimenol.
To drimanol (250 mg) in "AnalaR" acetic acid (3 ml) was added 
dropwise a solution of chromium trioxide (87 mg) in 80% acetic 
acid (3 ml) containing potassium hydrogen sulphate (83 mg). 
After 1 hour, the solution was diluted with water and 
extracted with diethyl ether. After washing with water to 
remove acetic acid, drying and removing the solvent, the 
extract yielded a pale green oil. This oil in ethanol (10 ml) 
was added dropwise to a freshly prepared suspension of silver 
oxide (prepared from 360 mg AgNO  ^by treatment with aqueous 
potassium hydroxide) and the resulting solution adjusted to 
pH 11 . After stirring and refluxing at 95°C for 1 h, the 
solution was cooled, diluted with water, and filtered.
Ether extraction removed neutral organic material.
Acidification and ether extraction yielded a pale yellow oil 
which crystallized from aqueous methanol to give white prisms 
of drimanoic acid (60 mg), m.p. 133-136°C.
(S)-(+)-q-Phenylpropionic acid was obtained from the 
racemic acid by fractional crystallisation of the salts 
formed with (R)-(+)-cc-phenylethylamine, from acetone. After 
four recrystallisations the free acid was liberated with HC1 
and extracted into ether. The liberated acid had [ct]p +45°
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(C, 1 g/100 ml in chloroform). Gas chromatographic 
analysis of the R-(+)-a-phenylethylamide indicated an 
optical purity of approximately 90$.
Isoborneol
The lithium aluminium hydride reduction of (+)- and (-)- 
camphor produced (-)- and (+)-isoborneol, respectively as 
the major product. The minor product was (+)- or (-)- 
borneol.
Fenchol
Similarly the major product from the reduction of (+)-fenchone 
was (-)-fenchol, and (+)-fenchol was obtained from 
(-)-fenchone.
(-)-170-hydroxy-4-estren-3-one was obtained by the 
selective borohydride reduction-^^ of 4-estrene-3,17-dione.
2.1.2. Methods of acylation
(a) Acid chlorides
Acid chlorides were prepared in toluene by the action 
of freshly redistilled thionyl chloride on the acid, at 
40-60°C for 1 h. In the small scale preparations, excess 
thionyl chloride was removed in a stream of nitrogen and the 
acid chloride was used immediately without purification.
Drimanoyl and chrysanthemoyl derivatives were prepared 
with 1 mg of alcohol or amine and an excess of acid 
chloride (3 molar ratio), in toluene at 60°C or 40°C 
respectively, for 1-2 h.
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Amides of the (2)-phenylalkanoic acids were 
prepared on a 10 jx molar scale using a molar equivalent 
of acid chloride, in toluene at room temperature for 
10 min.
The products of these acylations were analysed by
gas liquid chromatography (G-LC) without purification.
Synthesis of some reference samples of esters and amides
allowed standardisation of the analytical method.
Drimanoic acid (30 mg) in dry toluene (3 ml) was
treated with redistilled thionyl chloride (300 jil) under
reflux for 1 h. Removal of excess thionyl chloride and
solvent yielded a yellow oil which was purified by vacuum
distillation (60°C/0.2 mm Hg) to give a colourless oil, which
_ ^
showed Vq_q 1805 cm- (liquid film). The purified 
drimanoyl chloride was added to a solution of 1-menthol 
(30 mg) in toluene and refluxed for 2 h. The toluene was 
removed by distillation leaving a dark yellow oil which was 
purified by preparative thin layer chromatography (TLC) 
using benzene:Et0Ac, 20:1 v/v as mobile phase, yielding a 
pale yellow oil (25 mg),V q_q = 1725 cm (liquid film).
After purification by vacuum sublimation (block temperature 
80°C/0.5 mm Hg)y analysis gave C, 80.0; H, 11.9$
C25H44°2 re(lu-^res 79.7; H, 11.8$.
Similarly 1-menthol chrysanthemate was prepared,
Pound : 0, 78.2; H, 11.2; Oalc. for 02QE^02 : C, 78.4;
H, 11 .2$.
The chrysanthemoyl derivative of 1-amphetamine was 
purified by vacuum sublimation (80°C/0.2 mm Hg) to give white
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crystals, m.p. 97-101 °C; y N_H = 3430, y c-0 = 1675 cm”1 
(CC14 solution). Pound : C, 79.9; H, 9.6; N, 4.9%
C^I^ON requires C, 80.0; H, 9.5; N, 4.9%.
(b) Acid anhydrides
Acid anhydrides were prepared by the reaction of the 
acid chloride with a slight ezcess of the sodium salt, in 
toluene solution, under reflux for 1 h. After filtration to 
remove sodium chloride, and removal of solvent in vacuo, 
traces of unreacted acid were removed by vacuum sublimation 
using a cold finger apparatus. The purity of the anhydride 
was checked by infra red spectroscopy.
Phenylbutyric : a c i d y = 1700; acid-Cl "y = 1799;
anhydride y = 1810 and 1742 cm”1. 
Phenylpropionic : acidVG_0 = 1705; acid-01 Vq_q = 1800;
anhydride y = 1815 and 1745 cm”1. 
Preparation of amides : The amine or amino acid methyl
ester (10 jimol) was treated with an equimolar quantity of 
acid anhydride in toluene (50 ^ .1) at room temperature, for 
10 min. After dilution with ethyl acetate (1 ml), the 
products were analysed by G-LC and gas chromatography-mass 
spectrometry (GC-MS) without further purification.
A reference standard of amide was prepared from (+)-a- 
phenylethylamine and (-)-a-phenylbutyric anhydride. After 
purification by vacuum sublimation (block temperature 105°C,
4 mm) this had m.p. 70-73°C. Pound : 0, 80.9; H, 7.8;
N, 5.4%. C^gH^NO requires C, 81.2; H, 7.9; N, 5.3%. 
Infra-red spectroscopy showed V = 3280 andVg^Q = 1640 cm
- 60 -
(c) Imidazolides
The preparation of imidazolides is outlined below for 
phenylbutyric acid.
N^N^carbonyldiimidazole (180 mg) was stirred at room 
temperature with (RS)-a-phenylbutyric acid (180 mg) in dry, 
redistilled chloroform for 30 min. Evolution of CO2 was 
observed. After shaking with water to remove imidazole the 
chloroform layer was dried over Na2S0  ^and evaporated to 
dryness to yield a pale yellow oil which crystallised on 
standing. Recrystallisation was effected from benzene
_ i
yielding white crystals, m.p. 75-80 C,yc_Q = 1740 cm”
(CC14 soln.).
Pound : C, 71.3; H, 6.8; N, 12.8%. requires
C, 71.9; H, 6.6; N, 13.1%.
The 1H M R  spectrum showed 8, 8.15 (1H, S) [-H on C-2
of imidazole ring]; 7.4 (1H, d, J = 2 Hz) [-H on C-5 of
imidazole ring]; 7.2 (5H, s) [aromatic-H]; 6.94 (1H, d,
J = 2 Hz) [-H on C-4 of imidazole ring]; b-o(1H, t, J = 7 Hz)
[benzylic-CH-]; 2.0 (2H, m, J = 7 Hz) [-Ci^ -]; 0.92
(3H, t, J = 6 Hz) [-CHj].
The resonances were assigned to the protons in the
1
imidazole ring on the basis of the H M R  spectrum of N-acetyl
• n 528imidazole•
The mass spectrum (22.5 eV) showed M* 214, 12%; 91, 100%
[tropylium cation]; 119, 92% [Ph-CH-Et]+; 146, 47% 
[M^-imidazole].
Por small scale reactions the imidazolides were
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prepared using 10 ^ irnol of acid in dry chloroform (50 ul) 
with an equimolar amount of N,N'-carhonyldiimidazole.
After 10-15 min at room temperature the amine or amino 
acid methyl ester (10 jomol) was added and the reaction mixture 
left at room temperature for 2\ h. The solution was 
shaken with 50 yil water for 1 min, then centrifuged for 5 
min. The chloroform layer was removed, passed through a 
small column of and blown to dryness in a stream
of nitrogen. The sample was then dissolved in ethyl 
acetate for analysis by G-LC.
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2.2. Drug metabolism
2.2.1. Isolation of urinary metabolites
(a) Spironolactone metabolites
Steroids and steroid conjugates were selectively 
adsorbed from urine onto the surface of Amberlite XAD-2 
(Rohm and Haas, Ltd.), a synthetic insoluble crosslinked 
polystyrene polymer, supplied in bead form. 1 Kg resin was 
washed with distilled water until free from chloride and 
washed with methanol until no further elution of styrene 
was observed. A column was packed using a slurry of the
resin in distilled water and prepared for use according to
32Qthe method of Bradlow. J 2-4 Litres of urine were 
percolated through the column under gravity flow, followed 
by 4-6 litres of water. The steroids were then eluted 
with 4-5 litres of methanol.
After removal of the solvent under vacuum the residue was 
partitioned between chloroform and water, yielding free 
steroids (chloroform layer) and conjugated steroids 
(aqueous layer).
(b) Ibuprofen metabolites
Urine was diluted with saturated brine and extracted with 
ether and ethyl acetate. The pH was then adjusted to 1 
with 12M HC1 and the urine was re-extracted with ether-ethyl- 
acetate. The combined extracts were back-washed with 
aqueous NaOH solution and the organic phase was discarded. 
After re-acidification the aqueous layer was extracted with
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ether and ethyl acetate and the combined extracts dried 
over Na2S04 and evaporated at reduced pressure to yield a 
crude acidic extract. The aqueous layer was retained 
since it contained conjugated metabolites.
2.2.2. Hydrolysis of conjugated metabolites
Conjugates were hydrolysed by incubation with 
"G-lusulase" (Endo Lab. Inc. ; 179,000 units/ml p-
glucuronidase, 47,000 units/ml sulphatase) in 0.1M acetate 
buffer at pH 4.6 and 37°C for 24 h. 2.5 ml enzyme was 
used per litre of urine. After adjustment of the pH 
to 5.5 and addition of another 1.5 ml enzyme per litre 
urine, the incubation was continued for a further 24 h.
The solution was then diluted with saturated brine and 
solvent extracted as before.
2.2.3. Rat liver preparations
A rat was killed by a blow to the neck, the liver 
removed and immediately minced and homogenised in 
phosphate buffer (0,1M, pH 7.6). The homogenate was spun 
at 2,000 g for 10 min and the supernatant removed.
NADP, NADPH, GSH, Glc-6-phosphate, MgCl2 and EDTA were added 
to the supernatant as co-factors, then ibuprofen and Grlc-6- 
phosphate-dehydrogenase were added and the mixture 
incubated at 37°C for 3 h. Solvent extraction as previously 
described yielded a crude acidic extract.
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2.3. Analytical techniques
2.3.1. Column chromatography
Silicic acid columns were prepared using silica 
gel for "dry column chromatography” (Woelm, Ltd.,
Eschwege, G-.F.R.). The silica was packed dry in glass 
columns fitted with sintered glass discs and stopcocks.
A loading of approximately 10 mg of crude material per 
g of silica was used and the sample was applied to the 
top of the column in a small portion of solvent. The 
stopcock was left open during application of the sample and 
addition of the solvent to avoid the introduction of gaps 
into the column.
A suitable solvent was chosen by examining the 
separations achieved on TLC. ftp values obtained on the 
columns were in general slightly higher than those found 
for the same compounds on TLC using the same mobile phase.
An elution technique was employed, and the size of the 
fractions collected was estimated from the thin layer 
chromatographic separation. Progress was monitored by micro 
plate TLC.
Liquid-gel chromatography was performed on the
lipophilic gel, Sephadex LH-20 (Pharmacia, Uppsala, Sweden)
with 1 ,2-dichloroethane/methanol, 7:3 v/v as mobile phase
330,331or on the substituted gel N1518 LH20 using benzene
(straight phase) or methanol/heptane 9:1 v/v (reverse phase) 
as solvent. All solvents were dried and redistilled prior 
to use, and glassware was silanised with a 5$ solution of
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dimethyldichlorosilane in toluene. The gel was pre­
swollen in the elution solvent and packed by 
sedimentation under gravity flow in glass columns
(100 x 0.9 cm), fitted with Glenco No. 3020 Teflon
332
Connectors at the bottom. Samples were applied to
the top of the column in a small portion of eluting 
solvent using a drawn-out Pasteur pipette or a Hamilton 
syringe. The eluate was monitored with a Pye-Unicam 
System 2 liquid chromatograph and fractions were collected 
with an automatic fraction collector (BTL Chromafrac).
2.3.2. Thin layer chromatography (TLC)
Glass plates (20 x 20 cm or 5 x 20 cm) were coated to 
a thickness of 0.25 mm or 0.5 mm with Kieselgel ^254 
(E. Merck, Darmstadt, Germany) using a Quickfit (Quickfit 
and Quartz Ltd., Stone, Staffordshire) Spreader. The 
adsorbent was applied as a slurry in distilled water. 
Plates were air dried for 20 min after spreading, then 
activated at 120°C for 30 min-1 h in a clean oven.
Chromatograms were developed in Shandon Chromatanks 
(Shandon Scientific Co. Ltd., London) (20 x 20 cm) or 
gas-jars (5 x 20 cm) lined with filter paper to aid 
atmosphere saturation, through a distance of 15 cm, from 
origin to solvent front.
For analytical TLC samples (10-30 jig in a volatile 
solvent) were applied to the 0.25 mm. layers using a 
1° F1 Hamilton syringe or drawn-out capillary tubes.
Spots on the developed chromatograms were generally
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detected by spraying with a solution of 5$ (w/v) 
eerie sulphate in 10$ sulphuric acid followed by heating 
at 1 50°C for a few min. In many cases, particularly 
steroids, characteristic colours developed after heating 
for 1-2 min. The ibuprofen metabolites were not 
well detected with eerie sulphate, and a superior spray 
reagent for their detection was found to be 5$ (w/v) 
phosphomolybdic acid in ethanol. After heating for 
2-3 min, blue spots appeared. Ketonic material was 
detected by spraying with a solution of 0.5$ (w/v) 2,4- 
dinitrophenylhydrazine in ethanol (1 litre) plus 10 ml 
concentrated hydrochloric acid. Yellow or orange spots 
appeared without heating.
A load of approximately 30-40 mg material could be 
applied to a 20 x 20 cm, 0.5 mm layer for preparative 
TLC without considerable deterioration in separation. 
Samples were applied in a band across the plate using a 
50^ .1 Hamilton syringe. Bands on developed chromatograms 
were located by the quenching of the fluorescence of the 
modified layer at 254 nm. On the few occasions where no 
material was visible under u.v. light, brief exposure to 
iodine vapour was employed. The silica was scraped from 
the plate and the material eluted in chloroform:methanol 
9:1 (v/v). In the case of aromatic and/or very polar 
compounds the silica was first deactivated with water and 
then extracted with ethyl acetate.
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2.5.3. G-as liquid chromatography (GLC)
G-LC was performed on either a Perkin-Elmer 881 or a 
Pye Unicam Series 104-dual column chromatograph, both 
fitted with flame ionisation detectors. G-lass columns 
of length 1,5 m, 3 m or 5 ni and 3 mm i.d. were used.
Before packing, the columns were treated with a 5$ solution 
of dimethyldichlorosilane in toluene. Column packings 
were obtained from Applied Science Laboratories, Inc.,
State College, Pa., and the following were used :
1 $ SE-30 (methyl siloxane polymer) on 100-120 mesh 
G-as-Chrom Q.
1 $ OV-1 (methyl siloxane polymer) on 100-120 mesh 
Gas-Chrom Q.
1 $ OV-17 (phenyl methyl siloxane polymer, 50$ phenyl) 
on 100-120 mesh Gas-Chrom Q.
1$ QF-1 (fluoroalkyl siloxane polymer) on 100-120 mesh 
Gas-Chrom Q.
Oxygen-free nitrogen was used as carrier gas with a 
flow rate of 40 ml/min. Both instruments were fitted 
with injection port heaters which were kept approximately 
50° above the temperature of the column.
Samples forGLC were dissolved in ethyl acetate 
(1-2 mg/ml) and aliquots of 1-2 jul were injected using 
a 10^1 Hamilton syringe. Retention indices were 
measured with respect to n-alkanes.
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2.3.4. Gas chromatography-mass spectrometry (GC-MS)
Mass spectra were recorded at electron energy 22.5 or 
70 eV using an LKB 9000 gas chromatograph-mass spectrometer. 
A glass column (3 m x 3 mm i.d.) packed with 1% OV-1 was 
used to effect GJ-C separations with helium as carrier gas.
The trap current was 60 ^ lA; accelerating voltage 3.5 kV; 
electron multiplier voltage, 2.3-2.7 kV; molecule separator 
temperature, 250-270°C;ion source temperature, 250-270°C; 
entrance slit, 0.1 mm; exit slit, 0.1 mm. Spectra were 
obtained using an oscillographic recorder. Scans taken in 
the absence of sample allowed correction of the spectra for 
background ions.
Accurate mass measurements were carried out by Mr. A. 
Ritchie using an A.E.I. MS-902S instrument at 70 eV.
2.3.5. Infra-red spectroscopy (IR)
IR spectra were recorded as carbon tetrachloride 
solutions, KBr discs, or liquid films using a Perkin-Elmer 
257 Spectrophotometer.
2.3.6. Nuclear magnetic resonance spectroscopy (NMR)
NMR spectra were recorded at 100MHz on a Varian HA 100 
instrument, using CDCl^ as solvent. Interpretation of the 
spectrum of hydroxy-fenoprofen was facilitated by the use 
of a lanthanide shift reagent - europium 1 ,1 ,1 ,2,2,3,3- 
heptafluoro—7,7-dimethyl-4,6-octanedionate[Eu(fod)^ ].
Spectra were recorded at 0.2 M-1M Eu(fod)^ concentrations.
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2.3.7. Ultra-violet spectroscopy (UV)
UV spectra were recorded in ethanol solution 
using a Pye-Unicam SP 8000 spectrophotometer.
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2.4. Chemical techniques
2.4.1. Preparation of methyl esters
Carboxylic acids were methylated with an ethereal
solution of diazomethane (freshly prepared from bis-
333
(N-methyl-N-nitroso)terephthalamide) at room temperature.
When the yellow colour of diazomethane persisted the 
reaction was complete and excess reagent was removed in 
a stream of nitrogen.
Amino acids were converted to their methyl esters by 
refluxing in methanolic HC1 solution (prepared from methanol 
and acetyl chloride) for 1 h. After removal of methanol 
the free bases were liberated by aqueous bicarbonate and 
the amino acid methyl ester extracted into ethyl acetate.
2.4.2. Trimethylsilylation of alcohols
Unhindered alcohols were trimethylsilylated in 
dry pyridine with hexamethyldisilazane-trimethylchlorosilane 
(5:1), or bis(trimethylsilyl)acetamide without catalyst, 
at 60°C for 15-30 min.
More hindered tertiary alcohols were completely 
trimethylsilylated with bis(trimethylsilyl)acetamide- 
trimethylchlorosilane at 60° after 30 min.
Perdeuterated trimethylsilyl ethers were formed with 
[ckj g]--bis(trimethylsilyl)acetamide, (Merck Sharp & Dohme, 
Montreal, Canada) under the same conditions.
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2.4.3. Preparation of chlorometh.yldimeth.ylsil.yl (CMDMS) 
ethers
CMDMS ethers were prepared with 1,3-bis-(chloromethyl) 
-1 ,1 ,3,3-tetramethyldisilazane-chloromethyldimethylchloro- 
silane (2:1) in pyridine for 1 h at 60°C.
2.4.4. Reduction of esters with lithium aluminium hydride
The ester sample (100-500 p.g) was dissolved in sodium- 
dried diethyl ether and LiAlH^ added. The mixture was 
warmed gently for 10 min, then excess reagent was removed 
by cautious addition of ethyl acetate. When effervescence 
had ceased water and more ether was added. The products 
were recovered from the dried ethereal layer.
Deuterated products were obtained by reducing the 
ester as above with lithium aluminium deuteride (Ciba, 
Basle, Switzerland).
2.4.5. Alkaline hydrolysis of esters
The ester was treated with an ethanolic solution of 
potassium hydroxide (6 ml 33$ KOH in 50 ml ethanol) at 
40°C for 1 h. Ether extraction removed any neutral 
material; subsequent acidification followed by ether 
extraction yielded the acidic components.
2.4.6. Oxidation
Oxidations with CrO^/HgSO^ were carried out in 
acetone at 5-10° for 15 min.
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2.5. Synthesis of 2,41 -(1-hydroxy-2-methylpropyl) 
phenyl-propionic acid
Ibuprofen methyl ester (200 mg) was dissolved in 
carbon tetrachloride and N-bromosuccinimide (150 mg) in 
carbon tetrachloride added. The reaction mixture was 
refluxed for 5 h, then left at room temperature overnight.
The crystallised succinimide was removed by filtration and 
after removal of solvent in vacuo a pale yellow oil (267 mg) 
was obtained. The oil was dissolved in methanol (10 ml) and 
10$ aqueous NaHCO^ solution (10 ml) was added. After 
refluxing for 2 h the solution was acidified with dilute 
HC1 and extracted with ether. The ether extract was 
dried over ^ 2^0  ^and evaporated to dryness yielding a pale 
yellow oil (217 mg).
The purity of the product was assessed by TLC and G-LC. 
Analytical TLC showed three spots,
R-p = 0.49, 0.63, 0.74 (CHCl^/EtOAc, 3:1 v/v)
GLC on 10* 1$ OV-1 at 150°C indicated that the product 
was 40$ 2,41-(1-hydroxy-2-methylpropyl)phenylpropionic 
acid methyl ester (I = 1700) and 25$ unreacted starting 
material (I = 1510). The third peak (I = 1605) was shown 
by GC-MS to be the methyl ether of the product, presumably 
produced on hydrolysis of the bromide.
Purification was effected by preparative TLC with 
chloroform/ethyl acetate 3:1 v/v as mobile phase, and the 
product characterised as described in Sec. 3.3.2,
Section 3. Results
SEPARATION OF (±)~TERPENOLS 
AS ESTERS OF CHRYSANTHEMIC
ACID
1) (±)- FENCHYL ALCOHOL
2) (t)-neo-MENTHOL
3) (t)-MENTHOL
-5m 1°/o SE-30 
143°C
8 16 24 32 40
minutes
48 56
Fig. 12. Gas chromatographic separation of (-)-fenchol, 
(-)-neomenthol and (-)-menthol as esters of 
chrysanthemic acid.
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3.1 • Resolution of enantiomeric alcohols and amines 
•with terpenoid reagents
3.1.1. Drimanoates and chrysanthemates of chiral 
secondary alcohols
The degree of resolution achieved varied greatly
(Table 7), although in general chrysanthemic acid proved
a more suitable resolving agent for the alcohols studied.
The isomeric menthols illustrate this variation. Although
the drimanoates of (+)- and (-)-menthol were well separated
those of the enantiomeric neomenthols showed no resolution
while the isomenthols showed only a partial separation
(AI = 5). The chrysanthemates of all three diastereomeric
pairs gave a retention index difference of 15, which gives
complete peak resolution (e.g. Pig.12. and Table 7). A
better measure of diastereomeric differences is the relative 
1 "^7volatility, a : JX
tR2 " ta K2
v ^ ;  = ^
Where t-r, and t-n are the retention times of the first and 
R1 R2
second components respectively, t is the inert gas
a
retention time, and and are the respective gas- 
liquid partition coefficients.
Using the retention time of the solvent as t&, a 
values were calculated. On this basis the enantiomeric 
neomenthols (a = 1.13) showed a better resolution than the 
menthols (a - 1.11) and the isomenthols (a = 1.07). These
Table 7 . Retention index values for drimanoates and 
chrysanthemates
Drimanoates Chrysanthemates
Alcohols T11o SE-30 190 ± 2° A I
T1 fo SE-30 
143 ± 1° A I
(+)-2-0ctanol (§) 2280 1725
20 15
(-)-2-0ctanol (R) 2300 1740
(+)-Menthol (s) 2435 1880
15 15
(-)-Menthol (R) 2450 1895
(+)-Isomenthol (s) 2430 1880
5 15
(-)-Isomenthol (R) 2435 1895
(+)-Neomenthol (§) 2395 1835
0 15
(-)-Neomenthol (R) 2395 1850
(+)-Borneol (!) 2475 1900
0 5
(-)-Borneol (R) 2475 1905
(+)-Isoborneol (S) 2475 1895
0 10
(-)-Isoborneol (R) 2475 1905
(+)-Penchol (R) 2410 1825
5 15
(-)-Fenchol (S.) 2405 1810
(+)-Pantolactone (S) 2405 1820
15 10
(-)-Pantolactone (R) 2390 1810
Methyl (R)-(-)--1 2-hydroxystearate 3580a 2920e
15 10
Methyl (S)-(+)--1 2-hydroxystearate 3565a 291 oe
Methyl (R)-(-)--13-hydroxystearate 3570b —
>v 15 —
Methyl (§)-(+)--1 3-hydroxystearate 3555° —
Methyl (R)-(-)--mandelate 2580 2030°
5 10
Methyl (S)-(+)--mand elate 2575 2020°
(-)-17|3-Hydroxy-4-estren-3-one 4110d 331 oe
(-)Estradiol 3-methyl ether - 3355f's
a 262°0; b 272°C; c 160°C; d 285°C; e 225°C; f 250°C;
^ partial resolution of peak.
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H
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Pig, 13. Space projection of (a) (S)-menthol -(S)-drimanoate, 
(b) (S)-pantolactone, and (c) (Sj-menthol-(R)- 
chrysanthemate.
SEPARATION OF (±)-PANTOLACTONE 
AS ESTERS OF DRIMANOIC ACID 
5 m 1% SE-30
189 °C
"0  8 *16 24 32 40  48 56
minutes
Pig. 14. Gas chromatographic separation of (-)-
pantolactone as esters of drimanoic acid.
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were some of the best separation factors achieved.
Trends could also be observed in the order of elution 
of the diastereomers. With the exception of pantolactone, 
the diastereomeric drimanoates were always eluted in the 
order (SS) before (SR) while the chrysanthemates showed the 
reverse order, (rs) before (RR). On examination of molecular 
models these elution orders could be correlated with the
225
mechanism of "bulkiness chirality” proposed by Feibush : 
the diastereomer emerging last from the column, when 
viewed along its long axis, has the same direction of 
bulkiness chirality (L ■* M ■* S) at both asymmetric carbons. 
Figure 13 illustrates the situation for menthol. Viewing 
the (ss)-drimanoate diastereomer it is seen that the two 
asymmetric centres have the substituents arranged in 
opposite directions (L M S) and this should be the 
diastereomer eluted first. This is also the situation 
for all the other alcohols except pantolactone. In this 
case (Pig.13) the carbonyl carbon (C-1 ) takes precedence 
over C-3 in the sequence rule but the dimethyl grpup is 
bulkier than the carbonyl and the (SS) diastereomer is 
eluted later thanfSR) (Fig.14)•
A similar correlation may be observed in the case of 
the chrysanthemates. Although, according to the 
sequence rule C-4 takes precedence over C-3, the isobutenyl 
group is bulkier than the dimethyl group so the 
chrysanthemoyl moiety shows an anticlockwise arrangement 
in the bulkiness diagram (Pig.13) and consequently the (rs) 
diastereomers are eluted first.
oPig.
5m 1°/o SE~30 
272°C 
METHYL 13 (±)r HYDROXY- 
-STEARATE 
DRIMANOATE
13 H
■€.
T TT TT
8 16 24
minutes
32 40
15. Gas chromatographic separation of (-)- 
methyl-13-hydroxystearate as esters of 
drimanoic acid.
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Enantiomeric alcohols in which the chiral carbinol
group is followed by methylene chains are difficult to
resolve as diastereomeric derivatives.^^ Several
methyl hydroxystearates have been analysed as diastereomeric
2jp)-phenylpropionate derivatives using QF-1 as stationary 
145phase. Good separations were achieved for methyl-
3-hydroxy-, 16-hydroxy-, and 17-hydroxy stearates and an 
adequate separation of methyl 15-hydroxystearates was 
observed. However no visible separation of the phenyl- 
propionates of methyl 13-hydroxystearates could be obtained. 
Attempts to resolve the enantiomeric methyl 13-hydroxy- 
stearates as (R)-(+)-1-phenylethylurethanes or (R)-(-)- 
menthylcarbonates, or (R)-(-)-menthoxyacetates proved 
unsuccessful, but the corresponding drimanoates were 
satisfactorily distinguished,^^>534 (pig. -j 5) # Partial 
separation of methyl 12-hydroxystearates, both as 
drimanoyl and chrysanthemoyl derivatives, was also achieved.
The minor peaks of shorter retention time, observed in 
the traces of all drimanoyl derivatives, were shown by 
GrC-MS to be isomeric with the major derivatives. The 
shorter retention time and the reversal of the order of 
elution of diastereomers suggested that these might be 9- 
epidrimanoyl derivatives. Methylation of a sample of 
drimanoic acid with diazomethane produced one peak on G-LC,
= 1700, but methylation via the acid chloride
1 OV—1
with methanol gave two peaks, = 1665, 1700 the
minor peak being eluted first. G-C-MS confirmed that 
these peaks were isomeric methyl drimanoates. However,
5 m 1°/o SE-30 
200°C
(±)-AMPHETAMINE
DRIMANAMIDE
minutes
Pig. 16. Gas chromatographic separation of the N« 
drimanoyl derivatives of (+)- and (-)- 
amphetamine.
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attempts to separate and fully characterise these 
minor products formed during the acylation process 
were unsuccessful. No similar complications were 
observed with chrysanthemoyl chloride.
3.1.2. Drimanoyl and chrysanthemoyl derivatives of 
chiral amines and amino acids
Considerable variations were observed in the degree
of resolution achieved within the series of amines and
amino acids studied (Table 8). The primary, amines were
adequately resolved by drimanoic acid, as illustrated by
the N-drimanoylamphetamines in Figure 16. However the
secondary amine, N-methyl a-phenylethylamine showed no
141separation. It has been suggested that the amide 
hydrogen is involved in hydrogen bonding which enhances the 
differential between diastereomers. This could explain the 
loss in resolution on replacement of the amide hydrogen 
by a methyl group.
The results obtained with chrysanthemic acid did 
not directly match those of the drimanoyl derivatives.
Since no separation was observed for either a-phenylethylamine 
or N-methyl a-phenylethylamine, while both amphetamine and 
N-methylamphetamine were well resolved, a critical factor 
might appear to be the distance of the amino function 
from the aromatic ring. A similar result was noted with 
the amino acid methyl esters : phenylglycine methyl ester
was not separated as the chrysanthemamide, whereas the 
N-chrysanthemoyl-phenylalanine methyl esters were well
Table 8. Retention index values for drimanamid.es and
chrys anthemamid e s
Drimanamides Chrysanthemamides
x1fo SE-30 A I Temp, j\lo SE-30 AI Temp
(R)-(+)-a-Pheny1- 
ethylamine
2535
20
187 1990
0
171
(S) - (-)-a-Pheny1- 
"ethylamine
2515 187 1990 171
(S)-(+)-Amphetamine 
(R)-(-)-Amphetamine
2600
2620
20
200
200
2025
2035
10
160
160
(R)-(+)-N-methyl-a- 
phenylethylamine
2630
0
200 2035
0
171
(S)-(-)-N-me thyl-a- 
phenylethylamine
2630 200 2035 171
(S)-(+)-Me thamphe t amine 
(R)-(-)-Methamphetamine
2095
2110
15
186
186
(R)-(-)-Valine methyl 
"ester
2335
5
190 1800
15
143
(S)-(+)-Valine methyl 
"ester
2-340 190 1815 143
(R)-(+)-Proline methyl 
ester
2465
5
220 1925
5
143
(S)-(-)-Proline methyl 
ester
2470 220 1930 143
(R)-(-)-Phenylglyc ine 
methyl ester
2750
0
220 2170
0
189
(§)-(+)-Phenylglycine 
methyl ester
2750 220 2170 189
(R)-(+)-Phenylalanine 
methyl ester
2810
10
218 2240
15
189
(§.)-(-) -Phenylalanine 2820 218 2255 189
methyl ester
 ^ !SEPARATION OF 
| (±)— PHENYLALANINE 
METHYL ESTER AS 
AMIDES OF 
CHRYSANTHEMIC ACID 
5 m 1%  SE-30 
189°C
O 8 24 §2
minutes
I
Pig. 17. Gas chromatographic separation of the N-
chrysanthemoyl derivatives of (+)- and (-)- 
phenylalanine methyl ester.
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distinguished (Pig.17).
The order of elution of the diastereomers predicted
on the basis of the bulkiness of the groups around the
chiral centres agreed with that observed in all cases.
In the case of the four amines studied the order of
groups in the sequence rule was the same as the order of
bulkiness and the observed elution pattern was (ss) before
(SR) for the drimanoyl derivatives and (RS) before (rr) for
the chrysanthemamides. When considering the amino acids
the carbomethoxyl group took precedence in the sequence
rule but the phenyl group (phenylalanine) or the isopropyl
group (valine) was seen to be larger on examination of
molecular models and the order of elution of the
diastereomers was reversed. In the case of proline
methyl ester the rigid ring system must take preference
over the carbomethoxyl group to explain the observed
elution order, but this was not obvious from an examination
of molecular models. Hence the N-drimanoyl amino acid
methyl esters followed the elution order proposed by
1 54Westleyand Halpern, based on the analysis of N- 
trifluoroacetyl-(S)-(-)-prolyl derivatives, viz. an (RS) 
or(SR) derivative generally has a shorter retention time 
than its (JIR) or (SS) diastereomer. The N-chrysanthemoyl 
amino acid methyl esters, however, showed the reverse 
order.
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3.1.3» Mass spectral characteristics
Salient features of the mass spectra of 0- and N- 
drimanoyl derivatives are cited in Table 9. Simple 
fragmentation modes represented in Figure 18 are indicated 
by superscripts in the table. Ions below ffi/e 80 have 
been disregarded since they are generally of limited 
value in structural diagnosis. Molecular ions were 
observed in all instances and were particularly abundant 
in the spectra of the R-drimanoyl derivatives.
Drimanoates
Major fragments characteristic of the drimanoyl 
moiety were observed in all the spectra . Alkyl-oxygen 
cleavage produced an ion at S/e 237 from the drimahoyl 
portion or [M-237]+ characteristic of the alcohol. The 
abundance of the [M-237]+ ion varied considerably : this
fragment constituted the base peak in the spectra of the 
esters of borneol, fenchol and methyl mandelate, but was 
absent in those of 2-octyl drimanoate and pantolactone 
drimanoate. Alkyl-oxygen cleavage also occurred with 
rearrangement of one hydrogen atom to produce the 
drimanoic acid ion, m/e 238 (Scheme 1).
m/e 238
Scheme
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Pig. 19. Illustrative mass spectra of O-drimanoyl 
derivatives.
a) Mass spectrum of menthyl drimanoate.
b) Mass spectrum of methyl-13-hydroxystearate 
drimanoate.
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Acyl-oxygen cleavage produced the drimanoyl ion 
[^ 1^ 2^03 at m/©, 221 . No evidence was obtained in 
the present work for the occurrence of acyl-oxygen 
cleavage with the charge residing on the alcohol moiety.
Other characteristic ions of high abundance were the 
nordrimanyl ion [C^H2 ]^+, m/e 193, and the fragment 
from ring A of the drimane nucleus at m/e 123.
Typical ester spectra are presented in Figure 19 for 
menthyl drimanoate and methyl 13-hydroxystearate drimanoate.
N-drimanoyl derivatives
In addition to the ions already mentioned from the 
drimanoyl portion, the amide spectra showed more ions 
characteristic of the amine or amino acid under 
consideration. Salient features of these are further 
discussed below.
a) a-Phenylethylamine and N-methyl-a-phenylethylamine 
The base peaks in these spectra at m/e 163 and 177, 
respectively were ascribed to species formed by methyl 
group migration, (Scheme 2).
/ C H M e P h  
R CHMePh 
\ * /  
N
/ \
Me CO
(A) m/e 178 (B) m/e 163,177
Scheme 2
->
19
3
o
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High resolution mass spectrometry of the N-drimanoyl 
derivative of N-methyl-a-phenylethylamine showed the 
peak at m/e 177 to comprise two ions in the ratio 4:1, 
viz C^H^NO ((B) as above) : calc. 177*1154; found,
177-1645; found, 177 1647.
b) Amphetamine (Pig. 2 0a)
The major ions in the mass spectrum of amphetamine 
drimanamide were produced by simple fissions as shown 
in Figure 20a. Evidence for formation of the base peak, 
the 11 -nordrimanyl ion (m/e 193) via the ion of m/e 2.2.1. 
was obtained from a "metastable” ion at m/e 168.6. The 
abundant ion at m/e 118 was formed by alky1-nitrogen 
cleavage with transfer of one hydrogen atom as shown in 
Scheme 3.
c) Valine methyl ester
The base peak (m/e 132) in this spectrum was formed 
by cleavage of the amide bond together with the transfer 
of two hydrogen atoms on to the nitrogen (Scheme 4).
177*1158; and , corresponding to [(A)-H]+ : calc.
9 h 3
nt
Scheme 5
-81 -
CH2-fH) C 0 2M c 
C ^ N H -C H  “
b  C3H7
C 0 0Me 
+ / ^
n h 2- c h
C3H7
1
C 0 2Me / W c H29  C O jM e
C jH y—C H -N H j ^  X fV N H ^ C H
m/G 132 ^  'b  ^ 7
Scheme 4
The abundant ion at m/e 173 was formed by cleavage 
adjacent to the C=0 group with migration of a methyl 
group, according to Scheme 2, while that at m/e 114 was 
due to alkyl-nitrogen cleavage with hydrogen transfer as 
shown in Scheme 3.
d) Phenylglycine methyl ester and Phenylalanine methyl 
ester.
Again the base peaks (m/e 385 and 399 respectively) 
were formed by cleavage of the amide bond with 
rearrangement of two hydrogen atoms (cf. Scheme 4).
Major ions at m/e 106 and 120 respectively, could be
335
attributed to the imonium fragment, (Scheme 5).
COOH 
m/e 168
tO O H  
m/e 153
OR
ti
m/e 123
m/e 151
m/e 81
Pig. 21. Mass spectral fragmentation scheme for 
derivatives of chrysanthemic acid.
CHo" L-n-iNrl
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c h 2-  c h = nh
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I
R R
1
+
m/e 120
Scheme 5
Fragmentation according to Scheme 2 was also 
observed producing ions at m/e 207 and 221 . The ion 
at m/e 221 in the spectrum of phenylalanine methyl 
ester drimanamide (Fig. 2Ob) could also be formulated as
produced the ion at m/e 149 in the spectrum of phenyl- 
glycine methyl ester drimanamide but this fragmentation 
was accompanied by hydrogen transfer in the case of N- 
drimanoyl phenylalanine methyl ester to give the ion at 
m/e 162 (cf. Scheme 3).
The mass spectral fragmentation of chrysanthemate 
esters is already known for the naturally occurring 
pyrethrins. The principal ions previously
observed are presented in Figure 21 and indicated by 
superscripts in Table 10.
Ohrys anthemate s
The synthetic diastereomeric esters showed a similar
336fragmentation pattern to that noted earlier. The base
peak in the majority of the spectra was represented by 
the norchrysanthemyl cation [CgH^]+ (m/e 123), and other 
major ions were produced from the chrysanthemoyl moiety.
the drimanoyl ion [C^IL^O]4". Alkyl-nitrogen cleavage
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Illustrative mass spectra of 0- and N- 
chrysanthemoyl derivatives.
a) Mass spectrum of menthyl chrysanthemate.
b) Mass spectrum of amphetamine chrysanthemamide.
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Ions characteristic of the alcohol were produced by 
alkyl-oxygen cleavage in all cases except those of 2- 
octyl chrysanthemate and pantolactone chrysanthemate.
The terpenol esters (cf. Pig. 22a for menthol chrysanthemate) 
showed ions at m/e 83 ]+ or m/£ 81 [C^ H^ ]+ due to
further fragmentation of the alcohol portion.
N-Chrysanthemoyl derivatives
Major fragnents were again observed from the 
chrysanthemoyl moiety and p-cleavage produced ions 
characteristic of the amine or amino acid. The base 
peaks in the spectra of derivatives of N-methyl-a- 
phenylethylamine (m/e 105) and methamphetamine (m/e 91) 
were the methyl-benzyl and benzyl ions respectively. The 
spectrum of amphetamine chrysanthemamide is represented 
in Pigure 22b and the formation of the major ions is 
indicated. Ions produced by N-acyl cleavage with the 
charge residing on the amine fragment were not observed to 
any great extent except in the case of chrysanthemoylproline 
methyl ester, where the methyl pyrrolidine-2-carboxylate 
ion (m/e 128) formed the base peak. The rearrangement 
ions which characterised the spectra of the N-drimanoyl 
derivatives were not observed from the chrysanthemamides.
3.1.4. Comparison of other chiral reagents
As a means of assessing the usefulness of the 
terpenoid reagents a comparison was made with a few gas 
chromatographic resolving agents which had previously been
Table 11, Retention index values for diastereomeric
derivatives of (-)-Amphetamine and (-)- 
Menthol (1 jo SE-30 column)
Derivative A Ma Amphetamine Menthol
x(+) *(-)
A I V) Z<-> AI
1j
(+)-Chrysanthemoyl 150 2025 2055 10 1880 1895 15
(-)-Menthoxycarbonyl0 168 2205 2205 0 2080 2080 0
(+)-a-Phenylethyl- 
carbamoyl' 161 - - - 2100 2110 10
(-)-Menthoxyacetyl0 182 2555 2550 5 2200 2200 0
Drimanoyl^ 220 2600 2620 20 2455 2450 15
5£-Acetoxy-5-etienyl 560 5840 5840 0 5570 5570 0
a Molecular weight increment accompanying derivative 
formation
■L
Column temperatures as in Tables 7 and 8.
c 185° 
d 280°
- 8 4 -
146used, viz : (R)-(-)-menthylchloroformate, (R)-(-)-
337 1menthoxyacetic acid, (R)-(+)-a-phenylethylisocyanate,
1 51and 3(3-acetoxy-5-etienic acid.
The results obtained for a representative alcohol, 
menthol, and amine, amphetamine, are presented in 
Table 11.
The only separations observed were for the 
(R)-1 -phenylethylcarbamates of (-)-menthol and 
(R)-(-)-menthoxyacetyl derivatives of (-)-amphetamine 
but the retention index differences were considerably 
inferior to those obtained with the terpenoid acids.
144
Table 1 2. Retention indices of amides of (1 ) (Rf (-)-phenylbutyric 
(3) (R^-3-methyl-2-phenylbutyric, (4) (RSj-cx-methoxy- 
(5) (sJ_(+)_a-Cl phenylacetic acid.
( 2 ) (s}-(+)-pheny lpropionic 
phenylacetic acid, and
(1) (2) (3)
($-a-phenylethylamine 2030 1995 r 2040
a-phe ny 1 e thy lamine 2060 1965 1 2070
(l^ -amphe t amine 2115 2065 " 2135
@-amphe t amine 2125 2065 . 2155
(RS)-p-chloro-amphetamine 2305 2235 2320
2320 2220 2345
(RS)-3-methoxy-4, 5- 261 5 2570 2660
me t hyle ne d i oxyamphe t amine 2635 2550 2700
(RVN-methyl-a-phenylethylamine 2105 2060 ' 2110
(s)-E-methyl-a-phenylethylamine 2120 2050 . 2120
(i^-me t hamphe t amine 2160 2130 ' 2190
(S)-me t hamphe t amine 2195 2110 . 2215
(R)-norvaline methyl ester* 1900 1830 r 1920
(s)-norvaline methyl ester* 1900 1830 „ 1920
(R)-valine methyl ester* 1870 1805 r 1900
(s)-valine methyl ester* 1880 1790 (1900
(ify-proline methyl ester 1990 1955 " 2015
(S)-proline methyl ester 2015 1940 . 2045
(R}-pheny lgly cine methyl ester 2230 2155 - 2225
(S)-phenylglycine methyl ester 2215 2165 ' 2250
(R)“phenylalanine methyl ester 2300 2245 ‘2330
(s)-phenylalanine methyl ester 2300 2245 .2330
T1# SE-30 
1 9 0 °c *1 w * c
(4)
f 2050 
12085 
f 21 50 
12175 
2315 
2345 
2640 
2690 
r 2150  
1 2150 
f 2210
I 2215 
f 1910 
1 1925 
f 1375 
11875 
2010 
2010 
f 2235 
2270 
2325 
2340
i
(5) (1) (2)
2090 2370 2355
2120 2400 2330
2180 2455 2420
2195 2470
2685
2705
2410
2230 2420 2415
2230 2445 2400
2310 2490 2485
2310 2515 2460
1970 2190 2140
1970 2190 2140
1920 2145 2100
1940 2155 2080
2120 2360 2360
2130 2390 2335
2305 2640 2580
2285 2620 2600
2375 2700 2650
2375 2700 2650
M o  ov-17
220°C
(3)
r 2410 
(2450 
c 2495 
\ 2520
2450 
2465 
2520 
12550 
'2235 
.2235 
[2190 
121 90 
f 2385 
12430 
C 2665 
12690 
'2740 
.2760
* 2 o s ° c  
(4)
'2445 
,2475 
’ 2525 
,2550 
'2710 
.2750
("2520 
1 2520 
f 2585 
* 2600 
2260 
2280 
f 2225 
2225 
2455 
2465 
2700 
2740 
2775 
2795
S E P A R A T I O N  O F  
A M I D E S  O F  ( - ) - P H E N Y L  
B U T Y R I C  A C I D
5 m  1 %  O V - 1 7  
2 20°C
O I O  . 2 0  3 0  4 0
minutes
Pig. 23. G-as chromatographic separation of (1) (R,S)- 
proline methyl ester; (2) (R,S)-amphetamine; 
(3) (R,S)-phenylglycine methyl ester as amides 
of (R)-(-)-a-phenylbutyric acid.
SEPARATION OF AMIDES 
OF (+)-PHENYL PROPIONIC 
ACID
5m I°/o O V- 17 
2 0 5 °  C
1.
3
2 .
v V_
O IO 2 0  30  4 0
minutes
Pig. 24. Gas chromatographic separation of (1) (R,S)-
valine methyl ester; (2) (R,S)-a-phenylethylam 
(3) (R,S)-N-methy1-a-phenylethylam ine as amides 
of (S)-(+)-a-phenylpropionic acid.
SEPARATION OF AMIDES 
OF RS-3-METHYL—2 —
1 PHENYLBUTYRIC ACID
2.
3m 1%  OV-17 
2 0 0 °C
1. *-PHENYLETHYL AMINE
2. PHENYLGLYCINE 
METHYL ESTER
v__
8 16 24 32 4 0
minutes
25. Gas chromatographic separation of (R,S)-3-methyl- 
2-phenylhutyric acid as amides of (1) (R)-(+)-a- 
phenylethylamine and (2) (S)-(-)-phenylglycine 
methyl ester.
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5.2, G-as chromatographic resolution of amines and
amino acids by formation of diastereomeric amides 
with substituted phenylacetic acids
3.2.1. G-as chromatography
The acids used as resolving agents all had the 
general formula R-CHjPhJ-COgH. Considerable differences 
could be noted in the degree of separation achieved as 
R varied (Table 12.).
a) R = methyl, ethyl, isopropyl
Examples of the resolutions achievable with these acids 
are shown in Figures 23-25. In general, as R increased 
in size from methyl to ethyl to isopropyl, the retention 
index difference between any two diastereomers increased.
This is illustrated in Figure 26. No significant 
differences were observed between the resolutions achieved 
on SE-30 and OV-17 phases, except in the case of phenyl­
alanine methyl ester 3-methyl-2-phenylbutyramide, suggesting 
that hydrogen bonding with the phase is not a dominant factor 
involved in the separation mechanism. However there was 
some evidence for intramolecular hydrogen bonding between 
the amide hydrogen and the phenyl ring (cf. Fig. 26) : CO 
an increase in alkyl chain length between the chiral 
centre and the aromatic centre decreased the separation 
(e.g. a-phenylethylamine and amphetamine or phenylglycine 
methyl ester and phenylalanine methyl ester); (2) substitition 
of the amide hydrogen by a methyl group in the a-phenylethylamine 
derivatives, resulted in a decrease in resolution of the
R
R' R" c h 3 c h2c h3 c h (c h3)2 o c h 3
c h 3 n h2 25 3 0 4 0 3 0
c h 3 NH-CH3 15 25 15 O
H
c h 3
c h -n h2
10 15 25 25
H
CH3 <pH3
C H -N H
25 25 3 0 15
COoCHL n h2 20 20 25 4 0
H
c o 2c h 3
c h -n h 2
O O 20 20
Comparison of A lva lues (OV-17) f o r a  series 
of structurally  re lated diastereomeric amides.
Pig, 26. The variation in gas chromatographic separation 
achieved for a series of structurally related 
amides as the side chain substituents are 
changed.
SEPARATION OF AMIDES 
OF RS-«-METHOXY -  
PHENYLACETIC ACID t
3m 1°/o OV-17 
2 0 0 °C
1 oc-PHENYLETHYLAMINE
2 AMPHETAMINE
3 PHENYLALANINE METHYL ESTER
minutes
Fig. 27. G-as chromatographic separation of (R,3Ca­
rrie thoxy-phenylacetic acid as amides of (1) (R)- 
(+)-a-phenylethylamine, (2) (R)-(-)-amphetamine 
and (3) (R)-(+)-phenylalanine methyl ester.
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diastereomers. When such bonded conformations could 
not be achieved the influence of bulky groups around the 
chiral centre probably assumed greater importance, hence 
the increased resolution for methamphetamine compared 
to amphetamine.
Norvaline methyl ester proved very difficult to 
resolve but the isomeric valine methyl esters, containing 
the branched alkyl chain, were well distinguished as 
amides of a-phenylpropionic acid. In this example the 
degree of resolution achieved decreased as R increased in 
size and no difference was observed for the 3-methyl-2- 
phenylbutyramides.
b) R = methoxyl
Substitution of the alkyl group in the resolving 
agent by a methoxyl group caused an enhancement of the 
separations with the primary amines but sharply decreased 
those of the secondary amines. This suggests that 
hydrogen bonding involving the amide hydrogen is an 
important factor in the resolution. The most noticeable 
differences were observed with the amino acid methyl 
esters. The previously unobserved resolution of 
norvaline methyl ester was achieved, but no separation 
could be obtained for the diastereomeric valine methyl 
ester derivatives. Phenylalanine methyl ester had also 
presented problems with the a-alkylphenylacetic acids but 
a satisfactory separation was achieved of the a-methoxy- 
phenylacetamides (Pig. 27). The increased polarity of the 
methoxyl group, with respect to the previous alkyl groups,
- 87 -
produced a slight enhancement of the resolutions on the 
more polar OV-17 phase. The most striking example of 
this was observed with proline methyl ester : no
separation was observed on SE-30 but a retention index 
difference of ten units was obtained on OV-17.
c) R = chloro
a-Chlorophenylacetic acid proved to be a less useful 
resolving agent for two reasons. Pewer resolutions 
were achieved throughout the series and secondly 
racemisation of the reagent was observed during the 
acylation.
The elution order of the ct-phenylpropionamides and
a-phenylbutyramides was (RR)/(SS) before (RS)/(SR) in
all cases except that of phenylglycine methyl ester.
This is the reverse of the sequence established for
1154. 1^6 202
N-trifluoroacetyl prolyl amides 9 9 but is in
225agreement with the order predicted by Feibush's rule.
The anomalous behaviour of phenylglycine has been noted 
previously as the N-trifluoroacetyl-2-octyl ester.
Since the 3-methyl-2-phenylbutyric acid and a- 
methoxyphenylacetic acid employed were racemic it is 
not possible to state the elution order in these cases.
The absolute configuration of 3-niethyl-2-phenylbutyric
1 64acid was at one time ass igned as (R)-(+), (S)-(-), 
while a-phenylpropionic and a-phenylbutyric acids were 
known to be (S)-(+), (R)-(-). The amides of the (+)- 
acids with (S)-(+)-methamphetamine were, however, found 
to elute before those of the (-)-acids on G-LC, in every
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166 168,169case. On re-examination the assignment of
absolute configuration on the basis of the gas
chromatographic data was shown to be correct.
It, therefore, seems likely that the 3-niethyl-2- 
phenylbutyramides would follow the same elution order 
as that observed for the derivatives of the other 
two 2-phenylalkanoic acids. It is not possible, 
however to predict the effect of substituting a more 
polar substituent, and in fact a reversal of the 
elution order was observed for the a-chlorophenylacetamides.
3.2.2. Mass spectra
The principal ions in the 22.5 eV mass spectra of the 
amides are presented in Table 13,. Ions below m/e 80 have 
been excluded (except for proline, valine and norvaline 
derivatives) since they have limited diagnostic value. 
Molecular ions were observed in all instances, although 
they were generally of low abundance in the a-methoxyphenyl- 
acetamides and the a-chlorophenylacetamides. The super­
scripts in Table 13 refer to the fragmentation modes shown 
in Figure 28• Salient features of the spectra are 
discussed below :
a) a-Phenylethylamine and N-methyl-a-phenylethylamine
The base peak in all the spectra, except those of the 
a-methoxyphenylacetamides was at m/e 105 due to benzylic 
cleavage at the NH group. The spectra of the N-a- 
methoxyphenylacetyl derivatives were dominated by a base
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Pig. 29. Illustrative mass spectra of a-phenylbutyramides.
a) Hass spectrum of amphetamine a-phenyl- 
butyramide.
b) Mass spectrum of p-chloroamphetamine a- 
phenylbutyramide.
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peak at m/e 121 produced by cleavage adjacent to the 
carbonyl group. This fragmentation was also important 
in the phenylalkanoic acid derivatives (m/e 105, 119,
153 respectively) but was largely suppressed in the a- 
chlorophenylacetamides. Ions produced by cleavage of 
the amide bond with elimination of PhCHR-C=0 were also 
present but they were generally of fairly low abundance. 
However, this fragmentation appeared to be enhanced in the 
case of N-methyl-a-phenylethylamine a-chlorophenylacetamide 
producing an ion at m/e 154 of 40% abundance. The 
structure of this ion was confirmed by high resolution mass 
spectrometry : found, m/e 154.0972; calc, for
134.0972. A characteristic ion, although of fairly low 
abundance, was produced from the 5-methyl-2-phenylbutyramides 
by elimination of from the side chain.
b) Amphetamine, methamphetamine, p-chloroamphetamine, 
and 5-methoxy-4,5-methylenedioxyamphetamine.
The base peak in most of the spectra arose from benzylic 
cleavage with the charge remaining on the amide fragment.
The ions obtained from the aralkyl portion were also 
present but to a lesser extent. These fragmentations are 
illustrated for the a-phenylbutyramides in Figure 29.
In addition, abundant ions were produced by benzylic 
fission at the acyl group; the base peaks in the spectra 
of the a-methoxyphenylacetamides were formed in this way. 
Other major fragments were due to alkyl-nitrogen fission, 
or alkyl-nitrogen cleavage accompanied by hydrogen transfer 
(Scheme 6).
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CH "I
CHi NR — » Ar - CH = CH - CH. 
>\
Ar-CH  (CR Ar
V\o'
1+
C6H5, s/s. 118
Ar = p-ClCgHc, m/e 152
Scheme 6
OMe
Ar m/e 192.
The latter process produced the base peak in all the 
spectra of 3-inethoxy-4,5-methylenedioxyamphetamine 
derivatives. High resolution mass spectrometry confirmed 
the assignment of the ion at m/e 192 to this fragment in the 
case of the oc-phenylbutyramide : found, m/e 192.0778;
calc, for 192.0786. Rearrangement ions with
double hydrogen transfer were also present, although to a 
lesser extent (Scheme 7).
*OvN CHRPh
N c '
HO* CHRPh
^ . N H
CH.rH
/
HO .CHRPh R = Et m/e 164
Q  R = Me m/e 150
NH
Scheme 7
R = 1Pr m/e 178 
R = OMe m/e 166 
R = Cl m/e 170
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For amphetamine a-chlorophenylacetamide accurate mass 
measurement at m/e 170 gave m/e 170.0374; calc, for 
CgH9K035Cl, 170.0373.
c) Norvaline methyl ester and valine methyl ester.
The spectra of the isomeric amides were very similar 
with the base peaks in most cases being produced by 
cleavage of the amide bond. The exceptions were the a- 
methoxyphenylacetamides where benzylic cleavage was the 
major process. Very abundant ions at m/e 72 in the 
spectra of the phenylalkanoic acid amides were shown to be 
due to the imonium fragment?^ (Scheme 8) by accurate mass 
measurement in the case of the N-phenylbutyramide.
(Found : m/e 72.0808; calc, for C^H^N, 72.0813).
V OM* CoH-yCH=NHy _  . . 3 /  I
CoH7-  CH1 NH 0 - °
C=0 Ph-CH-R
Ph-CH-R I
m /e  7 2
This ion was of lower abundance in the spectra of the a- 
chlorophenylacetamides and was not observed from the a- 
methoxyphenylacetamides. In the spectra of the amides 
of the phenylalkanoic acids ions produced by benzylic 
fission with hydrogen transfer were observed (Scheme 9).
Scheme 8
72
118
91
J I * I. 1 uli
130
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13CX n
C H j  C H j  C H ^
C 02Me
C H - N H
ffH
O
II
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^249
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-I—l|— Lai.--
C H  ' 3
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!-----»133
249
291 L(Mj
100 150 200 25 0
Pig. 30. Mass spectrum (22.5 eV) of norvaline methyl 
ester 3-methyl-2-phenyl'butyramide.
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Pig. 31. Mass spectrum (22.5 eV) of proline methyl 
ester a-phenylpropionamide.
O R  it " 92 "
R -N -^ C /-C H -P h  j. R -N -C = 0
H 4"
R -C H 2-P h 1t
R = Et, m/e 120 
Scheme 9 R = Me, m/e 106
R = 1Pr, m/e 154
When R = Et and Me the ions produced by benzylic cleavage 
accompanied by hydrogen transfer were more prominent than 
those produced by cleavage without hydrogen transfer, but 
the reverse was true when R = ^Tr (Pig. 30). Both ions 
were also observed in the spectra of the a-chlorophenylacet- 
amides but they were of considerably lower abundance. In
all the spectra ions due to loss of the carbomethoxyl 
group were observed.
d) Proline methyl ester
The major fragments in all the spectra, except that 
of the a-methoxyphenylacetamide, were the pyrrolidinium 
ion (m/e 70) and the ion produced by amide cleavage (m/e 
128) (Pig. 31). Benzylic cleavages were also observed 
in all the spectra with the base peak (m/e 121) being 
produced by this process in the a-methoxyphenylacetamide. 
Ions produced by loss of -C02CH^  were present in all cases.
e) Phenylglycine methyl ester and phenylalanine methyl
ester
As noted in the spectra of the drimanamides major 
ions due to the imonium fragment (m/e 106, 120 respectively) 
were produced (cf. Scheme 8). This fragment produced the 
base peak in the spectra of the phenylalkanoic acid amides
164* ---; —  >119
106
149
91
119
1-1 ■■
qp2Me |9
•NH-rC -c h ;
.Et
149*~J 
164 252 (M-59)
31KM+)
100 150 200 250 3 0 0
Pig. 32. Mass spectrum (22.5 eV) of 
phenylglycine methyl ester 
a-phenylbutyramide.
c
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of phenylglycine methyl ester. Abundant ions also 
arose by simple benzylic cleavages as illustrated in 
Figure 52. The base peak in the spectra of the amides 
of phenylalanine methyl ester (except the a-methoxy 
phenylacetamide) arose by alkyl-nitrogen fission with 
hydrogen transfer resulting in a methyl cinnamate ion^^ 
(Scheme 10).
Ph - CH CH - C0oMe -► Ph - CH = CHC0oMe'1+'
K ^ i  2 2
H V NHCOCHRPh m/e 162
Scheme 10
The composition of this ion was verified (for the N- 
phenylbutyramide) by accurate mass measurement. (Found, 
m/e 162.0680; calc, for C-|oH10^2’ 162.0681 ).
3.2.5. Application to amino-alcohols : The ephedrines
By making use of the greater reactivity of the amino 
function it was found possible to derivatise the amine 
in the presence of the alcohol without producing any 
bis-derivative. Using an equimolar quantity of 
phenylbutyryl chloride or phenylbutyric anhydride the 
best yields were obtained with a ten-minute reaction 
time at room temperature. Use of phenylbutyric 
imidazolide provided more selectivity since imidazolides
340react only very slowly with alcohols at room temperature. 
When the imidazolide was used a 50 min reaction time was 
employed. Under these conditions no bisphenylbutyryl 
derivatives were detected on GKLC.
CHo R O
J I. liC H ^ S i O
1 ,CH-CH-N-C-qH 
Ph *■
C H 5CH. 
9 2
Ph
I R*H, a 1S.2S 
b 1R.2R 
D R=CH3 a .1S,2S 
'b:1R,2R
3m 1®/o OV-17 
210°C
a .a I
8 16 24 32 4 0
minutes
Fig. 33. G-as chromatographic separation of (1)
(-)-nor-^ -ephedrine-O-fllS and (2) (i)-'lj, 
ephedrine-O-TMS as (R)-H-phenylbutyryl 
derivatives.
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Only ephedrine itself gave any indication of a 
resolution as the N-phenylbutyryl derivative. However, 
when the free hydroxyl group was trimethylsilylated, good 
separations were also observed for the *\J, -ephedrines and 
nor-^ephedrines (Table 14, Pig. 39). This change was 
presumably due to the steric requirements of the large 
trimethylsilyloxy group forcing "preferred” conformations 
on the molecule which enhanced the differences between the 
diastereomers. The free hydroxyl group would participate 
in hydrogen bonding, and removal of this effect would also 
change the preferred conformations. The order of elution 
of the diastereomers, with respect to the chiral centre 
carrying the amine, was (RR) < (RS) for the ephedrine 
derivative but (RS) < (RR) for the derivatives of the 
T|,-ephedrine s.
Under electron ionisation (E.I.) conditions (22.5 eV) 
the N-phenylbutyryl, O-TMS-ephedrine derivatives were 
completely fragmented. The molecular ions were of very 
low abundance (0.1-0.2%). The base peak in all cases were 
produced by benzylic cleavage. The fragment containing 
the amine moiety was the base peak in the spectra of the 
ephedrine derivatives (m/e 204), but the charge was 
preferentially retained on the fragment containing the 
trimethylsilyl ether group in the spectra of the nor­
ephedrine derivatives (m/e 179). Cleavage adjacent to 
the carbonyl produced the ion at m/e 119 characteristic 
of the phenylbutyryl moiety.
An abundant ion at m/e 263 was observed in the spectra
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of the nor-ephedrine derivatives. This rose by 
9 a.m.u. to m/e 272 when perdeuterated TMS ethers were 
prepared, indicating that the fragment contained the 
trimethylsilyl group. This could be ascribed to a 
rearrangement ion produced by transfer of the trimethyl­
silyl group and elimination of benzaldehyde. The silyl 
group could possibly be transferred either to the nitrogen 
(A) or to the carbonyl oxygen (B) as represented in 
Scheme 11.
C
^ i
PhCHO +- CH
c=o
i
c=o
IPh Et
Ph Et
P h -C -,- ^ -S i(C H 3)3 
CHo-CH Qt ___ , PhCHO
J I (I 7 mN H -C -C H  (B) 
/  \  
Ph Et (CH3)3Si - 6 = c
NH
l
Scheme 11
AhPh Et 
m/e 263
CO
COCOCD
CO CDvD
CO
0 y  
J— LO I
T x 1J CM I1 U—u
CO
CO
CM
CO
o
oIs* — ^o
o
o
-  96  -
The chemical ionisation (C.I.) spectra using 
isobutane as reagent gas, showed considerable enhancement 
of the ions in the higher mass range. Abundant [M+1]* 
ions were observed in all cases (this constituted the 
base peak in the C.I. spectrum of the -ephedrine derivative), 
but fragment ions were also present. A major fragmentation 
under C.I. conditions was loss of trimethylsilanol 
[[M+l]t - 90], and otherwise the molecules fragmented in a 
manner similar to that observed under E.I. conditions.
A comparison of the E.I. and C.I. spectra of 
N-phenylbutyryl, O-TMS-ephedrine is shown in Pig. 34.
3m 1°/o OV-17 
170°C
2 0 0 5  ~
£ 1725
1 .1 86 0
16 2 0  24  2812
minutes
. 35. Gas liquid chromatogram of the urinary metabolites j 
of ibuprofen as their methyl ester trimethylsilyl j
I
ethers. (B = ibuprofen; H = hippuric acid; the j 
metabolites are numbered 1 to 4 as in the text.)
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3.3. The urinary metabolism of ibuprofen. 2—(4— 
isobutylphenyl)propionic acid
3.3.1. Isolation and identification of metabolites
Urine samples were initially obtained from a male 
volunteer after ingestion of 3 x 200 mg. tablets of 
"Brufen" and subsequently from patients receiving 
daily treatment with the drug.
Purification of the extract, obtained as described 
in section 2.2.1., was at first attempted by chromatography 
of the free acidic components on a column of silica gel, 
using chloroform-methanol-acetic acid (80:20:5 v/v) as 
eluting solvent. Examination of aliquots from each fraction, 
after methylation, on G-LC showed that the major components 
had been eluted in the first three fractions. Further 
purification of these samples was achieved by preparative 
TLC (mobile phase  ^ chloroform-methanol-acetic acid, 
20:1:0.5). After methylation and trimethylsilylation 
the samples were examined by GLC and GC-MS. The major 
component of fractions 1 and 2 was shown to be unmetabolised 
2-(4-isobutylphenyl)propionic acid by comparison of its G-LC 
and G-C-MS behaviour with that of the authentic acid isolated 
from "Brufen** tablets. Fraction 3 contained four components 
which were identified as metabolites of ibuprofen (Fig. 35 ).
Subsequently extracts were first methylated and then 
purified by preparative TLC using chloroform-ethyl acetate 
(3:1 v/v) as mobile phase. Typical R-p values and gas liquid 
chromatographic data for ibuprofen and its metabolites are
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summarised in Table 1 5.
The mass spectrum of ibuprofen methyl ester is
shown in Figure 36. The base peak in this spectrum was
due to loss of the carbomethoxyl group and a major
fragment was observed due to cleavage of the side chain
at the tertiary centre. Ibuprofen was reduced with 
2LiAlH^ and LiAl and the diols characterised as their 
trimethylsilyl ethers by GLC and GC-MS (Table 16). The 
base peak in the spectrum of the diol-TMS was again at 
m/e 161, produced by cleavage adjacent to the primary 
trimethylsilyl ether group. Abundant ions were observed 
from the trimethylsilyloxy group at m/e 73, [Si(GH^)^]+ 
and m/e 75, [HO = SiCCH^^] an(i "the ion characteristic of
the primary trimethylsilyloxy function was present at
+ + 
m/e 103(105), [CH2 = 0 - Si(CH5)_], [CD2 = 0 - Si(Cttj)5].
Methyl ibuprofen was further characterised by H NMR 
spectrometry (Fig. 37) : 67.2 (4H, q, J = 8 Hz)
[aromatic-H]; 3.7 (3H, S) [-COOCH^ ]; 3.6 (1H, q, J = 6 Hz) 
[benzylic CH-]; 2.5 (2H, d, J = 8 Hz) [benzylic-CHg-];
1.9 (1H, m) [side-chain CH-]; 1.5 (3H, d, J = 6 Hz)
[-CH^  coupled to benzylic CH-]; 1.0 (6H, d, J = 6 Hz)
[side chain-CH^].
I.R. spectroscopy showed an ester carbonyl, 
y C_Q ss 1745 cm (CCl^ ) and the U.V. spectrum of the free acid 
gave > = 222 nm. (£ = 4,120) and } = 263 nm
(£ = 129).
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Pig. 39. Mass spectral characterisation of metabolite 1.
a) Mass spectrum of metabolite 1 methyl 
ester.
b) Mass spectrum of metabolite 1 methyl 
ester trimethylsilyl ether.
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Characterisation of metabolites
The structures of the three hydroxylated metabolites 
and the dicarboxylic acid (Pig. 38) were proposed on 
the basis of their G-LC and GC-MS characteristics. 
Confirmation of the structures was aided by micro­
chemical transformations, monitored by GLC and GC-MS.
341 342Metabolites 2 and 4 had previously been identified. 9
Metabolite 1 : 2,4 * -(1-hydroxy-2-methylpropyl)phenyl-
propionic acid
The mass spectrum of metabolite 1 methyl ester (Pig.
39) showed a very small molecular ion at m/e 236. This 
molecular weight corresponded to a mono-hydroxylated 
metabolite. Confirmation of this structure was obtained by 
formation of the trimethylsilyl ether. No molecular ion 
was observed after trimethylsilylation (Pig. 39) but an 
ion at m/e 293 corresponded to loss of a methyl radical 
from a molecule of weight 308. The base peaks in these 
spectra (Table 17) corresponded to a loss of 43 a.m.u. from 
the molecular ion. This cleavage at the tertiary centre 
was observed in the spectrum of the unhydroxylated acid 
methyl ester but its high abundance in this instance 
suggested that hydroxylation had occurred at the benzylic 
position in the side chain. Loss of the carbomethoxyl 
group produced the fragments at m/e 177 and 249 in the 
spectra of the free and trimethylsilylated derivatives 
respectively. These fragments together with loss of 
water or trimethylsilanol produced the ions at m/e 159. 
Elimination of trimethylsilanol from the molecular ion
/>^ Ns/^VdH5c02M<
91
jJli_ i
117
JsL
145 177
J
205
264(M*)
100 150 200 250
159
73
103
j| h JL A .L. 1 t
CH3
^A-ch-ch2otms 
ch2o tm s
,262(M-TMSOH)
3520vrt
100 150 200 250 3 0 0 350
Pig. 40. Mass spectral characterisation of metabolite 2.
a) Mass spectrum of metabolite 2 methyl 
ester.
b ) Mass spectrum of the LiAlH^ reduction 
product of metabolite 2 as the trimethyl- 
silyl ether.
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itself was not observed, but an ion of low abundance at 
m/e 219 indicated the loss of a trimethylsilyloxy radical 
as expected from a benzylic trimethylsilyl ether. The
assignment of ions to silyl ether fragments was aided by
343formation of the perdeuterated trimethylsilyl ether 
or the chloromethyldimethylsilyl ether.
The fact that the metabolite contained a secondary 
hydroxyl group was confirmed by its oxidation to a 
ketone with CrO^/acetone. The mass spectrum of the 
ketone was very similar to that of the hydroxylated 
metabolite with the major ion being produced by cleavage 
adjacent to the carbonyl group (m/e 191).
The metabolite was further characterised by reduction 
and analysis of the trimethylsilyl ether of the resulting 
diol. The major mode of fragmentation was still cleavage 
a to the secondary trimethylsilyloxy group.
Metabolite 2 : 2.4’-(2-carboxypropyl)phenylpropionic acid
The mass spectrum of metabolite 2 as the methyl ester 
gave a molecular ion of 264, corresponding to a di- 
carboxylic acid dimethyl ester (Pig. 40). The absence 
of hydroxyl groups agreed with the polarity observed for 
this compound on TLC and was confirmed by the unchanged 
retention index and mass spectrum, after treatment with 
trimethylsilylating reagent (Table 18). The position of 
the second carboxyl group was deduced by consideration of 
the mass spectrum. The ion at m/e 177 was observed in 
the spectrum of ’ibuprofen' methyl ester due to cleavage 
of the side chain at the tertiary centre. The occurrence
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of this ion in the spectrum of metabolite 2 methyl
ester suggested that it was one of the methyl groups in
the isobutyl side chain that had been oxidised. The
major fragments could be ascribed to the loss of a car-
bomethoxy group (m/e 205) and to the combined loss of
carbomethoxy and C2H^02. Reduction with LiAlH^ (or
LiAl H^ ) followed by trimethylsilylation yielded a product
of molecular weight 352 (or 356) thus confirming the
presence of two acid moieties. The base peak (m/e 159)
in the mass spectrum of this product (Pig. 40) was
produced by a combination of two processes, viz. loss of
trimethylsilanol (m/e 262) and elimination of the primary
[CH2-0TMS] radical. The ion characteristic of the
+
primary trimethylsilyl ether group, [CH2=0-Si(CH^)^] was
observed at m/e 103. Its identity was confirmed by a
shift of 9 a.m.u. to m/e 112 when perdeuterated TMS ethers
were formed and by the change to m/e 105 when the reduction
2was performed with LiAl H^ .
Metabolite 2 was the major metabolite of ibuprofen 
and isolation of 4*5 mg of pure material was achieved by 
a combination of lipophilic gel chromatography on 
Sephadex LH-20 (mobile phase : 1,2-dichloroethane-methanol,
7:3) and preparative TLC (mobile phase : chloroform-ethyl
acetate, 3:1 v/v) of the methyl ester. This allowed
i
confirmation of the metabolite structure by H HMR 
spectrometry (Pig. 41) : 6, 7.15 (4H, q, J = 8 Hz)
[aromatic-H]; 3.65 (3H, s) [original -COOOH^]; 3.6 (3H, s)
[new -COOCH^]; 3.6 (1H, q, J = 6 Hz) [benzylic CH-]; 2.8
(3H, m) [benzylic -CH^- and side chain CH-]; 1.5 (3H, d,
100
159
150
V ' T V g k
t m s o -c h 2
218
CO^Me
73
117 131
I til 1.1:1 ill 11. . IlII illL_...IJiii.... il • .i I . . , 3081M4)
200 250 3 0 0
Pig*. 42. Mass spectrum of metabolite 3 as 
, its methyl ester trimethylsilyl 
. ether.
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J = 6 Hz) [-CH^  coupled to benzylic CH-]; 1.25 (3H,
d, J = 6 Hz) [side-chain -CH^ ].
The IR spectrum showed V c=0 1745 cm"”1 (CCl^  solution) 
and confirmed the absence of hydroxyl groups. TJ.V.
^ T?4-("YCJ
spectrometry Save/\max = 221 nm (6 = 5,200).
Subsequent isolation of more material as the free 
acid by preparative TLC using toluene-acetic acid, 9:1 
v/v (Rp = 0.31) and recrystallisation from benzene-hexane 
gave white crystals, m.p. 96-103°C.
Metabolite 3: 2 .41 -(2-hydroxymethylpropyl)phenylpropionic
acid
The mass spectrum of the methyl ester trimethylsilyl 
ether of metabolite 3 (Table 1 9, Pig. 42) was characterised 
by the fact that none of the major ions contained the 
trimethylsilyloxy function, as shown by comparison with 
the spectrum of the perdeuterated trimethylsilyl ether 
or the chloromethyldimethylsilyl ether. The base peak 
(m/e 159) was produced by loss of the carbomethoxy group 
together with elimination of trimethylsilanol. The latter
process alone produced a major ion at m/e 218 (52$). The
ion at m/e 103, though of relatively low abundance (7$), 
was significant since it was shifted to m/e 112 in the 
spectrum of the perdeuterated trimethylsilyl ether; it 
thus corresponded to CHL^O-Si^H^)^ > consistent with a 
primary hydroxyl function. The proposed position of 
hydroxylation was confirmed by LiAlH^ reduction of the 
ester function since the trimethylsilyl ether of the 
resulting diol was identical to that obtained from
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metabolite 2 in both GLC and GC-MS behaviour.
Metabolite 4 : 2,41-(2-hydroxy-2-methylpropyl)phenyl-
propionic acid 
The mass spectral characteristics of derivatives of 
metabolite 4 are presented in Table 20 . The small 
molecular ion at m/e 236 in the mass spectrum of the 
methyl ester (Pig. 43 ) suggested that this was a 
hydroxylated metabolite. However, difficulty was 
experienced in forming the trimethylsilyl ether, 
suggesting that the hydroxyl group was at the tertiary 
position in the isobutyl side-chain. In accordance with 
this, the mass spectrum of the methyl ester showed intense 
peaks at m/e 178 ([M-58]+#) due to cleavage adjacent to 
the tertiary centre with hydrogen transfer, and m/e 119, 
resulting from additional loss of a carbomethoxyl radical. 
In the mass spectrum of the methyl ester trimethylsilyl 
ether, the base peak occurred at m/e 131, corresponding 
to (CH^)2C=S-SiMe^. As expected, this changed to m/e 
140 on formation of the perdeuterated trimethylsilyl ether, 
and to m/e 165 in the chloromethyldimethylsilyl ether.
The ion at m/e 250 in the methyl ester trimethylsilyl 
ether spectrum corresponded to a rearrangement of the 
trimethylsilyl group accompanied by elimination of acetone 
(M-58). This was shifted to m/e 259 and m/e 284 in the 
perdeuterated trimethylsilyl ether and chloromethyl 
dimethylsilyl ether spectra respectively. After reduction 
of metabolite 4 with LiAlH^, and trimethylsilylation, the 
fragment at m/e 131 was still the base peak. Isolation
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of a few mg of purified metabolite 4 methyl ester 
allowed the verification of the proposed structure by 
other spectroscopic techniques.
—  1I.R. spectrum (CCl^ ) solution : y = 3600 cm"’
v c=o = 1745 cm"1
NMR spectrum (Pig. 44) : 6, 7.2 (4H, q, J = 8 Hz)
[aromatic -H]; 3.7 (3H, s) [-COOCH^ ]; 3.6 (1H, q, J =
6 Hz) [benzylic CH-]; 2.75 (2H, s) [benzylic -CH2];
1.5 (3H, d, J = 6 Hz) [-CH^  coupled to benzylic CH-];
1.25 (6H, s) [side-chain -(CH5)2C(OH)-].
5.3.2. Synthesis and characterisation of 2,4!-(1-
hydroxy-2-methylpropyl)phenylpropionic acid
The structure of metabolite 1 was confirmed by the 
synthesis of 2,4*-(1-hydroxy-2-methylpropyl)phenylpropionic 
acid methyl ester by the action of N-bromosuccinimide 
on 2-(4-isobutylphenyl)propionic acid methyl ester, and 
subsequent hydrolysis of the bromide (cf. Sec. 2.5.).
The G-LC and GC-MS characteristics (Table 21 ) of the 
synthetic material as the methyl ester and the methyl 
ester trimethylsilyl ether were identical to those 
found for metabolite 1 (Table 17).
The methyl ester was a pale yellow oil which was 
purified by vacuum sublimation using a cold-finger 
apparatus (0.1 mm Hg, block temp. 60°C). Pound : C, 62.26
H, 8.£0% ; Calc, for C^H^qO^. C, 71.16; H, 8.53%.
The IR spectrum (CCl^  solution) showed V = 3610 
and V q_q = 1745 cm”^. The UV spectrum showed the predicted
* result indicates the presence of water of crystallisation. 1
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aromatic absorptions : ^ 215 nm, (£ = 3,330);
iTl rd.X
A max 250 nm* (€ = 1»550).
Pull characterisation was achieved by H NMR 
spectrometry (Pig. 45) : 6, 7.2 (4H, s) [aromatic -H];
OH
4.5 (1H, d, J = 8 Hz) [benzylic -CH-]; 5.7 (1H, q,
J = 6 Hz) [benzylic CH-]; 5.6 (5H, s) [-OOOCH^ ]; 2.0
(1H, m) [side-chain CH-]; 1.5 (3H, d, J = 6 Hz) [-CH^
coupled to benzylic CH-]; 1.0 (5H, d, J = 6 Hz) [side-
chain -CH ]^; 0.80 (5H, d, J = 6 Hz) [side-chain -CH^ ].
An interesting feature of the NMR spectrum was the non­
equivalence of the methyl groups in the side-chain. This 
verified the position of the hydroxyl group at the benzylic 
carbon since the introduction of an asymmetric centre 
produced non-equivalent environments for the two methyl 
groups on the adjacent carbon atom and such diastereotopic 
groups are distinguishable by NMR spectrometry.
When the bromide was hydrolysed in methanolic solution 
a less polar by-product was observed (Rp CHCl^/BtOAc 5:1 
= 0.65, free hydroxy compound Rp = 0.49). Analysis of 
this by-product by G-C-MS showed a compound with a molecular 
ion at m/e 250 and a fragmentation pattern similar to that 
of the major product. The molecular weight suggested that 
this was a methyl ether produced by displacement of 
bromide ion by "OMe instead of "OH. Isolation by 
preparative TLC (CHCl^:BtOAc, 5:1) and 1H NMR spectrometry 
confirmed this postulation : 6, 7.2 (4H, q, J = 2Hz)
[aromatic -H]; 5.7 (1H, q, J = 6Hz) [benzylic CH-]; OMe
I
5.6 (5H, s) [-COOCH^]; 5.2 (1H, d, J = 2 Hz) [benzylic -CH-]
ON OF RS-1-PHENYLSEPARAT 
2-METHY- , -
ESTERS OF R-2-PHENYL-
BUTYRIC a c id
a)
2195 I
20
minutes
Pig. 46. Gas chromatographic separation of the (£)-(-)-
phenylhutyryl derivatives of (a) (RS)-1-phenyl
2-methylpropanol and (h) (RS)-2,4'-(1 -hydroxy-
2—methylpropyl)phenylpropionic acid methyl 
ester.
3m 1°/o OV-17 
2 4 0 ° C
b)
CH3 y n 3
H-CH--<^ ~~^ 'c h~'c 0 2cH3
c h 3 ox c h 2c h 3
C-QH
2785
2 8 4 0
161284O
minutes
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5.15 (3H, s) [-0-CH,]; 1.9 (1H, m) [side-chain CH-];
1.0 (3H, d, J = 6 Hz) [side-chain -CH,]; 0.75 (3H, d,
J = 6 Hz) [side-chain -CH,].
Since hydroxylation at the henzylic position in the 
side-chain introduced a new asymmetric centre into the
'ibuprofen' structure it was of interest to be able to
characterise the configuration at this centre. The gas 
chromatographic separation of enantiomeric alcohols was 
first studied using a model compound viz 1-phenyl-2- 
methylpropanol obtained by reduction of isobutyrophenone with 
LiAlH^.' ..Since good separations were achieved with 
enantiomeric alcohols using chrysanthemic acid to form 
diastereomers (cf. Section 3.1.) this was the procedure 
employed. However, no resolution was observed for the 
diastereomeric 1-phenyl-2-methylpropanol chrysanthemates 
(Table 22) on a 5 m 1 °/o SE-30 column. Subsequent preparation 
of the (R)-(-) a-phenylbutyrates showed a separation of 30 
index units between the two enantiomers on 1% SE-30 phase and 
40 index units on OV-17 phase (Pig. 46a). Both peaks 
were shown to correspond to esters of phenylbutyric acid by 
GC-MS.
When the phenylbutyrates were prepared from the 
synthetic 2,4 *-(1-hydroxy-2-methylpropyl)phenylpropionic 
acid methyl ester, complete chromatographic resolution was 
achieved (Pig. 46b). To avoid any possible interference 
due to the second chiral centre (the original centre) another 
sample of 2,4’-(1-hydroxy — 2-methylpropyl)phenylpropionic 
acid methyl ester was synthesised starting with (R)-(-)
2-(4-isobutylphenyl)propionic acid methyl ester (obtained
Table 22 • Gas chromatographic data for diastereomeric
derivatives of benzylic secondary alcohols
Ester j5m1/.SE-30 Temp>oc i5b1 /OV-17
1-phenyl-2-methyl 
propanol chrysanthemate
1-phenyl-2-methyl 
propanol a-phenylbutyrate
2,4’-(1-hydroxy-2- 
methylpropyl)phenyl 
propionic acid methyl 
ester a-phenylbutyrate
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by resolution as salts of (R)-(+) a-phenylethylamine). 
Preparation of the phenylbutyrates and analysis by GLC 
gave the same two peaks as previously observed confirming 
that it was the pair of enantiomeric alcohols which was 
being resolved. The structure of the esters was 
confirmed by GC-MS analysis. The mass spectrum (Pig. 47) 
was similar to those observed for amides of phenylbutyric 
acid (Sec. 3.2.). The base peak (m/e 119) was produced 
by cleavage adjacent to the carbonyl group, and 0-alkyl 
cleavage gave the abundant ion at m/e 219. Subsequent 
loss of the carbomethoxy group gave the ion at m/e 159, or 
cleavage adjacent to the tertiary centre the ion at m/e 
177.
In order to determine the order of elution of the 
phenylbutyrates on GLC it was necessary to resolve the 
alcohols and determine the absolute configuration of one of 
them. The resolution of the enantiomeric alcohols was 
achieved by TLC of the diastereomeric (^-(-)-a-phenylbutyrates. 
After preparative TLC (two developments with mobile phase 
"benzene : EtOAc, 20:1 v/v) analysis of the lower band
by GLC showed it to consist of 67% the ester of shorter 
retention time. (The approximation of peak height x 
retention time was used to measure peak areas). Further 
TLC of the material from the lower band using a 
continuous elution method, in a Desaga chamber, for h 
(mobile phase : benzene : EtOAc, 100:1 v/v) enhanced the
separation so that material of 88% enantiomeric purity 
was obtained. Mild alkaline hydrolysis, acidification and 
extraction yielded the alcohol.
METABOLITE 1 METHYL 
ESTER
CYCLOHEXANOL
minutes
Pig. 48. Gas chromatogram of the N-phenylbutyryl derivatives 
of a-phenylethylamine obtained by reaction of the 
amine with excess a-phenylbutyric anhydride left 
after the reaction of (RS)-a-phenylbutyric anhydride 
with (a) cyclohexanol and (b) 2,4*-(1-hydroxy-2- 
methylpropyl)phenylpropionic acid methyl ester.
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Determination of absolute configuration using the Micro­
store au Method.
The absolute configuration of the secondary alcohol
could be determined on a micro-scale using the recently 
■544 345published * modification of Horeau’s method.
After methylation of the acid function with diazo- 
methane the alcohol (10 jumole) was dissolved in pyridine 
(7 p-l) and treated with (RS)-a-phenylbutyric anhydride 
(6.4 >11) at 50°C for 1-J- h. A parallel blank reaction was 
carried out with cyclohexanol. (R)-(+)-a-phenylethylamine
was added and mixed thoroughly. After 15 min the 
mixture was diluted with dry ethyl acetate (400 jil') and 
a sample analysed by G-LG (Pig. 48).
Peak area ratios were measured using the approximation 
of peak height x retention time. The percentage area 
representing the amide of the (-)-(R)-acid was assessed. 
Subtraction of the corresponding value for the reaction 
with cyclohexanol gave an increment of +2.54 representing 
excess of (-)-(R)-acid. This suggested that the alcohol 
was of Horeau’s ’’Type II”.
M
1I
H - C - OH1II
^ Type II
In most cases type II alcohols have the (S)-configuration
however, the previous work on 1,1-diphenyl-alkan-2-ols
347using the classical Horeau procedure showed that in 
the case where the side chain was an isopropyl group the 
isopropyl substituent took preference over the diphenyl-
-109 -
methyl group. In that situation the (S)-(-)-alcohol 
behaved as a type I alcohol. In order to clarify this 
situation 1-phenyl-2-methylpropanol was used. Asymmetric 
reduction of isobutyrophenone using the complex hydride 
prepared in situ by reaction of LiAlH^ with (-) quinine
produced^8 an excess of the (R)-(+)-carbinol. Optical 
rotation confirmed that the product contained an excess of 
the dextroratory enantiomer ([a]p = +3.3). GLC analysis 
of the derived phenylbutyrates showed only a slight 
enhancement (64%) of the first ester peak, but the optical 
purity was increased to Q6fo by repeated TLC of the 
diastereomeric phenylbutyrates (mobile phase : benzene s
EtOAc, 100:1 v/v). After hydrolysis of the ester with 
LiAlH^ a sample of the alcohol was treated with (RS)-ct- 
phenylbutyric anhydride as previously described. A blank 
reaction was also performed with cyclohexanol. (R)-(+)-a- 
Phenylethylamides were prepared with the excess reagent 
and analysed as before. The peak increment for the amide 
of the (R)-acid was -1.52. (+)-1-Phenyl-2-methylpropanol
therefore behaved as a type I alcohol, and its absolute 
configuration was known to be (R). On this basis the 
order of elution of the enantiomeric 2,4'-(1-hydroxy-2- 
methylpropyl)phenylpropionic acid methyl ester as esters 
of (R)-(-)-a-phenylbutyric acid was (S) < (R), and the 
resolved alcohol had the (S)-configuration.
3.3.3. Quantification of metabolites
A 24 h urine was obtained from a female patient 
receiving daily ’Brufen’ treatment. Extraction and work
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up as described in section 2.2.1. yielded extract A. 
Hydrolysis of the aqueous acidic urine with "G-lusulase" 
and work-up yielded extract C.
<7 of the total of extract A was methylated with 
ethereal diazomethane and trimethylsilylated with BSA 
at 60°C for 10 min : the product was dissolved in 1.5 ml
ethyl acetate. A known aliquot was removed and a 
solution of ^-phenylbenzoic acid methyl ester (2 mg/ml) was 
added to give a final concentration of 1 mg/ml with respect 
to the standard. Similarly fa 0f extract G was methylated 
and trimethylsilylated and a sample containing 1 mg/ml 
internal standard was prepared. Aliquots from these samples 
were analysed by GLC on a 3 m 1 % 0V-17 column using 
temperature programming at 2°/min from 120 to 220°C (Pig.
49).
A standard solution of 2 mg/ml concentration of 
methylibuprofen in ethyl acetate was prepared. 100 }il of 
this was added to 100 jil of a solution of 2 mg/ml*-phenyl- 
benzoic acid methyl ester. This was the reference 
standard for the quantification.
The quantity of ibuprofen methyl ester could be 
calculated :
Q = 2 x fs__ z y
^ref
Where v - peak height ibuprofen methyl ester . extractWhere *s _ peak height standard ln extrao1;
peak height ibuprofen methyl ester in reference
ref = peak height standard
s tandard
Table 23. Quantities of ibuprofen and its metabolites
present in a 24 h urine from a patient 
receiving daily treatment.
Extract A - free acid and metabolites
Metabolite Quantity (mg) Concentration (jig/ml)
Ibuprofen 4 5.7
1 0.7 1
2 88 125.7
3 1.4 2
4 15 21.4
Extract C - conjugated acid and metabolites 
Metabolite Quantity (mg) Concentration (jug/ml)
Ibuprofen 5.7 8.1
1 1 1.4
2 100 142.8
3 1 1.4
4 14.8 21.1
- 111 -
V = volume of extract (i.e. 1.5 ml for extract A)
This equation holds if 100 jil of extract from Y is added 
to 100 jj.1 of the 2 mg/ml solution of the standard. If 
this is not the case a suitable correction factor must be 
included.
Using this method the quantity of unmetabolised acid 
present as the free acid (extract A) or as a conjugate 
(extract 0 ) was estimated (Table 23). Assuming that the 
response factors on GLC for the metabolites would be the 
same as that of ibuprofen methyl ester, and by applying a 
correction for the differences in retention time, values 
were also calculated for the amounts of metabolites 
present.
Prom Table 23 it can be seen that ibuprofen and 
metabolite 2 are excreted to a slightly greater extent 
as conjugates whereas more of metabolite 3 is present in 
the free extract. Metabolites 1 and 4 appear to be 
present to the same extent in both extracts.
This method does not take account of any losses which 
may occur during work-up and therefore too much reliance 
cannot be placed on these values. However, it gives an 
indication of the relative amounts of the various 
metabolites present.
3.3.4. Stereochemical aspects of metabolism
The amides of (RS)-2-(4— isobutylphenyl)propionic 
acid with (R)-(+)-a-phenylethylamine were completely 
resolved (AI = 35) on a 5 m 1% OV-17 column (Table 24)
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The peak with 1=2720 was not investigated.
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This allowed the determination of the enantiomeric 
composition of the "unmetabolised" acid recovered from 
urine. After formation of the amides with (R)-(+)-ct- 
phenylethylamine, GLC showed that the excreted acid 
consisted of Q0% (+)-2-(4-isobutylphenyl)propionic acid 
(Fig. 50). The principal MS characteristics of the amides 
are also contained in Table 24. Identical mass spectra 
were obtained for the amides of the authentic and 
isolated acid. The fragmentations were similar to those 
observed for corresponding amides of a-phenylbutyric and 
a-phenylpropionic acids (Section 3.2.), C-acyl cleavage 
yielding m/e 161 characteristic of the acid and N-alkyl 
cleavage giving m/£ 105, characteristic of the amine moiety.
Metabolite 1
Hydroxylation at the benzylic position in the side 
chain introduces a new chiral centre and hence there are 
four possible diastereomers. A sample of metabolite 1, 
isolated from a urine extract was methylated and treated 
with excess (R)-(-)-phenylbutyryl chloride. Analysis of 
the resulting phenylbutyrates on GLC showed two peaks 
(Pig. 51) which corresponded to those previously observed 
with the synthetic material (Table 22). GC-MS confirmed 
that these were the phenylbutyryl esters. The mass 
spectra of the esters obtained from the isolated material 
were identical to those of the synthetic alcohol (Pig. 47) • 
Hydroxylation at the benzylic position appeared not to have 
been stereospecific since both ester peaks were present. 
However, the alcohol was not completely racemic.
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Pig. 52. Mass spectrum of the amide of oxidised
metabolite 1 with (R)-a-phenylethylamine.
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Measurement of peak areas showed that it contained 
57% of the (R)-form. Since the extraction procedure 
involved the use of basic solutions it was possible that 
some racemisation might have occurred. A sample of 
the resolved alcohol (88% -(S)) (cf. Sec. 3.3.2.) was 
taken through the normal.work-up procedure, methylated 
and esterified with (R)-(-)-a-phenylbutyryl chloride. 
Analysis of the resulting phenylbutyrates showed that the 
enantiomeric composition was 87% of (S)-form to 13% of (R). 
This confirmed that no racemisation had taken place 
during work-up, and that the excreted metabolite was 57% 
the (R)-form.
In order to determine the enantiomeric composition at 
the second chiral centre without any possible interference 
from the asymmetric centre in the side chain, the alcohol 
was first oxidised to the ketone with CrO^/^SO^. After 
formation of (R)-(+)-a-phenylethylamides, GrLC showed that 
the metabolite comprised 58% of the (S)-form and 42% 
of the (R)-form. The principal MS characteristics of
the amides are presented in Table 25. The base peak was 
produced by N-alkyl cleavage and the abundant ion at m/e 
176, characteristic of the acid moiety, by C-acyl cleavage 
with hydrogen transfer, (Pig. 52).
Metabolite 4
(R)-(+)-a-phenylethylamides were prepared for 
metabolite 4 via the imidazolide to prevent any 
interaction with the hydroxyl group. G-LC and MS data 
for the amides of the metabolite, both as the free hydroxy-
Amides of Met.4-TMS with {R)-(-+-) 
rf-Phenylethylamine
3m 1°/o OV-17
0 4 8 12 16 20
« minutes
Pig. .53. Gas chromatographic resolution of metabolite 
4 - trimethylsilyl ether as the amides formed 
with (R)-(+)-a-phenylethylamine.
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compound and as the TMS ether are presented in Table 25. 
The excreted metabolite was shown to be 64$ the (S)- 
2,41-(2-hydroxy-2-methylpropyl)phenylpropionic acid, 
(Pig. 53) assuming the order of elution of the amides is 
the same as that for the derivatives of ibuprofen methyl 
ester.
The base peak in the mass spectrum of the amide of 
metabolite 4 was produced by N-alkyl cleavage (m/e 105) 
and N-acyl cleavage gave the abundant ion at m/e 119. 
Loss of acetone formed the ion at m/e 267, and (combined 
with N-alkyl cleavage) the ion at m/e 163. After 
trimethylsilylation, the base peak (m/e 131) was 
produced by cleavage at the tertiary centre. The 
ethylbenzyl ion was still abundant (33$). The ion at 
m/e 339 could be ascribed to loss of acetone from the 
molecular ion and required rearrangement of the 
trimethylsily1-group.
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3.3.5. In vitro metabolism using rat liver 
preparation
(RS)-ibuprofen (10 mg) was incubated with an 
enzymatic preparation obtained from a rat liver homo- 
genate, for 3 b. After extraction of an acid fraction 
the total sample was methylated and applied to a 
preparative plate which was eluted in chloroform:ethyl 
acetate, 3:1 v/v. The material isolated from the plate 
was examined on GLC and GC-MS and three metabolites of 
ibuprofen were identified, as well as unmetabolised 
ibuprofen (Table 26). All three hydroxylated metabolites 
were present, but no evidence was observed for the 
presence of the dicarboxylic acid, metabolite 2. The 
primary hydroxylated metabolite, metabolite 3, was only a 
minor constituent of the urine extracts but was present to 
a much larger extent in this case. It seemed likely that 
this was an intermediate on the pathway to the dicarboxylic 
acid and under the present conditions further oxidation 
had not occurred.
After mild alkaline hydrolysis, the a-phenylethylamides 
of the unmetabolised ibuprofen and metabolite 4 were 
prepared. GLC analysis showed that both these acids 
were racemic and no evidence for stereospecific 
metabolism was obtained.
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3.4. The urinary metabolism of fenoprofen, (RS)-2-(3- 
phenoxyphenyl)propionic acid
Daring the study of ibuprofen metabolism a urine
sample was obtained from a patient who had also received
treatment with fenoprofen, 2-(3-phenoxyphenyl)propionic
349acid. Previous work on the metabolism of this drug 
had identified the main urinary constituents as the drug 
itself and a hydroxylated derivative of the drug as well 
as the glucuronide conjugates of both of these.
3.4.1. Gas chromatographic and mass spectral characteristics 
of metabolites
A 20 ml sample of urine was extracted with ether and 
ethyl acetate in the same manner as described for the 
isolation of metabolites of ibuprofen, to yield extract A.
The acidified urine (pH~1) was heated at 80°C for 1 h to 
hydrolyse any acid-labile conjugates and re-extracted with 
ether and ethyl acetate to yield extract B. Another 
20 ml sample of urine was treated with "Glusulase*’ in 
acetate buffer for 48 h at 37°C. After extraction this 
yielded extract C. Each sample was then methylated and 
trimethylsilylated and analysed by GLC on a 1% 0V-1 
column, programming from 120-220°C at 2°/min (Pig. 54). 
Extracts A and B showed three peaks of longer retention 
time than the ibuprofen metabolites. GC-MS analysis of 
these peaks (Table 27) showed that peak I corresponded to 
fenoprofen methyl ester. Peak II had M 286 corresponding 
to a methoxy-derivative of fenoprofen methyl ester and

4-0
197 *-J
256 (M+)
200
Fig. 55. Mass spectrum of fenoprofen methyl ester.
285 *■
CH* ! Ov3 i |
H-j- C-O—C H3
TM S
73
%• 3 4 4  (M
69
JL Li it i
135
L . Ihi M it Hill
285 
269 I
1 . 1  ,
Fig. 56. Mass spectrum of hydroxy~fenoprofen as its methyl 
ester trimethylsilyl ether.
peak III had M+ 344^  corresponding to a trimethylsiloxy 
derivative.
The major fragmentation in the mass spectrum of 
fenoprofen methyl ester (Fig. 55) was loss of the 
carbomethoxy group (M-59). Other large fragments were 
the benzyl (m/e 77) and tropylium (m/e 91) cations produced 
by cleavage adjacent to the ethereal oxygen, and loss of 
the carbomethoxy and methyl radicals from the phenyl- 
propionic acid moiety.
Peak II may have arisen by methylation of the phenolic 
hydroxyl group on treatment with diazomethane and may not 
in fact be a genuine metabolite. The base peak in the 
spectrum of this methyl ester was the molecular ion. A 
large ion was observed due to the loss of the carbomethoxy 
group (m/e 227) and cleavage adjacent to the phenyl ether 
oxygen with the charge being retained on the ethereal 
fragment produced the ion at m/e 123.
Hydroxy-fenoprofen (peak III) The base peak in the 
spectrum of the methyl ester was produced by loss of the 
carbomethoxy group, while cleavage at the ethereal 
oxygen produced the abundant ion at m/e 109. After 
trimethylsilylation of the hydroxyl group the molecular 
ion became the base peak. Loss of the carbomethoxy group 
produced an ion of 20°/o abundance (m/e 285) (Fig. 56). The 
ion at m/e 151 was shown to contain two methyl groups from 
the trimethylsilyl ether group by preparation of the per- 
deuterated ether. It could be seen to arise by loss of a 
methyl radical and cleavage adjacent to the phenyl-ether 
with hydrogen transfer (Scheme 12). Transfer of a methyl
- 118-
radical from the trimethylsilyl ether group on to 
the phenolic ether produced the ion at m/e 135. This 
changed to m/e 138 on formation of the perdeuterated 
trimethylsilyl ether.
9 H 3 “i+
O -S i-C H
\CH
m/e 285
C H o >
5 ^ H
O-CH3 
m/e 135
m/e 150
Scheme 12
3.4.2. Isolation and identification of hydroxy-fenoprofen
349According to previous work the position of 
hydroxylation in fenoprofen is para to the ether, in the 
second ring. Since no evidence was presented for this 
structure it was decided to isolate purified material 
and use spectroscopic evidence to verify the structure.
The methylated extract was applied to a silicic
(J=7Hz)
9H3
-C-COOCH
->3
Fig. 57. Proton 1IMR spectrum of hydroxy-fenoprofen methyl 
ester.
a) formal spectrum.
h) Spectrum obtained with added paramagnetic shift 
reagent, Pu(fod)^ (0.4 M concentration).
- 1 1 9 -
acid column which was eluted with CHCl^/EtOAc, 3:1 v/v. 
The first compounds to appear in the eluate were 
fenoprofen, ibuprofen and dicarboxy ibuprofen (Metabolite 
2). The next fraction contained hydroxy-fenoprofen 
(R^, = 0.46). Removal of solvent yielded crystalline 
material which was recrystallised from benzene to give 
white needles, m.p. 118-120°C. Found : C, 70.05; H,
5.70$. Calc, for C16H1604 : C, 70.57; H, 5.92$.
Analysis by IR spectroscopy gave Vqjj = 3600 and V q_q = 
1740 cm""^ (CCl^  solution).
The ^H HMR spectrum showed : 6, 7.3-6.7 (8H)
[aromatic -H]; 5.3 (1H) [-0H]; 3.7 (1H, q, J = 7 Hz)
(benzylic OH-]; 3.7 (3H, s) [-COOCH^ ]; 1.5 (3H, d,
J = 7 Hz) [-CH^  coupled to benzylic CH-].
The aromatic region of the spectrum was too 
complicated to determine any substitution pattern. 
However, simplification was effected by the use of a 
paramagnetic shift reagent - Eu(fod)^. Several 
reagent concentrations were used but the best spectrum 
was obtained with a 0.4 M concentration (Fig. 57).
This showed the presence of two doublets (6 = 8.65 and 
7.9 J = 8 Hz) which could be assigned to the protons 
in the hydroxylated phenyl ring. This could only arise 
from an A2B2 system present in a para-substituted ring. 
The signal at 6 8.5 was assigned to the proton at 0-2 in 
the first phenyl ring and the multiplet at 6 7.4 to the 
ABX system at C-4,5 and 6 . This evidence confirmed 
that the hydroxyl group was in the 4'-position.
Pig. 58. Analytical thin layer chromatogram of material
isolated by preparative TLC from a urinary extract, 
after enzymic hydrolysis, obtained from a patient 
receiving spironolactone treatment.
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5.5. The urinary metabolism of spironolactone
Urine, from patients receiving spironolactone 
treatment, was obtained via, the Blood Pressure Unit 
at the Western Infirmary. After extraction of the 
steroids and steroid conjugates from the urine, by 
adsorption onto the neutral resin, Amberlite XAD-2, 
the free steroids were separated from the conjugates by 
solvent extraction and the conjugates were hydrolysed 
enzymically. Analysis of the steroid fractions by 
analytical TLC (mobile phase CHCl^:MeOH, 9:1 v/v) 
showed several components. Purification was effected 
by preparative TLC using chloroform:methanol, 9:1 v/v
as mobile phase. Since previous workers had
^ soidentified^ several components of the free steroid 
extract, it was decided to concentrate on the 
hydrolysate, using the free extract for comparison.
After purification of the hydrolysate by preparative TLC, 
the material recovered from each band was re-examined 
by analytical TLC (Pig. 58) and Rp values were recorded 
for the major components (Table 28). The purified 
fractions were analysed by G-LC and G-C-MS before and 
after trimethylsilylation. The use of perdeuterated 
trimethylsilyl ethers aided identification by 
indicating the number of hydroxyl groups present.
Several metabolite structures could be postulated 
by examination of their mass spectral fragmentations. 
Unfortunately most of the sulphur functions proved 
thermally labile so that introduction into the mass
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spectrometer via the G-LC system resulted in the spectra 
of the thermal degradation products containing a A6-7 
double bond. However, knowledge of the mobility on 
TLC allowed reasonable speculation as to the oxidation 
state of the sulphur function present (Pig. 59).
Band 4 showed a major component at R^ 0.26 
(metabolite 1) and a minor component, R^ 0.21 
(metabolite 2). Metabolite 2 was also present in 
band 3. These metabolites had similar gas chromatographic 
and mass spectral properties. Mass spectral analysis 
indicated a molecular weight of 356. Trimethylsilyl- 
ation gave a molecular ion at m/e 428 (Pig. 60) rising 
to 437 on treatment with cL jq -B S A , demonstrating that 
the molecule contained one free hydroxyl group. The 
presence of abundant ions at m/e 136 and 137 in the
spectrum of the underivatised sample was consistent
351 4 6 352with a 6-ketone, or A * -3-one^ structure.
o+ o+
137 136
Ions of this type disappeared after trimethyl- 
silylation, perhaps suggesting that the 6-keto or
-  122 -
^^-^-one structure arose from thermal degradation
If the metabolite contained a 6-hydroxyl group and a
7-sulphoxide or sulphone, thermal elimination of the
sulphur function followed by tautomerism would produce
the required structure. Trimethylsilylation of the
hydroxyl function prior to gas chromatographic analysis
would prevent the latter process, and the spectrum obtained
implied the possible formation of an enol ether, since no
loss of trimethylsilanol was observed from the molecular
ion. It seemed likely from the polarity of the metabolites
(indicated by mobility on TLC) that the function at C-7
should be a sulphoxide. The two metabolites could then
be assigned as the two sulphoxide epimers, since such
epimeric compounds are known to show different chromatographic 
353properties. This structure of a methyl sulphoxide would 
agree with that of a major metabolite which had been
Band 5 contained two drug related compounds : 
metabolite 3 (Rp 0.35) and metabolite 4 (Rp 0.44). 
Metabolite 3 also showed the same gas chromatographic and 
mass spectral properties as metabolites 1 and 2. This 
metabolite must, therefore, have the same basic structure 
as metabolites 1 and 2 but have a different sulphur 
function as C-7. It seemed probable that the function at 
C-7 was a sulphone, which would give metabolite 3 the 
structure shown in Pig. 59 .
Metabolite 4 had a molecular weight of 550 after 
trimethylsilylation which rose to 568 on formation of the
in a free steroid extract
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dn-TMS ether indicating the presence of two hydroxyl groups. 
~~y
A loss of 48 (methylthiol) suggested the possibility 
of an intact methylsulphide at C-7. It seemed feasible 
that this function might be less prone to elimination.
No molecular ion was observed in the spectrum of the 
untrimethylsilylated sample, but an ion at mje 358 due to 
loss of methylthiol was noted. Once again fairly 
abundant ions were observed at m/e 136 and 137, 
suggesting that one hydroxyl group was at C-6. Since 
the original drug contained a keto - group at C-3 this 
was the most likely site for the second hydroxyl group.
The base peak in the spectrum of the trimethylsilyl 
ether (Pig. 61 ) arose by rearrangement and combination of the 
two trimethylsilyoxy functions. This was confirmed by a
rise of 15 a.m.u. to m/e 162 when perdeuterated TMS ethers 
were formed. An abundant ion at m/e 111 could be ascribed 
to the lactone ring by cleavage at ring D (Scheme 13)
CH - ^  - 0 - Si m/e 147
o
Scheme 13
m/e 111
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In this spectrum loss of trimethylsilanol from the
molecular ion was observed (m/e 460) and loss of both
silyl groups was also seen (m/e 370).
Band 6 contained a major metabolite with Rp 0.52.
The retention index and mass spectrum of this metabolite
was identical to that obtained from a reference standard
354.of aldadiene, a previously identif ied-'-^ metabolite of 
spironolactone. However this compound was more polar 
than aldadiene on TLG. The metabolite was therefore 
presumed to have contained a 0-7 sulphur function which 
was eliminated in the flash heater. Comparison of these
results with the metabolites which had been identified
3 5 0from the free extract suggested that this was a 
methyl sulphoxide.
The sulphur function was found to be labile and the 
metabolite was partially converted to aldadiene on work-up 
of the TLC band.
Band 8 contained two metabolites; a minor one at 
Rp 0.64 (Metabolite 6) and a major one at Rp 0.69 
(metabolite 7).
Metabolite 6 corresponded to aldadiene on GLC and 
gave an identical mass spectrum. Once again this 
metabolite was more polar than aldadiene but was readily 
converted to aldadiene, indicating the presence of a 
labile sulphur function at C-7. This metabolite was 
assigned the sulphone structure on consideration of data 
from TLC.
Metabolite 7 gave two peaks on GLC as the TMS ether,
B a n d  8 a s  T M S  ethers
3 m  1°/. O V  1 
2 5 0 ° C Pig. 62. Gas 
chromatogram of the 
material eluted in 
hand 8 as the 
trimethylsilyl ether.
o A 6 8
m i n u t e s
10
-SCH
OTMS
ml 
1 0 0 150
283
L-Jl-.L  Jiiu
373
200 250 3 0 0 350
. ii i
4 0 0
429
4761M1
450
Pig. 63 • Mass spectrum of metabolite 7(a) as its trimethyl- 
• silyl ether.
3170
Band 10 
3m 1% OV-1 
250#C
3275
\j
A 6 8 10
minut es
Fig. 64. Gas 
chromatogram of the 
material eluted in 
band 10.
2 4 3
356 (M*)
3 2 8
fl-UUU)!.. l.llip -^ulUUi . 11^------------Ji^ j. J .1 t I K l^ li_|_llU—t
200 250 300 350
o5. Mass spectrum of metabolite 8.
-  125 -
I = 5350 and I = 3410 (Fig. 62 ). The peak with lower 
retention index gave a mass spectrum similar to that 
of metabolite 1. This suggested that metabolite 7 
contained a C-6-hydroxyl group. The second peak had 
a molecular ion at m/e 476 which rose by 9 a.m.u. to 
m/^ 485 on formation of the perdeuterated TMS ether.
A loss of 47 a.m.u. from the molecular ion suggested that 
the function at C-7 might be a methyl sulphide. Either 
both these peaks arise from the same metabolite - the 
methyl sulphide,, by partial elimination of methylthiol on 
G-LC or the spot observed on TLC was a mixture of two 
metabolites, one of which (the methyl sulphide), was 
thermally stable : and the other (a thiol) labile.
The mass spectrum of metabolite 7(a) as the TMS ether 
is shown in Fig. 63.
Band 10 also contained two metabolites, metabolite 8, 
(Rp 0.77) and metabolite 9 (Rp 0.80) (Fig. 64). Neither 
of these metabolites showed a change in retention index or 
mass spectrum when treated with trimethylsilylating 
reagent, indicating that no hydroxyl groups were present.
The mass spectrum of metabolite 8 (Fig. 65) showed a 
molecular weight of 356. The spectrum was very similar 
to that obtained for metabolite 1 before trimethylsilylation 
and the A 4 -3,6-dione structure was proposed on the basis 
of its polarity on TLC. The base peak in the spectrum
(m/e 111) could be ascribed to the lactone ring produced
by cleavage across ring D. Abundant ions were also
observed at m/e 136 and 137 confirming the presence of a
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6-ketone. An ion at m/e 328 could be assigned to 
loss of carbon monoxide from the molecular ion.
Metabolite 9 was identical in chromatographic 
and mass spectral properties to aldadiene.
The base peak in the mass spectrum (Fig. 66) was 
the molecular ion. Major ions could be assigned to 
simple cleavages : loss of the lactone by cleavage
at C-17 produced an ion at m/e 227 and with the charge 
remaining on the lactone fragment, m/e 111; fragmentation 
between rings B and C produced a strong ion at m/e 161 
and further fragmentation of ring B produced the ion
A C
characteristic of the £ 9 dien-3-one structure at m/e 
136.
Section 4. Discussion
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4.1. Gas chromatographic resolution of enantiomers
4.1.1. Terpenoid reagents
The choice of the terpenoid acids as gas chromato­
graphic resolving agents was based on the hypothesis that 
an increase in the conformational immobility of the 
diastereomers, due to the incorporation of one of the 
chiral centres into a ring structure, would enhance the 
population of the "preferred” conformations of the 
diastereomers and hence the differences in their 
chromatographic mobility. This property is displayed 
by some of the reagents which have previously been applied 
to gas chromatographic resolutions (Pig. 67). In several 
cases, however, the rigid reagent skeleton is linked 
to the substrate via a flexible chain which will reduce 
the degree of conformational immobility. The increase 
in rigidity which would be conferred on the system by 
directly linking the chiral reagent to the substrate via 
an ester or amide bond was predicted to lead to better 
separations.
Drimanoic acid proved particularly effective for the 
resolution of straight-chain alcohols. When the alcohol 
is near the end of the chain, as in octan-2-ol, there is 
considerable size differential between the two alkyl 
groups on the asymmetric carbon and the achievement of a 
resolution is relatively straight-forward. Previous 
work on the resolution of alkan-2-ols, however, had mainly
a 7 Q  oori
been based on capillary columns or columns packed
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with very polar phases. The octan-2-ol drimanoates 
showed very good separation on a packed column coated 
with non-selective SE-30 phase.
When the alcohol function is near the middle of a
3^ng alkyl chain the size differential no longer applies
145 150and considerable difficulty had been experienced ’ 
with the resolution of long-chain hydroxy fatty acids 
of this type. During the present study no separation 
was observed for the (R)-(+)-1-phenylethylurethanes, 
(R)-(-)-menthylcarbonates, or the (R)-(-)-menthoxy 
acetates of the enantiomeric methyl 13-hydroxystearates, 
but the corresponding drimanoates were well resolved.
A comparable separation was also achieved for the drimanoyl 
derivatives of the methyl-12-hydroxystearates. These
results reflect the enhancement of diastereomeric 
differences produced when two chiral centres are directly 
linked via an ester bond.
Prom the preceding discussion it would seem likely 
that when both chiral centres are constrained within 
ring systems even better resolutions should result.
This, however, was not always observed, indicating the 
complexity of the separation mechanism.
Of the cyclic asymmetric alcohols studied the best 
resolutions achieved with the O-drimanoyl derivatives 
were for the enantiomeric pantolactones (2-hydroxy-3,3- 
dimethyl-4-butyrolactones) and the menthols. No noteworthy 
results were obtained with the other terpenols. However,
(R )-(+)-trans-chrysanthemic acid proved a very useful
-  129 -
resolving agent for the series of enantiomeric mono-
terpenols. Very good resolutions were achieved for all
the enantiomeric pairs of isomeric menthols and also the
fenchyl alcohols. The results were not quite so good
for the borneols or isoborneols, but separations were
observed. This last result indicates that the increased
rigidity of the borneol ring compared to menthol does not
improve the separation, and other opposing factors must
be involved in this situation. This decrease in
1 70resolution had also been noted by Murano when he used
(-)-menthol and (-)-borneol as resolving agents for 
(-)-trans-chrysanthemic acid.
An important criterion in the choice of a resolving 
agent is that it be enantiomerically pure. Both (S)-(+) 
drimanoic acid and (R)-(+)-trans-chrysanthemic acid 
comply with this requirement, being obtained in pure forms
7 A / :  v r  r
from naturally occurring materials. ’ The formation
of derivatives with enantiomerically pure alcohols 
(+)-octanol or (-)-menthol) gave only one ester peak on 
G-LC, verifying that no racemisation occurred during 
acylation via the acid chloride. This confirmed the 
suitability of these reagents for determining the enantiomeric 
composition of an unknown mixture. The use of drimanoyl 
derivatives showed that the 13-hydroxy-9,11-octadeca- 
dienoic acid isolated from human arterial cholesteryl ester 
fractions was racemic, and allowed postulation of a 
mechanism for its formation. The minor products formed 
during the preparation of drimanoyl derivatives (tentatively
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assigned to 9-epidrimanoyl derivatives) were always 
eluted much earlier on gas chromatography and hence did 
not interfere with any correlations.
In the present work a comparison was made of the 
effectiveness of several previously used resolving 
agents for the resolution of (-)-menthol (Table'll). Of 
the derivatives formed only the (R)-1-phenylethylcarbamates 
of (-)-menthol showed any resolution on 1 a/o  SE-30, and 
the separation was considerably inferior to those obtained 
with the terpenoid acids.
This present study is limited by the number of alcohols 
examined, but it differs from most previous ones in that 
a wide range of types of secondary alcohol have been 
considered. Since there is no simple structural relationship 
between most of the alcohols studied it is very difficult 
to draw any conclusions about the mechanism involved in 
the separation. However, the few comparisons which have 
been made between these derivatives and those formed with 
previously used gas chromatographic resolving agents 
indicate, in many instances, a considerable improvement in 
resolution with the new reagents. This effect is probably 
due to the presence of a rigid cyclic system, incorporating 
a chiral centre directly linked to the asymmetric carbinol 
via an ester bond. Further improvements in the resolution 
observed with the chrysanthemoyl derivatives could be 
ascribed either to the involvement of the two centres of 
electron density in the isobutenylcyclopropane system or 
simply to the lower molecular weight of the derivatives
-  131 -
allowing the use of lower chromatographic temperatures.
Six distinct types of secondary alcohol have been 
examined and resolutions were achieved for every 
enantiomeric pair with at least one, and in many cases 
both derivatives, with the exception of the steroidal 
alcohols. These present special problems because the 
high molecular weights which are involved require the use 
of temperatures above the optimum for gas chromatographic 
resolution.
In conclusion (S)-(+)-drimanoic acid and (R)-(+)- 
trans-chrysanthemic acid appear to be useful and 
versatile reagents for the gas chromatographic resolution 
of secondary alcohols.
Amines and amino acids
Excellent resolutions were obtained with drimanoic 
acid for the primary amines a-phenylethylamine and 
amphetamine. There has been considerable interest in 
determining the configuration of amphetamine and various 
analogues by gas chromatography. The most frequently 
used derivatives have been the N-trifluoroacetyl-(S)-(-)-
a p- r  a
prolylamides ’ which have been found suitable for the 
quantitative determination of (+)- and (-)-amphetamine.
The separation achieved with drimanoic acid would be 
suitable for semi-quantitative analysis and it could, 
presumably, be improved by the use of high efficiency 
capillary columns. A very good resolution was also 
obtained for the amphetamine N-chrysanthemoyl derivatives. 
However, under these conditions no separation was observed
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for the a-phenylethylamine chrysanthemamid.es nor either
of the terpenoid acyl derivatives of N-methyl-a-phenyl-
ethylamine. Improved resolution can, however he
achieved by using longer, more efficient chromatographic
columns and complete resolution of both ( -)-trans and
(-)-cis-chrysanthemic acids has been obtained when they
are analysed as amides of (+)-a-phenylethylamine on
1 72capillary columns. The application of chrysanthemic
acid to the resolution of several 1-phenyl or 1-
naphthylalkylamines or 1,2-diphenylethylamines has been 
357reported. The derivatives of trans-chrysanthemic
acid were separated better than those of cis-chrysanthemic
acid, but in general poor resolutions have been noted
for the 1-phenyl or 1-naphthylalkylamine derivatives. The
proximity of the phenyl ring to the amide centre seems,
therefore, to have an adverse effect on the resolution.
This is contrary to previous results for other diastereomeric 
14-1derivatives. Extensive studies with a-phenylethylamine
07^ oAn
on optically active stationary phases have indicated 9 9
that the presence of the bulky phenyl group at the
asymmetric centre in close proximity to hydrogen bonding
involving the amino group gave excellent resolution.
141The resolution of N-TEA-(S)-prolylamides and more
recently N-perfluoroacyl-(L)-leucyl-, -(L)-alanyl- and
358-(l)-valy1-derivatives have all indicated a decrease 
in resolution when the asymmetric centre and phenyl ring 
are separated by a methylene group. Similar results were 
obtained with the phenylalkylamides of substituted phenyl-
-  133 -
acetic acids (Sec. 3.2.1.). The excellent result 
obtained for (i)-methamphetamine-W-chrysanthemamide also 
indicates that hydrogen bonding involving an amide proton 
is not an important factor in this case. It would seem 
likely that in the case of the chrysanthemoyl derivatives 
electronic effects involving the isobutenylcyclopropane 
system are important, and interaction of this moiety with 
another electron dense region at close proximity can 
adversely affect the resolution.
Only four amino acid methyl esters were studied and 
the best resolutions were obtained for the chrysanthemoyl 
derivatives of valine methyl ester and phenylalanine 
methyl ester (A I = 15).
Proline methyl ester was expected to be resolved 
well since the chirality is embodied in a ring system.
This is the basis of the choice of N-trifluoroacetyl-(S)- 
(-)-prolyl chloride as a gas chromatographic resolving 
agent. Separations were observed with both drimanoic 
and chrysanthemic acids.
Phenylglycine methyl ester presents an interesting 
case. No separation was observed for either the N- 
drimanoyl or N-chrysanthemoyl derivatives. The analogous 
diastereomeric O-drimanoyl and O~chrysanthemoyl derivatives 
of mandelic acid methyl ester, however, were easily 
distinguished. This result is contrary to previous 
findings that diastereomeric amides are better separated by 
GrLC than analogous esters (e.g. ref. 221). Again this 
suggests that hydrogen bonding of an amido-proton is not
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an important factor for the resolution of derivatives of 
these terpenoid acids. Since the homologous phenyl­
alanine methyl ester showed good separations with both 
the drimanoyl and chrysanthemoyl derivatives the distance 
of the phenyl ring from the asymmetric centre is again 
seen to he critical.
Although the mechanism involved in these resolutions 
appears to he complicated the order of elution of
diastereomers could he easily predicted on the basis of
225bulkiness chirality. For a representative alcohol
or amine :
the order of elution of the (S*)-drimanoyl derivatives was 
(S*S) before (S*R), and of the (R*)-chrysanthemoyl 
derivatives, (R*S) before (R*R), as long as R* was 
bulkier than R. When R became bulkier than R f a reversal 
of elution order was noted.
The degree of success achieved with these reagents 
confirms the expectations of the value of chiral reagents 
containing conformationally immobile ring systems. The 
use of drimanoic acid is to some extent restricted by the 
large molecular weight increment produced on derivatisation.
H
' N R
n
R R*
(S) (S)
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The high temperatures which are required to elute high 
molecular weight compounds e.g. derivatives of steroid 
alcohols, are above the optimum for good column efficiency 
and hence resolution of these diastereomers is more 
difficult.
359The efficiency of a packed column can be given by
2
H = 4Xr + 2KDg/u + 8Kd o—  u
i ^ O + K ) ^
Where H is the height equivalent to a theoretical plate; 
Aand are constants of the order of unity; r = average 
particle radius; d = average liquid film thickness;
Dg and D^ = diffusion coefficients of vapour being 
chromatographed in the gas and liquid phases; u = true 
linear gas velocity in the column; K is the column 
capacity coefficient.
This equation can be simplified to :
H = A + B/u + Cu
Temperature is the most complex of the variables affecting 
column efficiency Increase of temperature increases
D-^  and Dg and decreases K. The variation of D^ and Dg
with temperature are not great provided that the liquid 
phase is not highly viscous. Their effects on column 
efficiency will tend to cancel out since one appears in 
the numerator of B and the other in the denominator of C. 
The major effect of temperature is through K. Any 
decrease in K tends to increase G and therefore increase 
of temperature will lower column efficiency.
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On this basis resolving agents analogous to
chrysanthemic acid probably hold more promise for the
resolution of high molecular weight compounds. A
partial peak resolution was in fact noted for (-)-
estradiol 3-methyl ether as its chrysanthemoyl derivative.
Natural chrysanthemic, pyrethric, and chrysanthemum-
356 361dicarboxylic acid ’ are readily accessible sources 
of a variety of related acids which would retain chirality. 
The examination of chrysanthemic acid analogues of lower 
molecular weight or higher polarity is being undertaken 
at present by a colleague. Examples of some of the acids
are :
CH3
Other monoterpenoid reagents may also be readily obtained 
e»g* (-)-cis-myrtanic acid, camphanecarboxylic acids. 
Three camphor related compounds : (+)-isoketopinyl
chloride(l), (-)-dihydroteresantalinyl chloride(ll) and 
(-)-teresantalinyl chloride(III), have recently been 
successfully
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cioc.
(I) (I) W)
applied to the gas chromatographic resolution of racemic 
21 2amino acids. The more rigid structure of the (-)-
teresantalinyl moiety, possessing a cyclopropane ring,
■was reflected in superior resolutions with this reagent.
4.1.2. Substituted phenylacetic acids
The best amine resolutions observed in this series 
were for the derivatives of a-phenylethylamine, where a 
retention index difference of 30 or more was achieved 
with every derivative. The lower resolution factors 
obtained with N-methyl-a-phenylethylamine and amphetamine 
derivatives indicate that the resolution mechanism involves 
hydrogen bonding of the proton on the amine and that the 
distance of the aromatic ring from the amide bond is 
important. In this case, unlike the terpenoid derivatives, 
the derivatives in which the aromatic ring is nearer to 
the amide bond were better separated.
Although thermodynamic parameters were not calculated 
during this study the retention index differences which 
were measured are related to the separation factors, a, 
as shown below.
In isothermal gas chromatography the retention 
index of any substance is found by logarithmic inter­
polation between the two relevant n - p a r a f f i n s . ^ 6 2
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I = 100 r (3ubst) ~ log r (n-Cz) + 500 z
108 " I”-0, * . )  ' 108 r <“- 'V
fr(n-C2) ^ r(subst) 6. r(n~cz+<j)^
Where r = adjusted retention time, net retention volume; 
n-C^ = n-paraffin with z carbon atoms, and n-Cz+<j = 
n-paraffin with (z+1) carbon atoms.
Therefore, for two compounds A and B,
log r^ - log r.
A I = 100
l0S r (n-Cz+1) " l0§ r (n-Cz)
log rB/r 
100 --------------- -— £-----------
los r(“- < W  " log r(n-°*>
log a
100
log  ^(n_cz+1) - l 0 S r(n-Cz)
Since a can be directly related to the free energy 
differences for the diastereomers,
-A(iG°) = RTlna
(see See. 1.2. p. 24 )
the trends observed in the retention index differences 
quantitatively reflect the variation of free energy 
differences for the pairs of diastereomers. -A(A0°) can 
be expected to increase as the substituent on the a- 
carbon of the resolving agent increases in size 
(Me <. Et <  since the separations increase in
(M) 
(L) Ph CH 
/  o  H (S)
(L) (M)
Ph Et
N - C
11
N
O  H  (S) /
Ph iPr 
O H (S)
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Pig, 68. Space projection of the (R)-substituted phenylacetic 
acids and an appropriate (S)-amine. When Y was 
bulkier than X the phenylpropionamides and phenyl- 
butyramides were eluted in the order (RR) <  (RS); the 
reverse order was observed when X was bulkier than Y. 
The a-chlorophenylacetamides behaved in the opposite
manner.
Fig.
(a) /R
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69. The apparently anomolous behaviour of the amino acids.
a) Space projection of (S)-valine methyl ester. The 
observed order of elution of these amides suggests 
that the carbomethoxyl group is bulkier than the 
isopropyl group when R is phenylpropionyl or 
phenylbutyryl, isosteric with the isopropropyl 
group when R is 3-methyl-2-phenylbutyryl, and 
smaller than the isopropyl group when R is 
drimanoyl or chrysanthemoyl.
b) Space projection for (S)-phenylglycine methyl ester 
The observed elution order of the phenylpropionyl- ; 
phenylbutyryl-derivatives of phenylglycine methyl 
ester can be explained by the phenyl group being 
bulkier than the carbomethoxyl group.
-  139 -
this order. The introduction of a more polar substituent, 
however, (-OMe or -Cl) produces electronic effects which 
makes interpretation of the results more difficult. 
Introduction of polar substituents into the aromatic 
ring in jp-chloroamphetamine and 3-methoxy-4,5-methylene- 
dioxyamphetamine increased the resolution (relative to 
amphetamine). This could either be an electronic effect 
or simply a result of the increased bulkiness.
The elution order of these diastereomers can also
225be predicted by Peibush’s rule. When R' is bulkier
than R (Pig. 68) the (RR)/(SSi) diastereomer is eluted 
before the (RS)/(SR) diastereomer as observed for the 
series of phenylbutyramides and phenylpropionamides.
This order should remain the same for the isopropylphenyl- 
acetamides provided that the isopropyl group is not bulkier 
than the phenyl substituent. The same elution order 
has been observed for all three cc-alkyl substituted 
phenylacetyl derivatives of (-)-methyl amphetamine which 
would suggest that the isopropyl group does not appear 
bulkier than the phenyl ring.
When the amino acid derivatives are considered the 
reversal of elution order observed with the terpenoid 
derivatives and explained on the basis of R having a 
greater effective bulk than R' was not apparent, except 
in the case of phenylglycine methyl ester. In these 
derivatives the carbomethoxyl group is effectively larger 
than the isopropyl group in valine and the ring in proline, 
but not the phenyl group in phenylglycine (Pig. 69).
Since the relative effective bulk of two groups is not
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expected to change when considered under similar conditions, 
this interpretation of the results may be oversimplified.
It is interesting to note that in the case of valine 
methyl ester the resolution achieved decreases as the 
bulk of the a-group in the reagent increases (i.e.
Me > Et > ^r). This might suggest that there are 
two opposing resolution mechanisms in operation which 
effectively cancel each other out when the a-isopropyl- 
phenylacetyl derivative is used, since no separation is 
obtained. It would be interesting to examine the 
situation with a-t-butylphenylacetyl derivatives to 
ascertain whether or not a reversal of elution order is 
observed.
The a-methoxyphenylacetyl derivatives should follow 
the same elution order as the other derivatives as long 
as the phenyl group is bulkier than the methoxyl group 
and no opposing polarity effects occur. This elution 
order has still to be ascertained. The a-chlorophenyl- 
acetamides were expected to follow the same elution order 
since the phenyl ring was thought to be bulkier than the 
chlorine atom; however, examination of the experimental 
results showed the opposite order. If these observed 
elution orders are to agree with Peibush's rule then the 
chlorine must appear bulkier than the phenyl ring, but 
the polarity of this group may result in a different 
resolution mechanism.
Assignments of configuration from gas chromatographic 
data may be made within a series of related compounds.
On the basis of the known order of elution of amphetamine
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and methamphetaniine phenylbutyramides as (RR) before 
(RS), the peak of shorter retention time for the 
diastereomeric (R)-phenylbutyryl derivatives of ja-chloro- 
amphetamine or 3-methoxy-4,5-methylenedioxyamphetamine 
can be assigned to the (R)-enantiomer.
Contrary to the results obtained with the terpenoid 
reagents, good resolutions were achieved for phenylglycine 
methyl ester with the arylalkanoic acids, but phenyl­
alanine methyl ester proved to be unresolved in most 
cases. A good resolution was obtained, however, for the 
3-methy1-2-phenylbutyryl derivative of phenylalanine 
methyl ester on OV-17 phase, reflecting the enhanced 
diastereomeric differences achieved when the ethyl group 
in phenylbutyryl derivatives is replaced by an isopropyl 
group. Since no separation of these diastereomers was 
observed on SE-30 phase the increased polarity of the 
stationary phase must also play a role in the separation 
mechanism. Replacement of the a-alkyl group by an ac­
me thoxyl group produced a reagent which adequately 
resolved both arylamino acid methyl esters on SE-30 
(AI = 35 for phenylglycine methyl ester and AI = 15 for 
phenylalanine methyl ester) and OV-17 phase (AI = 40 
and AI = 20 respectively).
Norvaline methyl ester presented problems with all 
the reagents, although the (branched) isomeric valine 
methyl ester was sufficiently differentiated with a- 
phenylpropionic, a-phenylbutyric, and a-chlorophenyl- 
acetic acids. Once again the a-methoxyphenylacetic acid
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proved a useful reagent in a difficult situation and a
separation of 20 index units was obtained on 0V-17
for the N-acyl norvaline methyl esters.
Compounds containing more than one functional group
present particular problems. The simplest case is the
amino acid where the acid function can be methylated
followed by derivatisation of the amino function with a
chiral reagent. Alternatively a diastereomeric
derivative can be obtained by esterification of the acid
function with a chiral alcohol and the polar amino group
may be trifluoroacetylated or trimethylsilylated. The
situation becomes more difficult when both an amino
function and an hydroxyl function are present since they
react with the same reagents. The selective derivatisation
of multifunctional amino acids has been accomplished in
several ways 80,201,363 o-TMS, N-(N-TFA-prolyl)-amino
201 363acid esters have been prepared by two approaches. 9
(3-Hydroxy-a-amino acid methyl esters have been examined
by trimethylsilylation with hexamethyldisila.zane (HMDS)
201before reaction with N-TFA-(S)-prolylchloride.
Alternatively the greater reactivity of the amino
function has been used to form the N-TFA-(S)-prolyl
derivative before trimethylsilylation of the phenolic
363amino acid n-butyl esters. The diastereomeric
derivatives prepared by esterification of the amino acid
with 2-butanol and trifluoroacetylation of the hydroxyl
and amino functions have been observed not to yield good
1 80chromatographic peaks. It has been found, however,
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Pig. 70. Suggested, ’preferred” conformation for the N-(R)-phenyl- 
butyryl derivative of ephedrine O-TMS :
a) (2R, 1S)-(+)-erythro; b) (2S, 1R)-(-)-erythro;
c) (2S, 1S)-(+)-threo; d) (2R, 1R)-(-)-threo
[Rf = Si(OH3)3].
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that leaving the sample in methanol for 24h at room 
temperature quantitatively removed the trifluoroacetate 
group from the hydroxyl function which could then he 
acetylated, resulting in a considerable improvement in 
chromatographic performance.
In the present work the amino alcohol ephedrine was 
examined. Previous workers have prepared the N-TFA-(S)- 
prolylamides by reacting the amino alcohol with one 
equivalent of N-TFA-(S)-prolylchloride. A similar
approach was successfully employed in the present study 
using (R)-(-)-phenylbutyryl chloride or (R)-(-)-phenyl- 
butyric anhydride with a short reaction time. Increased 
selectivity was expected with the imidazolide of phenyl- 
butyric acid since carboxylic acid imidazolides had been 
reported^^ to react readily with amines, but only very 
slowly with alcohols, at room temperature. Derivatisation 
was complete after ih at room temperature and no 0- 
phenylbutyryl derivative could be detected by TLC or G-LC.
Only ephedrine (Pig. 70 -erythro. R=H) was resolved 
as its (R)-(-)-phenylbutyramide on GLC. The observed
elution order was (+)-erythro (1S, 2R) before (-)-
erythro (1R, 2S). Considering the amine chiral centre (2) 
alone this shows the same elution order as that observed 
with the (R)-(-)-phenylbutyramides of the phenylalkylamines,
i.e. (RR) before (RS). A similar result has been found
for the diastereomeric ephedrines as the N-TPA-(S)-prolyl 
derivatives.^ ^
After trimethylsilylation of the free hydroxyl group
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resolutions were also observed for the (R) - (-)-phenyl­
butyryl derivatives of -ephedrine (Pig. 70 -threo,
R = TMS) and nor-Tj.-ephedrine. No separation was observed 
for the derivatives of nor-ephedrine.
The bulkiness of the trimethylsilyl ether group, and 
the removal of the hydroxylic proton for hydrogen bonding 
would change the preferred conformations of the diastereomers, 
producing different associations with the stationary phase 
and hence the observed resolutions. The (R)-(-)-phenyl­
butyryl derivatives of the ^ -ephedrines (O-TMS) were 
eluted in the order (+)-threo (1S, 2S) before (-)-threo
(1R, 2R), which is the opposite to that found for the
1 56N-TFA-(S)-prolyl derivatives. These results can,
however, be explained on the basis of differential 
accessibility to the central functional group. If the 
preferred conformation is assumed to be one in which the 
bulky trimethylsilyl ether group is as far removed from 
the amide centre as possible (Pig. 70) and the molecule 
is observed along the plane through the amide bond, the 
(-)-threo derivative has all the bulky groups, (Et, CH^
Ph) on one side of the plane and all the hydrogen atoms 
on the other side. The (+)-threo derivative will be 
less accessible to the stationary phase since there are 
bulky groups on both sides. The (-)-threo-(R)-(-)- 
phenylbutyramide would, therefore, be expected to interact 
more strongly with the stationary phase and be retained 
relative to the (+)-threo-derivative. This is the 
observed elution order. A similar argument applies to 
the ephedrine case (erythro) although in this situation
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neither diastereomer has all bulky groups on the one side
of the plane. In this case the diastereomer which has
the two bulkiest groups (Et and Ph) on the same side of
the plane i.e. (-)-erythro, allows the greatest accessibility
to the phase and is retained relative to the (+)-erythro-
derivative. The elution order cannot, therefore, be
predicted on the basis of the configuration at the amino- 
1 56chiral centre alone, and the spatial arrangement of 
the whole molecule must be considered.
This series of substituted phenylacetic acids are 
suitable for the analytical gas chromatographic resolution 
of many enantiomeric amino-compounds. All the compounds 
studied during this survey were effectively resolved by 
at least one of the reagents, and in many instances 
complete resolution was obtained. This renders these 
derivatives useful for the determination of the enantiomeric 
composition of amines derived from biological extracts.
Only the a-chlorophenylacetyl chloride proved unsatis­
factory because of its ready racemisation during acylation.
Several extensions of this project can be proposed. 
Mandelic acid would be a suitable substrate for the 
preparation of chiral acids incorporating various bulky or 
polar substituents in the a-position e.g. a-acetoxy- 
phenylacetic acid or a-trimethylsilyloxy-phenylacetic acid.
It would also be interesting to examine the resolutions 
obtained using the analogous amino acid-phenylglycine - 
as resolving agent. In this way an armoury of reagents 
can be built up, thus increasing the versatility of the
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method.
As a corollary, several substituted phenylpropionic 
acids were successfully resolved on G-LC as the amides with 
(R)-(+)-a-phenylethylamine (Appendix). Use of N,N‘- 
carbonyldiimidazole allowed the formation of the (R)-(+)- 
a-phenylethylamide of a hydroxy-acid without any 
interference of the hydroxyl group, during work on the 
hydroxylated metabolites of 'Brufen1 (Sec. 5.3.4.). Work 
is also in progress on the selective derivatisation of 
one carboxyl group in diastereomeric dicarboxylic acids.
It is hoped to extend this work to preparative scale 
diastereomer resolution either by ILC or liquid 
chromat ography.
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4.2. Mass spectral characteristics of diastereomeric 
esters and amides
The major mass spectral fragmentations of the 
diastereomeric esters and amides are discussed fully in 
Section 3. The main features of interest are the high 
abundance of molecular ions and characteristic 
fragmentations which would be of use in the 
identification of unknown compounds, particularly in the 
amide series.
No significant differences were noted between the 
spectra of diastereomeric compounds.
The use of chiral derivatives such as these in 
association with mass fragmentography could lead to the 
determination of the enantiomeric composition of chiral 
compounds occurring at very low levels in biological 
fluids.
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4.3. The metabolism of ibuprofen
Ibuprofen [(-)-2-(4-isobutylphenyl)propionic acid]
341 364has been shown ’ to be a potent orally active anti­
inflammatory antipyretic and analgesic agent. It is in 
widespread use for long term maintenance therapy at a 
dosage of about 500 mg/day. When drugs are administered 
in relatively high dosage over a long term it is important 
to establish the contribution of any metabolites to the 
pharmacological effects. It is of particular importance 
when racemic drugs are administered, to determine whether 
or not both enantiomeric forms have equal biological 
activity.
With these aims in view, gas chromatographic 
methods for determining the urinary metabolites of 
ibuprofen were devised.
4.3.1. general aspects of metabolism
Pour urinary metabolites were observed and 
identified as the oxidation products of the isobutyl side- 
chain. The three possible isomeric side-chain 
hydroxylated metabolites were identified and the fourth 
metabolite was a dicarboxylic acid obtained by further 
oxidation of the primary alcohol. This pattern is
365qualitatively similar to the one which had been observed 
in the metabolism of the hypoglycaemic agent, 2-p-methoxy- 
benzene sulphonamido-5-isobutyl-1,3,4-thiadiazole.
P’urther metabolism consisted of conjugation of ibuprofen
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and its metabolites.
The three isomeric hydroxy derivatives were easily 
distinguished by GLC as their methyl esters or methyl 
ester TMS ethers. The primary hydroxylated metabolite 
(metabolite 3), however, was indistinguishable from the 
dicarboxylic acid (metabolite 2) as their methyl esters, 
but trimethylsilylation of the alcohol function produced 
two well separated peaks.
The mass spectra obtained from the derivatives of 
ibuprofen and its metabolites were characterised by simple 
cleavages which aided structural elucidation.
Unfortunately, the molecular ions obtained from the 
hydroxylated metabolites were of relatively low 
abundance but this did not hinder identification. The 
preparation of perdeuterated derivatives and the use of 
simple chemical transformations helped to confirm proposed 
structures.
Isolation of a few mg of each of the two major
metabolites (2 and 4) allowed the use of infrared and
NMR spectroscopy to substantiate further the suggested
structures. These two metabolites had previously been 
341 342identified * in the serum and urine of experimental 
animals and humans after treatment with ibuprofen.
The two minor metabolites (1 and 3) were previously 
unidentified. The structure of metabolite 1 was 
confirmed by synthesis of authentic material from ibuprofen, 
and complete characterisation was achieved by GLC, MS,
IR and NMR spectroscopy. The isolated metabolite was
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identical to the synthetic material in all chromatographic 
and mass spectral properties.
Confirmation of the structure of metabolite 3 was 
obtained by reduction of the acid function to give a 
product identical to that obtained by reduction of 
metabolite 2.
The initial identification of these metabolites was 
obtained from the analysis of a single 20h urine sample. 
This indicates the advantage of using G-LC and GC-MS for 
metabolism studies since a great deal of structural 
information can be obtained without requiring the 
extraction of large batches of fluid.
4.3.2. Stereochemical aspects of metabolism
The (R)-(+)-a-phenylethylamides of (-)-ibuprofen
were completely separated on OV-17 phase. This allowed
the determination of the enantiomeric composition of the
’unmetabolised” ibuprofen excreted in urine. The
excreted acid was found by GLC to be 80^ (S)-(+)-2-(4-
isobutylphenyl)-propionic acid. A similar enhancement
of the (S)-enantiomer was observed with the ibuprofen
excreted as conjugated material. This result could
indicate stereoselective metabolism of the (R)-(-)-acid
or enhanced excretion of the (S)-(+)-acid. Both forms,
341however, had been reported to have equal biological 
activity. Preparation of the (R)-(+)-a-phenylethylamides
of the metabolised acid and GLC analysis, also showed 
an excess of the (S)-(+)-form. Metabolite 4 was shown
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by GLC of the derived amides to contain 64$ of the
(S)-(+)-enantiomer, while metabolite 1, after oxidation
of the alcohol to a ketone to remove the second chiral
centre, was found to contain 58$ of the (S)-form. In
accordance with these results, it had previously been 
341 342found * that the two major metabolites of ibuprofen,
isolated from human urine, were dextrorotatory, even
342when (R)-(-)-acid was administered. Metabolite 2
contains a second chiral centre which could have accounted 
for the change in rotation observed for this metabolite,
No such explanation however, could be proposed for metabolite 
4, and an inversion of configuration must have occurred.
In the present work the isolation of "unmetabolised” 
acid consisting mainly of the (S)-(+)-enantiomer also 
suggests that the (R)-(~)-acid is epimerized. Determination 
of the enantiomeric composition of the metabolites 
indicates that both forms of the ibuprofen are metabolised, 
and the enhancement of the (S)-(+)-form could be produced, 
either by epimerization of the (R)-(-)-acid before 
metabolism, or by the occurrence of a similar inversion at 
the chiral centre in the metabolite. Recent work by the 
Upjohn Co., involving the administration of the resolved 
forms of ibuprofen and deuterium labelled, (R)-(-)-[
*2
ibuprofen to male volunteers, has led to the proposition 
of the existence of an (R)-aryl-propionic acid isomerase 
system in man (Pig. 71 ).
An initial in vitro experiment performed with the 
racemic acid using an enzyme preparation from rat liver
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gave no indication of any isomerase activity. Both the 
isolated "unmetabolised" ibuprofen and metabolite 4 were 
racemic. further work is required however, particularly 
with the resolved forms of the drug, before any conclusions 
can be drawn about this system.
Metabolite 2 presented a special problem since two 
chiral centres are involved. The selective derivatisation 
of one centre at a time in order to determine the enantiomeric 
composition at both, is under investigation. It does, 
however, seem likely from the results obtained with 
metabolites 1 and 4, that the configuration at the 
original centre will be enhanced in the (S)-form.
Metabolite 1 also contains a second chiral centre 
but the enantiomeric composition at the alcohol centre 
was readily determined by GLC of the diastereomeric esters 
prepared with (R)-(-)-phenylbutyric acid. The second 
ester peak was larger than the first (57$) indicating 
that the hydroxylation showed some stereoselectivity.
The absolute configuration of the alcohol was determined, 
using the resolved synthetic sample, by the modified 
micro-Horeau method f^ 44,345 an(^ excreted metabolite 
was found to comprise 57$ the (R)-enantiomer.
This metabolite could be produced by either of two
metabolic processes : either direct enzymic hydroxylation,
or benzylic addition of oxygen to form a ketone followed
by reduction to the alcohol. Studies of the metabolic
68hydroxylation of alkylbenzenes have shown a preponderance 
of the (R)-enantiomer in the product, whereas metabolic
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82reduction of benzylic ketones has been seen to produce 
a greater proportion of the (S)-enantiomer. It "would,
therefore, seem likely that metabolite 1 is produced by 
a direct hydroxylation process which shows some product 
stereoselectivity.
These results (Pig. 72) further illustrate the 
convenience of gas-phase methods for the micro-analytical 
characterisation of enantiomers and present a practical 
application of the techniques described in sections
3.1. and 3.2.
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4.4. The metabolism of fenoprofen
During the work on ibuprofen metabolism one urine
sample was obtained from a patient who had received
treatment (unknown to us at the time) with fenoprofen,
(-)-2-(3-phenoxyphenyl)propionic acid, as well as ibuprofen.
Analysis of the acidic urine extract by G-LC showed three
peaks of longer retention time than the ibuprofen
metabolites. The conjugated fraction showed the same
peaks. These were identified by G-C-MS as fenoprofen
methyl ester, a hydroxylated metabolite and a methoxylated
metabolite. Only the 41-hydroxyfenoprofen had been
349previously identified as a metabolite, as well as the 
conjugates of fenoprofen and 4’-hydroxyfenoprofen. Since 
the hydroxyl group is phenolic it is possible that it was 
partially methylated when the acid was treated with 
diazomethane. This would explain the presence of the 
methoxylated derivative as an artefact and not a metabolite. 
The mass spectrum was consistent with this being the 
methylated derivative of the hydroxy-compound.
Fenoprofen was fully characterised by G-LC and GC-MS 
as its methyl ester. The structure of the hydroxylated 
metabolite was determined by GC-MS and confirmed by 
isolation of purified material followed by MIR spectroscopy. 
The position of hydroxylation was proved by NMR spectroscopy 
with the help of a lanthanide shift reagent, Eu(fod)^, to 
spread out the aromatic region of the spectrum and simplify 
interpretation.
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The pattern of metabolism was in agreement with
349the one which had already been described. J However, 
although the relative amounts of conjugated and 
unconjugated material excreted were not accurately 
measured, the urinary profiles (Fig. 54) indicated a 
larger portion of unconjugated fenoprofen and 4’- 
hydroxy-fenoprofen than had previously been suggested 
(2-5$ free; 45$ conjugated). Perhaps this difference 
could be attributed to an effect of the long term treat­
ment with ibuprofen before administration of fenoprofen.
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4.5. Spironolactone metabolism
In previous metabolism studies of spironolactone 
[3-(3-oxo-7a-acetylthio-1 7|3-hydroxy-4-andros ten-17 a- 
yl)propionic acid ^ -lactone], two major urinary metabolites 
have been identified in the free steroid extracts, viz : 
aldadienef ^ 4  [3_(3_0xo-17P-hydroxy-4,6-androstadiene- 
17a-yl)propionic acid -lactone] and 3-(3-oxo-7a- 
methylsulphinyl-6(3,17£-dih.ydroxy-4-androsten-17a-yl)-
»7r
propionic acid -lactone. The structures of three
other minor sulphur-containing metabolites have also been 
proposed. The present study confirmed the presence
of these metabolites in the conjugated fraction of urine 
extracts and provided additional mass spectral data in 
accordance with the proposed structures. Four other 
minor metabolites were tentatively identified on the 
basis of their chromatographic mobilities (TIC and G-LC) 
and mass spectral characteristics.
A possible metabolic pathway for spironolactone is 
represented in Fig. 73. The thiol resulting from 
hydrolysis of the thioacetyl group and the product of 
its S-methylation were not observed during this study 
but may presumably be intermediates in the metabolism.
The major sulphur containing metabolite (1 ) could 
arise from the proposed methylthiol intermediate either 
via metabolite (5) by oxidation of the methyl sulphide 
followed by hydroxylation, or by initial hydroxylation to 
metabolite (7) followed by sulphoxidation. Evidence 
was obtained on TLC for the presence of both sulphoxide
- 157 -
epimers suggesting that this oxidation was not 
stereospecific. Further oxidation of the sulphoxide 
would produce the methylsulphone (3) . Similarly the 
sulphone (6) could arise by oxidation of the 
sulphoxide (5).
These latter metabolites were present only in minor 
amounts and the lability of the sulphur functions 
rendered isolation of material difficult. The proposed 
structures are, therefore, only tentative assignments.
The major non-sulphur-containing metabolite was the 
de-thioacetylated compound, aldadiene (9). This 
metabolite might also arise from metabolites (5) and (6) 
by elimination of the sulphur function. These metabolites 
were easily converted to aldadiene under mild conditions 
and it seems feasible that a portion of the observed 
aldadiene would arise as an artefact during work-up.
Similarly metabolite (8) could arise by the
elimination of the sulphur functions from metabolites
(1), (2), (3) and (7). This elimination occurred
thermally and the former three metabolites were
.4
chromatographed completely as the A -3,6-dioxo steroid 
(8) on G1C. The methylthiol function appeared less 
labile and this metabolite (7) underwent chromatography 
intact. Whether any of metabolite (8) occurred 
metabolically or whether it was present merely as an 
artefact produced during work-up has not been ascertained.
The minor products of the metabolism of spirono­
lactone have been tentatively identified and the proposed
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structures fit into a logical metabolic pathway. How­
ever, further work using milder isolation procedures is 
required to obtain full structural identification. 
Initial observations using high pressure liquid 
chromatography of spironolactone indicate that it 
chromatographs with the thioacetate function intact.
This could provide a means of differentiating and 
isolating the various sulphur containing metabolites for 
further spectroscopic examination.
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APPENDIX
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Table 29. Gas chromatographic: data for the amides of
substituted phenylpropionic acids with iw -
(+)-a-phenylethylamine
Acid 1 io OY-1 Mo ov-17
(see Pig. 74) I T°C I T°C
/ (R) 2-Phenylpropionic (A)
(s)
1965
1995
190
2350
2355
220
2-(2,3,5,6-tetramethyl-
*
phenyl)propionic (B)
2305
2350
210
2690
2740
220
2-(4-isobutylphenyl) (R) 
propionic (C)"f (S)
2310
2340
230
2625
2660
220
2-(3-phenoxyphenyl) 
propionic (D)t
2640
2675
230
5185
5215
245
2-(3-b enz oylphe ny1) 
**
propionic (E)
2850
2890
230
5475
5525
245
2-([3-fluoro-4-phenyl] 
phenyl)propionic (F)+
2655
2695
230
5155
5200
255
a-(naphthyl) propionic
/ N*(G)
2440
2455
210
2900
2920
220
2-(4-[4*-(1-carboxy ethyl)-
benzyl]phenyl)propionic (H) 3260
250
5865
255
as mono-methyl ester-mono- 5275 5900
arnide*
■ft
Sources of acids : Organon Ltd., New House, Lanarkshire
+ Boots Ltd., Nottingham 
£ E. Lilly & Co. Ltd., Basingstoke 
** May and Baker Ltd., Dagenham, Essex
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